Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
Clin Infect Dis
    November 2021
  1. GILNER J, Kansal N, Biggio JR, Delaney S, et al
    Universal SARS-CoV-2 testing for obstetric inpatient units across the United States.
    Clin Infect Dis. 2021 Nov 17. pii: 6430425. doi: 10.1093.
    >> Share

  2. MADELON N, Lauper K, Breville G, Sabater Royo I, et al
    Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.
    Clin Infect Dis. 2021 Nov 17. pii: 6430423. doi: 10.1093.
    >> Share

  3. TEN DOESSCHATE T, Kuiper S, van Nieuwkoop C, Hassing RJ, et al
    Fosfomycin versus ciprofloxacin as oral stepdown treatment for Escherichia coli febrile urinary tract infection in women: a randomised, placebo-controlled, double blind, multicenter trial.
    Clin Infect Dis. 2021 Nov 16. pii: 6429720. doi: 10.1093.
    >> Share

  4. AKINBAMI LJ, Biggerstaff BJ, Chan PA, McGibbon E, et al
    Reinfection with SARS-CoV-2 among previously infected healthcare personnel and first responders.
    Clin Infect Dis. 2021 Nov 15. pii: 6428613. doi: 10.1093.
    >> Share

  5. LYNCH JB, Davitkov P, Anderson DJ, Bhimraj A, et al
    Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients with Suspected or Known COVID-19.
    Clin Infect Dis. 2021 Nov 15. pii: 6428563. doi: 10.1093.
    >> Share

  6. HARRIS TG, Jaszi E, Lamb MR, Laudari CA, et al
    Effects of the COVID-19 Pandemic on HIV Services: Findings from 11 Sub-Saharan African Countries.
    Clin Infect Dis. 2021 Nov 15. pii: 6428385. doi: 10.1093.
    >> Share

  7. SHEN Z, Xiao Y, Kang L, Ma W, et al
    Corrigendum to: Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021 Nov 13. pii: 6427503. doi: 10.1093.
    >> Share

  8. LI ZJ, Yu LJ, Zhang HY, Shan CX, et al
    Broad impacts of COVID-19 pandemic on acute respiratory infections in China: an observational study.
    Clin Infect Dis. 2021 Nov 12. pii: 6426178. doi: 10.1093.
    >> Share

  9. BEAN DJ, Monroe J, Turcinovic J, Moreau Y, et al
    SARS-CoV-2 reinfection associates with unstable housing and occurs in the presence of antibodies.
    Clin Infect Dis. 2021 Nov 10. pii: 6424810. doi: 10.1093.
    >> Share

  10. VIHTA KD, Pouwels KB, Peto T, Pritchard E, et al
    Symptoms and SARS-CoV-2 positivity in the general population in the UK.
    Clin Infect Dis. 2021 Nov 8. pii: 6423489. doi: 10.1093.
    >> Share

  11. LIEN CE, Kuo TY, Lin YJ, Lian WC, et al
    Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
    Clin Infect Dis. 2021 Nov 5. pii: 6421519. doi: 10.1093.
    >> Share

  12. PEREZ Y, Levy ER, Joshi AY, Virk A, et al
    Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination.
    Clin Infect Dis. 2021 Nov 3. pii: 6420408. doi: 10.1093.
    >> Share

  13. GRENINGER AL, Dien Bard J, Colgrove RC, Graf EH, et al
    Clinical and Infection Prevention Applications of SARS-CoV-2 Genotyping: An IDSA/ASM Consensus Review Document.
    Clin Infect Dis. 2021 Nov 3. pii: 6420112. doi: 10.1093.
    >> Share

  14. SHERMAN AC, Desjardins M, Cheng CA, Bausk B, et al
    SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
    Clin Infect Dis. 2021 Nov 2. pii: 6415965. doi: 10.1093.
    >> Share

  15. BOSCH W, Cowart JB, Bhakta S, Carter RE, et al
    COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021.
    Clin Infect Dis. 2021 Nov 2. pii: 6415962. doi: 10.1093.
    >> Share

  16. LIU K, Ai S, Song S, Zhu G, et al
    Corrigendum to: Population Movement, City Closure in Wuhan, and Geographical Expansion of the COVID-19 Infection in China in January 2020.
    Clin Infect Dis. 2021 Nov 1. pii: 6414998. doi: 10.1093.
    >> Share

    October 2021
  17. CONWAY MORRIS A, Sharrocks K, Bousfield R, Kermack L, et al
    The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units.
    Clin Infect Dis. 2021 Oct 30. pii: 6414657. doi: 10.1093.
    >> Share

  18. DOUGAN M, Azizad M, Mocherla B, Gottlieb RL, et al
    A randomized, placebo-controlled clinical trial of bamlanivimab and etesevimab together in high-risk ambulatory patients with COVID-19 and validation of the prognostic value of persistently high viral load.
    Clin Infect Dis. 2021 Oct 28. pii: 6413724. doi: 10.1093.
    >> Share

  19. LEDNICKY JA, Tagliamonte MS, White SK, Blohm GM, et al
    Isolation of a Novel Recombinant Canine Coronavirus from a Visitor to Haiti: Further Evidence of Transmission of Coronaviruses of Zoonotic Origin to Humans.
    Clin Infect Dis. 2021 Oct 28. pii: 6413759. doi: 10.1093.
    >> Share

  20. YANG B, Tsang TK, Gao H, Lau EHY, et al
    Universal community nucleic acid testing for COVID-19 in Hong Kong reveals insights into transmission dynamics: a cross-sectional and modelling study.
    Clin Infect Dis. 2021 Oct 28. pii: 6413763. doi: 10.1093.
    >> Share

  21. HORITA N, Kato H, Watanabe K, Hara Y, et al
    Declined mortality due to seasonal influenza in Japan during the coronavirus disease 2019 pandemic.
    Clin Infect Dis. 2021 Oct 28. pii: 6413653. doi: 10.1093.
    >> Share

  22. WILLIAMS LR, Ferguson NM, Donnelly CA, Grassly NC, et al
    Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates.
    Clin Infect Dis. 2021 Oct 26. pii: 6410688. doi: 10.1093.
    >> Share

  23. MUHSEN K, Maimon N, Mizrahi A, Bodenneimer O, et al
    Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.
    Clin Infect Dis. 2021 Oct 26. pii: 6410737. doi: 10.1093.
    >> Share

  24. DE CASTILHOS J, Zamir E, Hippchen T, Rohrbach R, et al
    Severe dysbiosis and specific Haemophilus and Neisseria signatures as hallmarks of the oropharyngeal microbiome in critically ill COVID-19 patients.
    Clin Infect Dis. 2021 Oct 25. pii: 6409876. doi: 10.1093.
    >> Share

  25. WOLDEMESKEL BA, Garliss CC, Blankson JN
    mRNA Vaccine-Elicited SARS-CoV-2-Specific T cells Persist at 6 Months and Recognize the Delta Variant.
    Clin Infect Dis. 2021 Oct 25. pii: 6409907. doi: 10.1093.
    >> Share

  26. WALDMAN SE, Buehring T, Escobar DJ, Gohil SK, et al
    Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare.
    Clin Infect Dis. 2021 Oct 25. pii: 6409806. doi: 10.1093.
    >> Share

  27. BHIMRAJ A, Morgan RL, Shumaker AH, Lavergne V, et al
    Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords.
    Clin Infect Dis. 2021 Oct 20. pii: 6398590. doi: 10.1093.
    >> Share

  28. BHIMRAJ A, Morgan RL, Shumaker AH, Baden L, et al
    Lessons learned from COVID-19 therapies: Critical perspectives from the IDSA COVID-19 treatment guideline panel.
    Clin Infect Dis. 2021 Oct 20. pii: 6398589. doi: 10.1093.
    >> Share

  29. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Severity, criticality, and fatality of the SARS-CoV-2 Beta variant.
    Clin Infect Dis. 2021 Oct 17. pii: 6398699. doi: 10.1093.
    >> Share

  30. BROSSEAU LM, Escandon K, Ulrich AK, Rasmussen AL, et al
    SARS-CoV-2 Dose, Infection, and Disease Outcomes for COVID-19 - A Review.
    Clin Infect Dis. 2021 Oct 15. pii: 6397523. doi: 10.1093.
    >> Share

  31. ROBILOTTI EV, Whiting K, Lucca A, Poon C, et al
    Clinical and Genomic Characterization of SARS CoV-2 infections in mRNA Vaccinated Health Care Personnel in New York City.
    Clin Infect Dis. 2021 Oct 13. pii: 6396142. doi: 10.1093.
    >> Share

  32. PELUSO MJ, Thomas IJ, Munter SE, Deeks SG, et al
    Lack of Antinuclear Antibodies in Convalescent COVID-19 Patients with Persistent Symptoms.
    Clin Infect Dis. 2021 Oct 7. pii: 6383256. doi: 10.1093.
    >> Share

  33. ZHANG J, Lin H, Ye B, Zhao M, et al
    One-year sustained cellular and humoral immunities of COVID-19 convalescents.
    Clin Infect Dis. 2021 Oct 5. pii: 6381561. doi: 10.1093.
    >> Share

  34. KLOMPAS M, Ye S, Vaidya V, Ochoa A, et al
    Association between Airborne Infection Isolation Room Utilization Rates and Healthcare Worker COVID-19 Infections in Two Academic Hospitals.
    Clin Infect Dis. 2021 Oct 2. pii: 6380290. doi: 10.1093.
    >> Share

  35. BAILLY B, Pere H, Veyer D, Berceanu A, et al
    Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2-specific monoclonal antibodies.
    Clin Infect Dis. 2021 Oct 1. pii: 6379055. doi: 10.1093.
    >> Share

  36. MOZAFFARI E, Chandak A, Zhang Z, Liang S, et al
    Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort.
    Clin Infect Dis. 2021 Oct 1. pii: 6378778. doi: 10.1093.
    >> Share

  37. ZHU N, Rawson TM, Mookerjee S, Price JR, et al
    Changing patterns of bloodstream infections in the community and acute care across two COVID-19 epidemic waves: a retrospective analysis using data linkage.
    Clin Infect Dis. 2021 Oct 1. pii: 6378783. doi: 10.1093.
    >> Share

    September 2021
  38. JAAFAR R, Aherfi S, Wurtz N, Grimaldier C, et al
    Corrigendum to: Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates.
    Clin Infect Dis. 2021 Sep 29. pii: 6377803. doi: 10.1093.
    >> Share

  39. FORD N, Vitoria M, Doherty M
    WHO guidance to support HIV care models during the Covid-19 era.
    Clin Infect Dis. 2021 Sep 24. pii: 6374892. doi: 10.1093.
    >> Share

  40. STAUFT CB, Tegenge M, Khurana S, Lee Y, et al
    Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters.
    Clin Infect Dis. 2021 Sep 23. pii: 6374486. doi: 10.1093.
    >> Share

  41. LESIEUR E, Torrents J, Fina F, Zandotti C, et al
    Congenital infection of SARS-CoV-2 with intrauterine foetal death: a clinicopathological study with molecular analysis.
    Clin Infect Dis. 2021 Sep 23. pii: 6374309. doi: 10.1093.
    >> Share

  42. ZHU F, Jin P, Zhu T, Wang W, et al
    Safety and immunogenicity of a recombinant adenovirus type-5-vectored COVID-19 vaccine with a homologous prime-boost regimen in healthy participants aged 6 years and above: a randomised, double-blind, placebo-controlled, phase 2b trial.
    Clin Infect Dis. 2021 Sep 22. pii: 6374123. doi: 10.1093.
    >> Share

  43. FRALEY E, LeMaster C, Khanal S, Banerjee D, et al
    Prior infection and age impacts antibody persistence after SARS-CoV-2 mRNA vaccine.
    Clin Infect Dis. 2021 Sep 22. pii: 6373987. doi: 10.1093.
    >> Share

  44. HASAN ALI O, Bomze D, Risch L, Brugger SD, et al
    Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
    Clin Infect Dis. 2021 Sep 22. pii: 6373914. doi: 10.1093.
    >> Share

  45. HU M, Wang J, Lin H, Ruktanonchai CW, et al
    Risk of SARS-CoV-2 Transmission among Air Passengers in China.
    Clin Infect Dis. 2021 Sep 21. pii: 6373518. doi: 10.1093.
    >> Share

  46. CHAUHAN L, Pattee J, Ford J, Thomas C, et al
    A Multi-center, Prospective, Observational-cohort controlled study of Clinical Outcomes following COVID-19 Convalescent plasma therapy in hospitalized COVID-19 patients.
    Clin Infect Dis. 2021 Sep 21. pii: 6373512. doi: 10.1093.
    >> Share

  47. WHITTAKER C, Watson OJ, Alvarez-Moreno C, Angkasekwinai N, et al
    Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis.
    Clin Infect Dis. 2021 Sep 21. pii: 6373521. doi: 10.1093.
    >> Share

  48. BUENO SM, Abarca K, Gonzalez PA, Galvez NMS, et al
    Safety and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in a Subgroup of Healthy Adults in Chile.
    Clin Infect Dis. 2021 Sep 19. pii: 6372423. doi: 10.1093.
    >> Share

  49. CHAN JF, Poon VK, Chan CC, Chik KK, et al
    Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters.
    Clin Infect Dis. 2021 Sep 18. pii: 6372264. doi: 10.1093.
    >> Share

  50. MAN NIU M, Cao Y, Li RX, Fan GZ, et al
    Outcome heterogeneity in COVID-19 patients receiving tocilizumab.
    Clin Infect Dis. 2021 Sep 17. pii: 6371851. doi: 10.1093.
    >> Share

  51. MOON RC, Mackey RH, Cao Z, Emont S, et al
    Is COVID-19 Less Deadly Now? -- Trends of In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States.
    Clin Infect Dis. 2021 Sep 17. pii: 6371824. doi: 10.1093.
    >> Share

  52. ANANWORANICH J, Mogg R, Dunne MW, Bassyouni M, et al
    Randomized study of rivaroxaban vs. placebo on disease progression and symptoms resolution in high-risk adults with mild COVID-19.
    Clin Infect Dis. 2021 Sep 15. pii: 6370549. doi: 10.1093.
    >> Share

  53. STRUTNER J, Ramchandar N, Dubey S, Gamboa M, et al
    Comparison of RT-PCR Cycle Threshold Values from Respiratory Specimens in Symptomatic and Asymptomatic Children with SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Sep 15. pii: 6370557. doi: 10.1093.
    >> Share

  54. PECHTER E, Lessin N, Brosseau L
    Schools and Coronavirus Disease 2019 Prevention.
    Clin Infect Dis. 2021;73:e1403-e1404.
    >> Share

  55. ADENAIYE OO, Lai J, de Mesquita PJB, Hong F, et al
    Infectious SARS-CoV-2 in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection.
    Clin Infect Dis. 2021 Sep 14. pii: 6370149. doi: 10.1093.
    >> Share

  56. PAMPA-ESPINOZA L, Silva-Valencia J, Fernandez M, Padilla-Rojas C, et al
    Reinfections are more frequent than currently considered in countries with high incidence of COVID-19 cases due to stringent definitions.
    Clin Infect Dis. 2021 Sep 11. pii: 6368494. doi: 10.1093.
    >> Share

  57. BAROCAS JA, Savinkina A, Lodi S, Epstein RL, et al
    Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study.
    Clin Infect Dis. 2021 Sep 9. pii: 6367757. doi: 10.1093.
    >> Share

  58. TO KK, Li X, Lung DC, Ip JD, et al
    False COVID-19 cases due to contamination by inactivated virus vaccine.
    Clin Infect Dis. 2021 Sep 9. pii: 6367446. doi: 10.1093.
    >> Share

  59. LEE M
    Lack of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Antibodies to Seasonal Coronaviruses: Making Sense of the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2021;73:e1212-e1213.
    >> Share

  60. KULKARNI O, Narreddy S, Zaveri L, Kalal IG, et al
    Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection Without Mutations in the Spike Protein.
    Clin Infect Dis. 2021;73:e1239-e1241.
    >> Share

  61. GUARALDI G, Milic J, Martinez E, Kamarulzaman A, et al
    Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era.
    Clin Infect Dis. 2021;73:e1222-e1227.
    >> Share

  62. GRINT DJ, Wing K, Houlihan C, Gibbs HP, et al
    Severity of SARS-CoV-2 alpha variant (B.1.1.7) in England.
    Clin Infect Dis. 2021 Sep 6. pii: 6365124. doi: 10.1093.
    >> Share

  63. WYNBERG E, van Willigen HDG, Dijkstra M, Boyd A, et al
    Evolution of COVID-19 symptoms during the first 12 months after illness onset.
    Clin Infect Dis. 2021 Sep 2. pii: 6362727. doi: 10.1093.
    >> Share

  64. FEDER KA, Patel A, Vepachedu VR, Dominguez C, et al
    Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021.
    Clin Infect Dis. 2021 Sep 2. pii: 6362726. doi: 10.1093.
    >> Share

  65. SNYMAN J, Hwa SH, Krause R, Muema D, et al
    Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave.
    Clin Infect Dis. 2021 Sep 2. pii: 6362722. doi: 10.1093.
    >> Share

  66. TAGLIAMONTE MS, Mavian C, Zainabadi K, Cash MN, et al
    Rapid emergence and spread of SARS-CoV-2 gamma (P.1) variant in Haiti.
    Clin Infect Dis. 2021 Sep 2. pii: 6359631. doi: 10.1093.
    >> Share

  67. STRICH JR, Tian X, Samour M, King CS, et al
    Fostamatinib for the treatment of hospitalized adults with COVD-19 A randomized trial.
    Clin Infect Dis. 2021 Sep 1. pii: 6358811. doi: 10.1093.
    >> Share

  68. SHAW J, Hanley S, Stewart T, Salmon DA, et al
    Health Care Personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization.
    Clin Infect Dis. 2021 Sep 1. pii: 6357694. doi: 10.1093.
    >> Share

    August 2021
  69. MARTINEZ DA, Klein EY, Parent C, Prieto D, et al
    Latino Household Transmission of SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 31. pii: 6360016. doi: 10.1093.
    >> Share

  70. CARAZO S, Talbot D, Boulianne N, Brisson M, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada.
    Clin Infect Dis. 2021 Aug 30. pii: 6359881. doi: 10.1093.
    >> Share

  71. XIN H, Li Y, Wu P, Li Z, et al
    Estimating the latent period of coronavirus disease 2019 (COVID-19).
    Clin Infect Dis. 2021 Aug 28. pii: 6359063. doi: 10.1093.
    >> Share

  72. KNOWLTON KU
    Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
    Clin Infect Dis. 2021 Aug 28. pii: 6359059. doi: 10.1093.
    >> Share

  73. GOTTLIEB L, Fridkin SK
    It's hard to measure success while caring for surges in COVID-19 hospitalizations.
    Clin Infect Dis. 2021 Aug 28. pii: 6359066. doi: 10.1093.
    >> Share

  74. MACK CD, Tai C, Sikka R, Grad YH, et al
    SARS-CoV-2 Reinfection: A Case Series from a 12-Month Longitudinal Occupational Cohort.
    Clin Infect Dis. 2021 Aug 28. pii: 6359055. doi: 10.1093.
    >> Share

  75. ONG SWX, Chiew CJ, Ang LW, Mak TM, et al
    Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta).
    Clin Infect Dis. 2021 Aug 23. pii: 6356459. doi: 10.1093.
    >> Share

  76. NARAYANAN S, Chua JV, Baddley JW
    COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease.
    Clin Infect Dis. 2021 Aug 22. pii: 6356215. doi: 10.1093.
    >> Share

  77. WONG CKH, Lau KTK, Au ICH, Xiong X, et al
    Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered with dexamethasone.
    Clin Infect Dis. 2021 Aug 22. pii: 6356217. doi: 10.1093.
    >> Share

  78. PETTI S
    Undetected and relatively sustained SARS-CoV-2 circulation worldwide during the year 2019.
    Clin Infect Dis. 2021 Aug 22. pii: 6356216. doi: 10.1093.
    >> Share

  79. MARR LC, Tang JW
    A Paradigm Shift to Align Transmission Routes with Mechanisms.
    Clin Infect Dis. 2021 Aug 20. pii: 6355601. doi: 10.1093.
    >> Share

  80. MAIER HE, Kuan G, Saborio S, Bustos Carrillo FA, et al
    Clinical spectrum of SARS-CoV-2 infection and protection from symptomatic re-infection.
    Clin Infect Dis. 2021 Aug 19. pii: 6354980. doi: 10.1093.
    >> Share

  81. BALTAS I, Boshier FAT, Williams CA, Bayzid N, et al
    Post-vaccination COVID-19: A case-control study and genomic analysis of 119 breakthrough infections in partially vaccinated individuals.
    Clin Infect Dis. 2021 Aug 19. pii: 6354928. doi: 10.1093.
    >> Share

  82. DUNAY MA, McClain SL, Holloway RL, Norris SLW, et al
    Pre-Hospital Administration of Remdesivir during a SARS-CoV-2 Outbreak in a Skilled Nursing Facility.
    Clin Infect Dis. 2021 Aug 19. pii: 6354937. doi: 10.1093.
    >> Share

  83. DAWOOD FS, Varner M, Tita A, Newes-Adeyi G, et al
    Incidence, Clinical Characteristics, and Risk Factors of SARS-CoV-2 Infection among Pregnant Individuals in the United States.
    Clin Infect Dis. 2021 Aug 19. pii: 6354856. doi: 10.1093.
    >> Share

  84. FINTZI J, Bonnett T, Sweeney DA, Huprikar NA, et al
    Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization.
    Clin Infect Dis. 2021 Aug 19. pii: 6354746. doi: 10.1093.
    >> Share

  85. DIAZ GA, Christensen AB, Pusch T, Goulet D, et al
    Remdesivir and Mortality in Patients with COVID-19.
    Clin Infect Dis. 2021 Aug 19. pii: 6352176. doi: 10.1093.
    >> Share

  86. LI C, Chen Y, Zhao Y, Lung DC, et al
    Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model.
    Clin Infect Dis. 2021 Aug 18. pii: 6353927. doi: 10.1093.
    >> Share

  87. LIU T, Wu D, Yan W, Wang X, et al
    Twelve-month systemic consequences of COVID-19 in patients discharged from hospital: a prospective cohort study in Wuhan, China.
    Clin Infect Dis. 2021 Aug 14. pii: 6352408. doi: 10.1093.
    >> Share

  88. DIMEGLIO C, Herin F, Da-Silva I, Jougla I, et al
    Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 12. pii: 6349304. doi: 10.1093.
    >> Share

  89. CERAMI C, Popkin-Hall ZR, Rapp T, Tompkins K, et al
    Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color.
    Clin Infect Dis. 2021 Aug 12. pii: 6349288. doi: 10.1093.
    >> Share

  90. CALDERON-PARRA J, Munez-Rubio E, Fernandez-Cruz A, Garcia Sanchez MC, et al
    Incidence, clinical presentation, relapses and outcome of SARS-CoV-2 infection in patients treated with anti-CD20 monoclonal antibodies.
    Clin Infect Dis. 2021 Aug 12. pii: 6348942. doi: 10.1093.
    >> Share

  91. PAULES CI, Gallagher SK, Rapaka RR, Davey RT, et al
    Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.
    Clin Infect Dis. 2021 Aug 11. pii: 6348134. doi: 10.1093.
    >> Share

  92. JACOBS JL, Bain W, Naqvi A, Staines B, et al
    SARS-CoV-2 Viremia is Associated with COVID-19 Severity and Predicts Clinical Outcomes.
    Clin Infect Dis. 2021 Aug 10. pii: 6347519. doi: 10.1093.
    >> Share

  93. CLIPMAN SJ, Wesolowski A, Mehta SH, Cobey S, et al
    Improvements in SARS-CoV-2 Testing Cascade in the US: Data from Serial Cross-sectional Assessments.
    Clin Infect Dis. 2021 Aug 10. pii: 6347429. doi: 10.1093.
    >> Share

  94. BAKER MA, Sands KE, Huang SS, Kleinman K, et al
    The Impact of COVID-19 on Healthcare-Associated Infections.
    Clin Infect Dis. 2021 Aug 9. pii: 6346721. doi: 10.1093.
    >> Share

  95. NORTH CM, Barczak A, Goldstein RH, Healy BC, et al
    Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines: A Prospective Cohort Study of Healthcare Workers before, during and after Vaccination [DISCOVER-COVID-19].
    Clin Infect Dis. 2021 Aug 7. pii: 6345339. doi: 10.1093.
    >> Share

  96. TENFORDE MW, Patel MM, Ginde AA, Douin DJ, et al
    Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
    Clin Infect Dis. 2021 Aug 6. pii: 6343399. doi: 10.1093.
    >> Share

  97. BANNO M, Tsujimoto Y, Ishikane M
    Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for the treatment of coronavirus disease.
    Clin Infect Dis. 2021 Aug 6. pii: 6343415. doi: 10.1093.
    >> Share

  98. COLEMAN KK, Tay DJW, Sen Tan K, Ong SWX, et al
    Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing.
    Clin Infect Dis. 2021 Aug 6. pii: 6343417. doi: 10.1093.
    >> Share

  99. PADHI S, Pati A, Panda AK
    Effect of ivermectin in the treatment of COVID-19: A trial sequential analysis highlighted the requirement of additional randomized controlled trials.
    Clin Infect Dis. 2021 Aug 6. pii: 6343157. doi: 10.1093.
    >> Share

  100. LAWANDI A, Warner S, Sun J, Demirkale CY, et al
    Suspected SARS-CoV-2 Reinfections: Incidence, Predictors, and Healthcare Use among Patients at 238 U.S. Healthcare Facilities, June 1, 2020- February 28, 2021.
    Clin Infect Dis. 2021 Aug 5. pii: 6342166. doi: 10.1093.
    >> Share

  101. BIGGERSTAFF M, Slayton RB, Johansson MA, Butler JC, et al
    Improving Pandemic Response: Employing Mathematical Modeling to Confront COVID-19.
    Clin Infect Dis. 2021 Aug 3. pii: 6338173. doi: 10.1093.
    >> Share

  102. FOURATI S, Bailly B, Le Bouter A, Guilpain L, et al
    Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (beta) in an elderly nursing home.
    Clin Infect Dis. 2021 Aug 3. pii: 6338175. doi: 10.1093.
    >> Share

  103. XIANG F, Sun J, Chen PH, Han P, et al
    Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021;73:e594-e601.
    >> Share

  104. LI P, Ikram A, Peppelenbosch MP, Ma Z, et al
    Systematically Mapping Clinical Features of Infections With Classical Endemic Human Coronaviruses.
    Clin Infect Dis. 2021;73:554-555.
    >> Share

  105. CASADEVALL A, Joyner MJ, Pirofski LA
    Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
    Clin Infect Dis. 2021;73:e540-e542.
    >> Share

  106. GIL E, Martyn E, Rokadiya S, Jain S, et al
    Bacterial Coinfection in COVID-19.
    Clin Infect Dis. 2021;73:e843-e845.
    >> Share

    July 2021
  107. CHOW K, Aslam A, McClure T, Singh J, et al
    Risk of Healthcare-Associated Transmission of SARS-CoV-2 in Hospitalized Cancer Patients.
    Clin Infect Dis. 2021 Jul 30. pii: 6331919. doi: 10.1093.
    >> Share

  108. MACCANNELL T, Batson J, Bonin B, Kc A, et al
    Genomic epidemiology and transmission dynamics of SARS-CoV-2 in congregate healthcare facilities in Santa Clara County, California.
    Clin Infect Dis. 2021 Jul 30. pii: 6330915. doi: 10.1093.
    >> Share

  109. SCHOOLEY RT
    Introduction to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Supplement.
    Clin Infect Dis. 2021;73.
    >> Share

  110. TSUBOI M, Hachiya M, Ohtsu H, Akashi H, et al
    Epidemiology and risk of COVID-19 among travelers at airport and port quarantine stations across Japan: a nationwide descriptive analysis and an individually matched case-control study.
    Clin Infect Dis. 2021 Jul 28. pii: 6329456. doi: 10.1093.
    >> Share

  111. HERSTEIN JJ, Lowe JJ, Wolf T, Vasoo S, et al
    Leveraging a preexisting global infectious disease network for local decision-making during a pandemic.
    Clin Infect Dis. 2021 Jul 28. pii: 6329401. doi: 10.1093.
    >> Share

  112. CHEN LL, Lu L, Choi CY, Cai JP, et al
    Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.
    Clin Infect Dis. 2021 Jul 26. pii: 6328361. doi: 10.1093.
    >> Share

  113. CORVOL H, Alimi A, Prevost B, Schnuriger A, et al
    Atypical severe organizing pneumonia following COVID-19 in an immunocompromised teenager.
    Clin Infect Dis. 2021 Jul 26. pii: 6328309. doi: 10.1093.
    >> Share

  114. CHEN X, Chen Z, Azman AS, Sun R, et al
    Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis.
    Clin Infect Dis. 2021 Jul 24. pii: 6327511. doi: 10.1093.
    >> Share

  115. SUHS T, Gerlach D, Garfin J, Lorentz A, et al
    COVID-19 Outbreak Associated with a Fitness Center - Minnesota, September-November 2020.
    Clin Infect Dis. 2021 Jul 23. pii: 6326825. doi: 10.1093.
    >> Share

  116. GHARBHARAN A, GeurtsvanKessel CH, Jordans CCE, Blaauw M, et al
    Effects of treatment of COVID-19 with convalescent plasma in 25 B-cell depleted patients.
    Clin Infect Dis. 2021 Jul 22. pii: 6325623. doi: 10.1093.
    >> Share

  117. WOLDEMESKEL BA, Karaba AH, Garliss CC, Beck EJ, et al
    The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV.
    Clin Infect Dis. 2021 Jul 22. pii: 6325617. doi: 10.1093.
    >> Share

  118. HALBROOK M, Gadoth A, Martin-Blais R, Gray AN, et al
    Longitudinal assessment of COVID-19 vaccine acceptance and uptake among frontline medical workers in Los Angeles, California.
    Clin Infect Dis. 2021 Jul 22. pii: 6325325. doi: 10.1093.
    >> Share

  119. ANDREJKO KL, Pry J, Myers JF, Jewell NP, et al
    Prevention of COVID-19 by mRNA-based vaccines within the general population of California.
    Clin Infect Dis. 2021 Jul 20. pii: 6324500. doi: 10.1093.
    >> Share

  120. MORRIS CP, Luo CH, Amadi A, Schwartz M, et al
    An Update on SARS-CoV-2 Diversity in the United States National Capital Region: Evolution of Novel and Variants of Concern.
    Clin Infect Dis. 2021 Jul 17. pii: 6323262. doi: 10.1093.
    >> Share

  121. ALBHAISI S, Wenzel RP
    The Value of Medical Registries and Observational Studies Early in Pandemics: The COVID-19 Experience.
    Clin Infect Dis. 2021 Jul 16. pii: 6322561. doi: 10.1093.
    >> Share

  122. TRAM KH, Saeed S, Bradley C, Fox B, et al
    Deliberation, Dissent, and Distrust: Understanding distinct drivers of COVID-19 vaccine hesitancy in the United States.
    Clin Infect Dis. 2021 Jul 16. pii: 6323151. doi: 10.1093.
    >> Share

  123. GOSWAMI ND, Fiore AE, Walke HT
    Evidence, Experience, Expertise, and the US Coronavirus Disease 2019 Public Health Response.
    Clin Infect Dis. 2021;73.
    >> Share

  124. MCCARTY T
    Candidemia and Severe COVID-19 - Which Risk Factors are Modifiable?
    Clin Infect Dis. 2021 Jul 15. pii: 6322064. doi: 10.1093.
    >> Share

  125. WONG CKH, Lau KTK, Au ICH, Xiong X, et al
    Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19.
    Clin Infect Dis. 2021 Jul 15. pii: 6321803. doi: 10.1093.
    >> Share

  126. LIN DY, Gu Y, Zeng D, Janes HE, et al
    Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Jul 14. pii: 6321290. doi: 10.1093.
    >> Share

  127. DAS ADHIKARI U, Eng G, Farcasanu M, Avena LE, et al
    Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival.
    Clin Infect Dis. 2021 Jul 10. pii: 6318824. doi: 10.1093.
    >> Share

  128. TORRES JR
    Sequential Dengue and Covid-19. A case of viral Dr. Jekyll or Mr. Hyde?
    Clin Infect Dis. 2021 Jul 10. pii: 6318742. doi: 10.1093.
    >> Share

  129. SULLIVAN PS, Siegler AJ, Shioda K, Hall EW, et al
    SARS-CoV-2 cumulative incidence, United States, August-December 2020.
    Clin Infect Dis. 2021 Jul 10. pii: 6318822. doi: 10.1093.
    >> Share

  130. SKOWRONSKI DM, Setayeshgar S, Zou M, Prystajecky N, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada.
    Clin Infect Dis. 2021 Jul 9. pii: 6318435. doi: 10.1093.
    >> Share

  131. WILLIAMS C, Al-Bargash D, Macalintal C, Stuart R, et al
    COVID-19 Outbreak Associated with a SARS-CoV-2 P.1 Lineage in a Long-Term Care Home after Implementation of a Vaccination Program - Ontario, April-May 2021.
    Clin Infect Dis. 2021 Jul 8. pii: 6317716. doi: 10.1093.
    >> Share

  132. SEESSLE J, Waterboer T, Hippchen T, Simon J, et al
    Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.
    Clin Infect Dis. 2021 Jul 5. pii: 6315216. doi: 10.1093.
    >> Share

  133. GRANDJEAN L, Saso A, Ortiz AT, Lam T, et al
    Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.
    Clin Infect Dis. 2021 Jul 4. pii: 6314536. doi: 10.1093.
    >> Share

  134. LUMLEY SF, Rodger G, Constantinides B, Sanderson N, et al
    An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.
    Clin Infect Dis. 2021 Jul 3. pii: 6314286. doi: 10.1093.
    >> Share

  135. BERBENYUK A, Bobkova P, Bordyugov S, Borisenko A, et al
    Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.
    Clin Infect Dis. 2021;73:174.
    >> Share

  136. ROTHENBERG R
    Death and the Virus.
    Clin Infect Dis. 2021;73:e86-e87.
    >> Share

    June 2021
  137. DARCIS G, Meuris C, Kremer C, Faes C, et al
    The risk of underestimating the contribution of children to SARS-CoV-2 pandemic.
    Clin Infect Dis. 2021 Jun 30. pii: 6311795. doi: 10.1093.
    >> Share

  138. SAGARA I, Woodford J, Kone M, Assadou MH, et al
    Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study.
    Clin Infect Dis. 2021 Jun 29. pii: 6311302. doi: 10.1093.
    >> Share

  139. ROMAN YM, Burela PA, Pasupuleti V, Piscoya A, et al
    Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.
    Clin Infect Dis. 2021 Jun 28. pii: 6310839. doi: 10.1093.
    >> Share

  140. WALKER A, Houwaart T, Finzer P, Ehlkes L, et al
    Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.
    Clin Infect Dis. 2021 Jun 28. pii: 6310838. doi: 10.1093.
    >> Share

  141. COLEBUNDERS R, Kenyon C
    Extensive SARS-CoV-2 transmission associated with low mortality in Kinshasa, Democratic Republic of Congo. For how long?
    Clin Infect Dis. 2021 Jun 28. pii: 6310791. doi: 10.1093.
    >> Share

  142. VERDERESE JP, Stepanova M, Lam B, Racila A, et al
    Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.
    Clin Infect Dis. 2021 Jun 24. pii: 6309036. doi: 10.1093.
    >> Share

  143. MAZZOLA A, Todesco E, Drouin S, Hazan F, et al
    Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.
    Clin Infect Dis. 2021 Jun 24. pii: 6309017. doi: 10.1093.
    >> Share

  144. MCEWEN AE, Cohen S, Bryson-Cahn C, Liu C, et al
    Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.
    Clin Infect Dis. 2021 Jun 24. pii: 6309019. doi: 10.1093.
    >> Share

  145. HANSON KE, Altayar O, Caliendo AM, Arias CA, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing.
    Clin Infect Dis. 2021 Jun 23. pii: 6308396. doi: 10.1093.
    >> Share

  146. ANTONIO-VILLA NE, Fernandez-Chirino L, Pisanty-Alatorre J, Mancilla-Galindo J, et al
    Comprehensive evaluation of the impact of sociodemographic inequalities on adverse outcomes and excess mortality during the COVID-19 pandemic in Mexico City.
    Clin Infect Dis. 2021 Jun 22. pii: 6308070. doi: 10.1093.
    >> Share

  147. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine.
    Clin Infect Dis. 2021 Jun 22. pii: 6307902. doi: 10.1093.
    >> Share

  148. LODI L, Moriondo M, Pucci A, Pisano L, et al
    Chronic asymptomatic SARS-CoV-2 infection in the immunocompromised patient: new challenges and urgent needs.
    Clin Infect Dis. 2021 Jun 22. pii: 6307947. doi: 10.1093.
    >> Share

  149. BUONSENSO D, Valentini P
    Children and SARS-CoV-2 transmission: a step closer to better understanding and evidence-based interventions?
    Clin Infect Dis. 2021 Jun 18. pii: 6305136. doi: 10.1093.
    >> Share

  150. SEAGLE EE, Jackson BR, Lockhart SR, Georgacopoulos O, et al
    The landscape of candidemia during the COVID-19 pandemic.
    Clin Infect Dis. 2021 Jun 18. pii: 6305138. doi: 10.1093.
    >> Share

  151. KARAN A, Klompas M, Tucker R, Baker M, et al
    The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center.
    Clin Infect Dis. 2021 Jun 18. pii: 6305137. doi: 10.1093.
    >> Share

  152. JACOBSON KB, Pinsky BA, Montez Rath ME, Wang H, et al
    Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center.
    Clin Infect Dis. 2021 Jun 17. pii: 6303032. doi: 10.1093.
    >> Share

  153. MANICA M, Pancheri S, Poletti P, Giovanazzi G, et al
    The risk of symptomatic infection during a second COVID-19 wave, in SARS-CoV-2 seropositive individuals.
    Clin Infect Dis. 2021 Jun 16. pii: 6301134. doi: 10.1093.
    >> Share

  154. STANKOV MV, Cossmann A, Bonifacius A, Dopfer-Jablonka A, et al
    Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.
    Clin Infect Dis. 2021 Jun 16. pii: 6301133. doi: 10.1093.
    >> Share

  155. ALTHOFF KN, Schlueter DJ, Anton-Culver H, Cherry J, et al
    Antibodies to SARS-CoV-2 in All of Us Research Program Participants, January 2-March 18, 2020.
    Clin Infect Dis. 2021 Jun 15. pii: 6294073. doi: 10.1093.
    >> Share

  156. MALGIE J, Schoones JW, Pijls BG
    Reply to Tleyjeh.
    Clin Infect Dis. 2021;72:e1155-e1156.
    >> Share

  157. WANG M, Hu K
    Reply to DeVito.
    Clin Infect Dis. 2021;72:e1165-e1166.
    >> Share

  158. DEVITO NJ
    Concerning Trials Registration.
    Clin Infect Dis. 2021;72:e1164-e1165.
    >> Share

  159. MUNBLIT D, Nekliudov NA, Bugaeva P, Blyuss O, et al
    Reply to Russo et al.
    Clin Infect Dis. 2021;72:e1159-e1160.
    >> Share

  160. MALGIE J, Schoones JW, Pijls BG
    Reply to Huang et al.
    Clin Infect Dis. 2021;72:e1157-e1158.
    >> Share

  161. GU S, Lv L, Wu Z, Li L, et al
    Reply to Klann et al.
    Clin Infect Dis. 2021;72:2248-2249.
    >> Share

  162. GU S, Chen Y, Lv L, Li L, et al
    Reply to Marcialis et al.
    Clin Infect Dis. 2021;72:2246-2247.
    >> Share

  163. POLLETT SD, Richard SA, Fries AC, Simons MP, et al
    The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity.
    Clin Infect Dis. 2021 Jun 12. pii: 6297424. doi: 10.1093.
    >> Share

  164. XIN H, Wong JY, Murphy C, Yeung A, et al
    The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.
    Clin Infect Dis. 2021 Jun 12. pii: 6297425. doi: 10.1093.
    >> Share

  165. KLOMPAS M, Rhee C, Baker M
    Universal Use of N95s in Healthcare Settings when Community Covid-19 Rates are High.
    Clin Infect Dis. 2021 Jun 11. pii: 6296401. doi: 10.1093.
    >> Share

  166. BENFIELD T, Bodilsen J, Brieghel C, Harboe ZB, et al
    Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study.
    Clin Infect Dis. 2021 Jun 10. pii: 6296026. doi: 10.1093.
    >> Share

  167. STONE M, Di Germanio C, Wright DJ, Sulaeman H, et al
    Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
    Clin Infect Dis. 2021 Jun 10. pii: 6296028. doi: 10.1093.
    >> Share

  168. ZHANG AW, Morjaria S, Kaltsas A, Hohl TM, et al
    The Effect of Neutropenia and Filgrastim (G-CSF) in Cancer Patients With COVID-19 Infection.
    Clin Infect Dis. 2021 Jun 10. pii: 6296025. doi: 10.1093.
    >> Share

  169. BUCHAN SA, Tibebu S, Daneman N, Whelan M, et al
    Increased household secondary attacks rates with Variant of Concern SARS-CoV-2 index cases.
    Clin Infect Dis. 2021 Jun 9. pii: 6295404. doi: 10.1093.
    >> Share

  170. CRANE MA, Popovic A, Panaparambil R, Stolbach AI, et al
    Reporting of Infectious Diseases in the United States During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 Jun 7. pii: 6294158. doi: 10.1093.
    >> Share

  171. VANKER A, McGeer A, O'Byrne G, Snyder ECR, et al
    Adverse Outcomes Associated with SARS-CoV-2 variant B.1.351 Infection in Vaccinated Residents of a Long Term Care Home, Ontario, Canada.
    Clin Infect Dis. 2021 Jun 6. pii: 6294072. doi: 10.1093.
    >> Share

  172. JENKS JD, Aslam S, Horton LE, Law N, et al
    Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients with COVID-19.
    Clin Infect Dis. 2021 Jun 6. pii: 6294071. doi: 10.1093.
    >> Share

  173. NKUBA AN, Makiala SM, Guichet E, Tshiminyi PM, et al
    High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey.
    Clin Infect Dis. 2021 Jun 5. pii: 6293985. doi: 10.1093.
    >> Share

  174. JACOBSON MA, Zakaria A, Maung Z, Hart C, et al
    Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 SARS-CoV2 Vaccine (Moderna) in a Cohort of Hospital Employees.
    Clin Infect Dis. 2021 Jun 4. pii: 6291929. doi: 10.1093.
    >> Share

  175. LESHO E, Corey B, Lebreton F, Ong AC, et al
    Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.345 in Upstate New York.
    Clin Infect Dis. 2021 Jun 4. pii: 6292251. doi: 10.1093.
    >> Share

  176. KAHN R, Holmdahl I, Reddy S, Jernigan J, et al
    Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes.
    Clin Infect Dis. 2021 Jun 4. pii: 6292250. doi: 10.1093.
    >> Share

  177. YEH HF
    The potential declining efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222) on inoculators with NSAIDs intake.
    Clin Infect Dis. 2021 Jun 3. pii: 6291428. doi: 10.1093.
    >> Share

  178. ROUSSEL Y, Million M, Chabriere E, Lagier JC, et al
    Be Careful With Big Data: Reanalysis of Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 Hospitalized Across the United States.
    Clin Infect Dis. 2021;72:e928.
    >> Share

  179. VAUGHN VM, Flanders SA
    Reply to Stevenson et al.
    Clin Infect Dis. 2021;72:e927.
    >> Share

    May 2021
  180. MAROT S, Malet I, Leducq V, Abdi B, et al
    Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers.
    Clin Infect Dis. 2021 May 29. pii: 6288468. doi: 10.1093.
    >> Share

  181. TALBOT HK, Martin ET, Gaglani M, Middleton DB, et al
    Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators.
    Clin Infect Dis. 2021 May 29. pii: 6288408. doi: 10.1093.
    >> Share

  182. COHEN MS, Wohl DA, Fischer WA, Smith DJ, et al
    Outpatient Treatment of SARS-CoV-2 Infection to Prevent COVID-19 Progression.
    Clin Infect Dis. 2021 May 28. pii: 6287650. doi: 10.1093.
    >> Share

  183. CANTERINO JE, Wang K, Golden M
    Provider Satisfaction with Infectious Diseases Telemedicine Consults for Hospitalized Patients During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 May 28. pii: 6287628. doi: 10.1093.
    >> Share

  184. ZHANG Y, Luo W, Li Q, Wang X, et al
    Risk Factors for Death Among the First 80 543 COVID-19 Cases in China: Relationships Between Age, Underlying Disease, Case Severity, and Region.
    Clin Infect Dis. 2021 May 27. pii: 6287117. doi: 10.1093.
    >> Share

  185. LEIDI A, Koegler F, Dumont R, Dubos R, et al
    Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study.
    Clin Infect Dis. 2021 May 27. pii: 6287116. doi: 10.1093.
    >> Share

  186. MEHRAVARAN S, Ahmed H, Chen YC
    Disparities in COVID-19 outcomes for African Americans: more studies are warranted.
    Clin Infect Dis. 2021 May 26. pii: 6285195. doi: 10.1093.
    >> Share

  187. ALI ST, Yeung A, Shan S, Wang L, et al
    Serial intervals and case isolation delays for COVID-19: a systematic review and meta-analysis.
    Clin Infect Dis. 2021 May 26. pii: 6284329. doi: 10.1093.
    >> Share

  188. KLOPFENSTEIN T, Gerazime A, Puyraveau M, Kadiane-Oussou NJ, et al
    It is time to determine Tocilizumab place in COVID-19.
    Clin Infect Dis. 2021 May 24. pii: 6283696. doi: 10.1093.
    >> Share

  189. GALANG RR, Newton SM, Woodworth KR, Griffin I, et al
    Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection - Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020 -March 5, 2021.
    Clin Infect Dis. 2021 May 22. pii: 6280195. doi: 10.1093.
    >> Share

  190. VERNA EC, Landis C, Brown RS Jr, Mospan AR, et al
    Factors Associated with Readmission in the US Following Hospitalization with COVID-19.
    Clin Infect Dis. 2021 May 20. pii: 6279074. doi: 10.1093.
    >> Share

  191. OGATA AF, Cheng CA, Desjardins M, Senussi Y, et al
    Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.
    Clin Infect Dis. 2021 May 20. pii: 6279075. doi: 10.1093.
    >> Share

  192. KARABA AH, Zhou W, Hsieh LL, Figueroa A, et al
    Differential Cytokine Signatures of SARS-CoV-2 and Influenza Infection Highlight Key Differences in Pathobiology.
    Clin Infect Dis. 2021 May 20. pii: 6278486. doi: 10.1093.
    >> Share

  193. VLASOVA AN, Diaz A, Damtie D, Xiu L, et al
    Novel Canine Coronavirus Isolated from a Hospitalized Pneumonia Patient, East Malaysia.
    Clin Infect Dis. 2021 May 20. pii: 6278597. doi: 10.1093.
    >> Share

  194. HIRSCHTICK JL, Titus AR, Slocum E, Power LE, et al
    Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics.
    Clin Infect Dis. 2021 May 19. pii: 6276644. doi: 10.1093.
    >> Share

  195. FURUKAWA D, Graber CJ
    Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces.
    Clin Infect Dis. 2021;72:e542-e544.
    >> Share

  196. PISCHEL L, Goshua G
    Cost-effectiveness of tocilizumab in severe COVID-19: to see or not to see.
    Clin Infect Dis. 2021 May 17. pii: 6277058. doi: 10.1093.
    >> Share

  197. CHODICK G, Tene L, Rotem RS, Patalon T, et al
    The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data.
    Clin Infect Dis. 2021 May 17. pii: 6276888. doi: 10.1093.
    >> Share

  198. HENSLEY KS, Jordans CCE, van Kampen JJA, Mollema FPN, et al
    Significant impact of COVID-19 on HIV care in hospitals affecting the first pillar of the HIV care continuum.
    Clin Infect Dis. 2021 May 16. pii: 6276393. doi: 10.1093.
    >> Share

  199. BAILLY B, Guilpain L, Bouiller K, Chirouze C, et al
    BNT162b2 mRNA vaccination did not prevent an outbreak of SARS COV-2 variant 501Y.V2 in an elderly nursing home but reduced transmission and disease severity.
    Clin Infect Dis. 2021 May 16. pii: 6276392. doi: 10.1093.
    >> Share

  200. CANADAY DH, Carias L, Oyebanji OA, Keresztesy D, et al
    Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents.
    Clin Infect Dis. 2021 May 16. pii: 6276391. doi: 10.1093.
    >> Share

  201. RENNERT L, McMahan C
    Risk of SARS-CoV-2 reinfection in a university student population.
    Clin Infect Dis. 2021 May 16. pii: 6276528. doi: 10.1093.
    >> Share

  202. HARRIS DA, Sobers M, Greenwald ZR, Simmons AE, et al
    Is 3 feet of physical distancing enough?
    Clin Infect Dis. 2021 May 14. pii: 6275593. doi: 10.1093.
    >> Share

  203. MASSO-SILVA JA, Moshensky A, Lam MTY, Odish M, et al
    Increased peripheral blood neutrophil activation phenotypes and NETosis in critically ill COVID-19 patients: a case series and review of the literature.
    Clin Infect Dis. 2021 May 14. pii: 6275596. doi: 10.1093.
    >> Share

  204. BRANCH-ELLIMAN W, Jack RS, Schechter-Perkins EM, van den Berg P, et al
    Reply to Author.
    Clin Infect Dis. 2021 May 14. pii: 6275594. doi: 10.1093.
    >> Share

  205. LUTGRING JD, Tobolowsky FA, Hatfield KM, Lehnertz NB, et al
    Evaluating the Presence of Replication-Competent SARS-CoV-2 from Nursing Home Residents with Persistently Positive RT-PCR Results.
    Clin Infect Dis. 2021 May 14. pii: 6275595. doi: 10.1093.
    >> Share

  206. GUAGLIARDO SAJ, Prasad PV, Rodriguez A, Fukunaga R, et al
    Cruise ship travel in the era of COVID-19: A summary of outbreaks and a model of public health interventions.
    Clin Infect Dis. 2021 May 12. pii: 6274545. doi: 10.1093.
    >> Share

  207. SAMI S, Tenforde MW, Talbot HK, Lindsell CJ, et al
    Adults Hospitalized with COVID-19 -United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
    Clin Infect Dis. 2021 May 12. pii: 6270754. doi: 10.1093.
    >> Share

  208. FOX MD, Leiszler MS, Seamon MD, Garmin BL, et al
    Results of a Shortened Quarantine Protocol on a Midwestern College Campus.
    Clin Infect Dis. 2021 May 12. pii: 6274299. doi: 10.1093.
    >> Share

  209. KO JY, DeSisto CL, Simeone RM, Ellington S, et al
    Adverse pregnancy outcomes, maternal complications, and severe illness among U.S. delivery hospitalizations with and without a COVID-19 diagnosis.
    Clin Infect Dis. 2021 May 12. pii: 6274300. doi: 10.1093.
    >> Share

  210. MARKS SM, Clara A, Fiebelkorn AP, Le X, et al
    Influenza Vaccination in Health Centers during the COVID-19 Pandemic-United States, November 7-27, 2020.
    Clin Infect Dis. 2021 May 12. pii: 6274304. doi: 10.1093.
    >> Share

  211. MORENO GK, Braun KM, Pray IW, Segaloff HE, et al
    SARS-CoV-2 transmission in intercollegiate athletics not fully mitigated with daily antigen testing.
    Clin Infect Dis. 2021 May 12. pii: 6274297. doi: 10.1093.
    >> Share

  212. IOANNOU GN, O'Hare AM, Berry K, Fan VS, et al
    Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection.
    Clin Infect Dis. 2021 May 11. pii: 6273415. doi: 10.1093.
    >> Share

  213. LEE LYW, Rozmanowski S, Pang M, Charlett A, et al
    SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission.
    Clin Infect Dis. 2021 May 11. pii: 6273394. doi: 10.1093.
    >> Share

  214. FITZGERALD KC, Mecoli CA, Douglas M, Harris S, et al
    Risk Factors For Infection And Health Impacts Of The Covid-19 Pandemic In People With Autoimmune Diseases.
    Clin Infect Dis. 2021 May 6. pii: 6270948. doi: 10.1093.
    >> Share

  215. NICOLETE VC, Rodrigues PT, Johansen IC, Corder RM, et al
    Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated with Increased COVID-19 Risk in a Population-Based Cohort Study.
    Clin Infect Dis. 2021 May 6. pii: 6270997. doi: 10.1093.
    >> Share

  216. SINHA P, Linas BP
    Combination therapy with tocilizumab and dexamethasone cost-effectively reduces Coronavirus disease 2019 mortality.
    Clin Infect Dis. 2021 May 6. pii: 6270961. doi: 10.1093.
    >> Share

  217. HUI KP, Cheung MC, Lai KL, Ng KC, et al
    Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection.
    Clin Infect Dis. 2021 May 6. pii: 6270945. doi: 10.1093.
    >> Share

  218. NARITA M, Hatt G, Toren KG, Vuong K, et al
    Delayed Tuberculosis Diagnoses During the COVID-19 Pandemic in 2020 - King County, Washington.
    Clin Infect Dis. 2021 May 6. pii: 6270740. doi: 10.1093.
    >> Share

  219. SCHRODT CA, Malenfant JH, Hunter JC, Slifka KJ, et al
    Investigation of a Suspect SARS-CoV-2 and Influenza A Mixed Outbreak: Lessons Learned for Long-Term Care Facilities Nationwide.
    Clin Infect Dis. 2021 May 6. pii: 6270741. doi: 10.1093.
    >> Share

  220. WILSON K, Dennison C, Struminger B, Armistad A, et al
    Building a Virtual Global Knowledge Network during COVID-19: The Infection Prevention and Control Global Webinar Series.
    Clin Infect Dis. 2021 May 6. pii: 6270763. doi: 10.1093.
    >> Share

  221. HANDBERRY M, Bull-Otterson L, Dai M, Mann CN, et al
    Changes in Emergency Medical Services before and during COVID-19 in the United States, January 2018-December 2020.
    Clin Infect Dis. 2021 May 6. pii: 6270742. doi: 10.1093.
    >> Share

  222. NUNES MC, Baillie VL, Kwatra G, Bhikha S, et al
    SARS-CoV-2 infection among healthcare workers in South Africa: a longitudinal cohort study.
    Clin Infect Dis. 2021 May 5. pii: 6265294. doi: 10.1093.
    >> Share

  223. RAM-MOHAN N, Kim D, Zudock EJ, Hashemi MM, et al
    SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19.
    Clin Infect Dis. 2021 May 5. pii: 6265285. doi: 10.1093.
    >> Share

  224. ROSE K, Grant-Kels JM, Striano P, Neubauer D, et al
    Warp speed for COVID-19 drugs and vaccines - time to re-consider how we use the term 'children'.
    Clin Infect Dis. 2021 May 5. pii: 6265295. doi: 10.1093.
    >> Share

  225. BELLON M, Baggio S, Bausch FJ, Spechbach H, et al
    SARS-CoV-2 viral load kinetics in symptomatic children, adolescents and adults.
    Clin Infect Dis. 2021 May 5. pii: 6265276. doi: 10.1093.
    >> Share

  226. ANDERSON EJ, Kamidani S, Orenstein W, Campbell JD, et al
    COVID-19 Vaccines Have Moved Out of Neutral, but Still Gearing Up in Children.
    Clin Infect Dis. 2021 May 5. pii: 6265296. doi: 10.1093.
    >> Share

  227. HAIDAR G, Mellors JW
    Improving the Outcomes of Immunocompromised Patients with COVID-19.
    Clin Infect Dis. 2021 May 5. pii: 6265293. doi: 10.1093.
    >> Share

  228. STRUTNER J, Ramchandar N, Dubey S, Gamboa M, et al
    Comparison of Reverse-Transcription Polymerase Chain Reaction Cycle Threshold Values From Respiratory Specimens in Symptomatic and Asymptomatic Children With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Clin Infect Dis. 2021 May 5. pii: 6266745. doi: 10.1093.
    >> Share

  229. MARTINEZ-URBISTONDO D, Costa Segovia R, Suarez Del Villar Carrero R, Risco Risco C, et al
    Early Combination of Tocilizumab and Corticosteroids: An Upgrade in Anti-inflammatory Therapy for Severe Coronavirus Disease (COVID).
    Clin Infect Dis. 2021;72:1682-1683.
    >> Share

  230. RAN L, Tan X
    Reply to Belingheri et al.
    Clin Infect Dis. 2021;72:1676-1677.
    >> Share

  231. MILLION M, Chaudet H, Raoult D
    Hydroxychloroquine Failure: The End Does Not Justify the Means.
    Clin Infect Dis. 2021;72:e439.
    >> Share

  232. HAJAGE D, Pourcher V, Paccoud O, Bleibtreu A, et al
    Reply to Million et al.
    Clin Infect Dis. 2021;72:e440-e441.
    >> Share

  233. ROSENBERG ES, Hall EW, Rosenthal EM, Maxted AM, et al
    Reply to Flannery et al.
    Clin Infect Dis. 2021;72:e429.
    >> Share

  234. ZHANG M, Yao X, Cui C, Liu X, et al
    Reply to Wolowich and Kwon.
    Clin Infect Dis. 2021;72:1678-1680.
    >> Share

  235. WOLOWICH WR, Kwon YM
    Simulation of Drug in the Lung Can Be Misleading.
    Clin Infect Dis. 2021;72:1677-1678.
    >> Share

  236. HILT EE, Boocock J, Trejo M, Le CQ, et al
    Retrospective Detection of SARS-CoV-2 in Symptomatic Patients prior to Widespread Diagnostic Testing in Southern California.
    Clin Infect Dis. 2021 May 3. pii: 6262672. doi: 10.1093.
    >> Share

    April 2021
  237. BEALL RF, Kesselheim AS, Hollis A
    Pre-market development times for innovative vaccines - to what extent are the COVID-19 vaccines outliers?
    Clin Infect Dis. 2021 Apr 29. pii: 6259217. doi: 10.1093.
    >> Share

  238. MARX GE, Biggerstaff BJ, Nawrocki CC, Totten SE, et al
    SARS-CoV-2 detection on self-collected saliva or anterior nasal specimens compared with healthcare personnel-collected nasopharyngeal specimens.
    Clin Infect Dis. 2021 Apr 29. pii: 6257585. doi: 10.1093.
    >> Share

  239. LAWS RL, Biraro S, Kirungi W, Gianetti B, et al
    COVID-19 Mitigation Efforts and Testing During an In-Person Training Event - Uganda, October 12-29, 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257593. doi: 10.1093.
    >> Share

  240. CARTER RJ, Rose D, Sabo R, Clayton J, et al
    Widespread SARS-CoV-2 Transmission Among Attendees at a Large Motorcycle Rally and their Contacts, 30 US Jurisdictions, August-September, 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257584. doi: 10.1093.
    >> Share

  241. TRAN VT, Riveros C, Clepier B, Desvarieux M, et al
    Development and validation of the long covid symptom and impact tools, a set of patient-reported instruments constructed from patients' lived experience.
    Clin Infect Dis. 2021 Apr 29. pii: 6252414. doi: 10.1093.
    >> Share

  242. RODGERS L, Sheppard M, Smith A, Dietz S, et al
    Changes in Seasonal Respiratory Illnesses in the United States During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 Apr 29. pii: 6257582. doi: 10.1093.
    >> Share

  243. BUSHMAN D, Sekaran J, Jeffery N, Rath C, et al
    COVID-19 Outbreaks at Two Construction Sites - New York City, October-November 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257583. doi: 10.1093.
    >> Share

  244. CHEVINSKY JR, Tao G, Lavery AM, Kukielka EA, et al
    Late conditions diagnosed 1-4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data - United States, March 1-June 30, 2020.
    Clin Infect Dis. 2021 Apr 28. pii: 6257082. doi: 10.1093.
    >> Share

  245. SHAH MM, Salvatore PP, Ford L, Kamitani E, et al
    Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020.
    Clin Infect Dis. 2021 Apr 28. pii: 6257223. doi: 10.1093.
    >> Share

  246. GABLE P, Huang JY, Gilbert SE, Bollinger S, et al
    A Comparison of Less Invasive SARS-CoV-2 Diagnostic Specimens in Nursing Home Residents - Arkansas, June-August 2020.
    Clin Infect Dis. 2021 Apr 28. pii: 6257222. doi: 10.1093.
    >> Share

  247. TENG JLL, Fok KMN, Lin KPK, Chan E, et al
    Substantial decline in invasive pneumococcal disease (IPD) during COVID-19 pandemic in Hong Kong.
    Clin Infect Dis. 2021 Apr 27. pii: 6255967. doi: 10.1093.
    >> Share

  248. MULLER L, Andree M, Moskorz W, Drexler I, et al
    Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination.
    Clin Infect Dis. 2021 Apr 27. pii: 6255965. doi: 10.1093.
    >> Share

  249. DEAR N, Duff E, Esber A, Parikh A, et al
    Transient reductions in HIV clinic attendance and food security during the COVID-19 pandemic for people living with HIV in four African countries.
    Clin Infect Dis. 2021 Apr 27. pii: 6255964. doi: 10.1093.
    >> Share

  250. CHOUDHARY MC, Crain CR, Qiu X, Hanage W, et al
    SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection.
    Clin Infect Dis. 2021 Apr 27. pii: 6255966. doi: 10.1093.
    >> Share

  251. PAPAYANNI PG, Chasiotis D, Koukoulias K, Georgakopoulou A, et al
    Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients.
    Clin Infect Dis. 2021 Apr 27. pii: 6255711. doi: 10.1093.
    >> Share

  252. PIROFSKI LA
    Disease severity and durability of the SARS-CoV-2 antibody response: A view through the lens of the second year of the pandemic.
    Clin Infect Dis. 2021 Apr 27. pii: 6255716. doi: 10.1093.
    >> Share

  253. BASTOS RH, Blos PK, Rodrigues VD, da S Miranda B, et al
    One in every three COVID-19 reinfections result in hospitalization in the US.
    Clin Infect Dis. 2021 Apr 26. pii: 6253740. doi: 10.1093.
    >> Share

  254. SWIFT MD, Breeher LE, Tande AJ, Tommaso CP, et al
    Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel.
    Clin Infect Dis. 2021 Apr 26. pii: 6253721. doi: 10.1093.
    >> Share

  255. ALANGADEN G, Ramesh MS
    Reply to Fernandez Cruz, et al.
    Clin Infect Dis. 2021;72:1487.
    >> Share

  256. YU F, Yan L, Wang N, Guo Y, et al
    Reply to Aquino-Jarquin.
    Clin Infect Dis. 2021;72:1490-1491.
    >> Share

  257. AQUINO-JARQUIN G
    The Raw Cycle Threshold Values From Reverse-transcription Polymerase Chain Reaction Detection Are Not Viral Load Quantitation Units.
    Clin Infect Dis. 2021;72:1489-1490.
    >> Share

  258. LYNCH RM, Favata E, Gochfeld M
    Assess Ventilation When Determining Safe Distancing in Schools to Control COVID-19 Transmission.
    Clin Infect Dis. 2021 Apr 25. pii: 6250101. doi: 10.1093.
    >> Share

  259. QURESHI AI, Baskett WI, Huang W, Lobanova I, et al
    Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing.
    Clin Infect Dis. 2021 Apr 25. pii: 6251701. doi: 10.1093.
    >> Share

  260. BRANCH-ELLIMAN W, Schechter-Perkins EM, Jack RS, van den Berg P, et al
    Reply to authors.
    Clin Infect Dis. 2021 Apr 25. pii: 6250099. doi: 10.1093.
    >> Share

  261. GOSWAMI ND, Fiore AE, Walke HT
    Evidence, Experience, Expertise, and the U.S. COVID-19 Public Health Response.
    Clin Infect Dis. 2021 Apr 24. pii: 6248544. doi: 10.1093.
    >> Share

  262. ETYANG AO, Lucinde R, Karanja H, Kalu C, et al
    Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya.
    Clin Infect Dis. 2021 Apr 24. pii: 6248493. doi: 10.1093.
    >> Share

  263. BROCCIA MM, de Knegt VEVE, Mills EHAEHA, Moller ALAL, et al
    Household exposure to SARS-CoV-2 and association with COVID-19 severity: a Danish nationwide cohort study.
    Clin Infect Dis. 2021 Apr 24. pii: 6248492. doi: 10.1093.
    >> Share

  264. FINSTERER J, Scorza FA
    COVID-19 can be complicated by immune-encephalopathy rather than encephalitis.
    Clin Infect Dis. 2021 Apr 24. pii: 6248513. doi: 10.1093.
    >> Share

  265. GAUTAM N, Madathil S, Tahani N, Bolton S, et al
    Medium-term outcome of severe to critically ill patients with SARS-CoV-2 infection.
    Clin Infect Dis. 2021 Apr 24. pii: 6248543. doi: 10.1093.
    >> Share

  266. LILLIE PJ, O'Brien P, Lawtie M, Jessop S, et al
    First dose of BNT162b2 mRNA vaccine in a Health Care Worker cohort is associated with reduced symptomatic and asymptomatic SARS-CoV-2 infection.
    Clin Infect Dis. 2021 Apr 24. pii: 6248435. doi: 10.1093.
    >> Share

  267. JONES LD, Chan ER, Zabarsky TF, Cadnum JL, et al
    Transmission of SARS-CoV-2 on a Patient Transport Van.
    Clin Infect Dis. 2021 Apr 24. pii: 6248519. doi: 10.1093.
    >> Share

  268. TOVAR M, Peinado J, Palomino S, Llanos F, et al
    Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru.
    Clin Infect Dis. 2021 Apr 21. pii: 6243873. doi: 10.1093.
    >> Share

  269. GETTINGS JR, Gold JAW, Kimball A, Forsberg K, et al
    SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021.
    Clin Infect Dis. 2021 Apr 17. pii: 6232104. doi: 10.1093.
    >> Share

  270. TANG J, Grubbs G, Lee Y, Golding H, et al
    Impact of convalescent plasma therapy on SARS CoV-2 antibody profile in COVID-19 patients.
    Clin Infect Dis. 2021 Apr 16. pii: 6228549. doi: 10.1093.
    >> Share

  271. BRAUN KM, Moreno GK, Buys A, Somsen ED, et al
    Viral sequencing reveals US healthcare personnel rarely become infected with SARS-CoV-2 through patient contact.
    Clin Infect Dis. 2021 Apr 15. pii: 6226897. doi: 10.1093.
    >> Share

  272. BETTON M, Livrozet M, Planas D, Fayol A, et al
    Sera neutralizing activities against SARS-CoV-2 and multiple variants six month after hospitalization for COVID-19.
    Clin Infect Dis. 2021 Apr 14. pii: 6225251. doi: 10.1093.
    >> Share

  273. CHENG VC, Fung KS, Siu GK, Wong SC, et al
    Nosocomial outbreak of COVID-19 by possible airborne transmission leading to a superspreading event.
    Clin Infect Dis. 2021 Apr 14. pii: 6225253. doi: 10.1093.
    >> Share

  274. KUMAR RN, Wu EL, Stosor V, Moore WJ, et al
    Real-World Experience of Bamlanivimab for COVID-19: A Case-Control Study.
    Clin Infect Dis. 2021 Apr 13. pii: 6224410. doi: 10.1093.
    >> Share

  275. FORD L, Lee C, Pray IW, Cole D, et al
    Epidemiologic characteristics associated with SARS-CoV-2 antigen-based test results, rRT-PCR cycle threshold values, subgenomic RNA, and viral culture results from university testing.
    Clin Infect Dis. 2021 Apr 13. pii: 6224406. doi: 10.1093.
    >> Share

  276. BOSSLET GT, Pollak M, Jang JH, Roll R, et al
    The effect of in-person primary and secondary school instruction on county-level SARS-CoV-2 spread in Indiana.
    Clin Infect Dis. 2021 Apr 13. pii: 6224418. doi: 10.1093.
    >> Share

  277. WANG H, Hogan CA, Verghese M, Solis D, et al
    Ultra-sensitive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection for the Diagnosis of Coronavirus Disease 2019 (COVID-19) in Upper Respiratory Samples.
    Clin Infect Dis. 2021 Apr 8. pii: 6217390. doi: 10.1093.
    >> Share

  278. CHEN Y, Li L
    Influence of Corticosteroid Dose on Viral Shedding Duration in Patients With COVID-19.
    Clin Infect Dis. 2021;72:1298-1300.
    >> Share

  279. GUO L, Ren L, Sharma L, Wang J, et al
    Reply to Yamaoka, et al.
    Clin Infect Dis. 2021;72:1293.
    >> Share

  280. VAN PRAET JT, Vandecasteele S, De Roo A, De Vriese AS, et al
    Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents.
    Clin Infect Dis. 2021 Apr 7. pii: 6213866. doi: 10.1093.
    >> Share

  281. WESTHOLTER D, Taube C
    SARS-CoV-2 outbreak in a long-term care facility after vaccination with BNT162b2.
    Clin Infect Dis. 2021 Apr 7. pii: 6213878. doi: 10.1093.
    >> Share

  282. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Zigron R, et al
    Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccination.
    Clin Infect Dis. 2021 Apr 3. pii: 6209876. doi: 10.1093.
    >> Share

  283. WILEY Z, Ross-Driscoll K, Wang Z, Smothers L, et al
    Racial and Ethnic Differences and Clinical Outcomes of COVID-19 Patients Presenting to the Emergency Department.
    Clin Infect Dis. 2021 Apr 2. pii: 6209403. doi: 10.1093.
    >> Share

  284. REUKERS DFM, van Boven M, Meijer A, Rots N, et al
    High infection secondary attack rates of SARS-CoV-2 in Dutch households revealed by dense sampling.
    Clin Infect Dis. 2021 Apr 2. pii: 6209401. doi: 10.1093.
    >> Share

    March 2021
  285. PENG J, Liu J, Mann SA, Mitchell AM, et al
    Estimation of secondary household attack rates for emergent spike L452R SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco.
    Clin Infect Dis. 2021 Mar 31. pii: 6206738. doi: 10.1093.
    >> Share

  286. DEGRAZIA D, Miller FG
    SARS-CoV-2 Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective.
    Clin Infect Dis. 2021 Mar 31. pii: 6205379. doi: 10.1093.
    >> Share

  287. FWOLOSHI S, Hines JZ, Barradas DT, Yingst S, et al
    Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) among Health Care Workers-Zambia, July 2020.
    Clin Infect Dis. 2021 Mar 30. pii: 6204763. doi: 10.1093.
    >> Share

  288. WU P, Liu F, Chang Z, Lin Y, et al
    Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2.
    Clin Infect Dis. 2021 Mar 27. pii: 6193430. doi: 10.1093.
    >> Share

  289. VOS ERA, van Boven M, den Hartog G, Backer JA, et al
    Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands.
    Clin Infect Dis. 2021 Mar 27. pii: 6189768. doi: 10.1093.
    >> Share

  290. CHAILLON A, Smith DM
    Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution.
    Clin Infect Dis. 2021 Mar 27. pii: 6189784. doi: 10.1093.
    >> Share

  291. MCELLISTREM MC, Clancy CJ, Buehrle DJ, Lucas A, et al
    Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19.
    Clin Infect Dis. 2021 Mar 26. pii: 6188727. doi: 10.1093.
    >> Share

  292. ECKSTEIN L, Rid A, Kamuya D, Shah SK, et al
    The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19.
    Clin Infect Dis. 2021 Mar 24. pii: 6184613. doi: 10.1093.
    >> Share

  293. ESCANDON K, Ulrich AK, Chou R
    Concerns with and recommendations for COVID-19 research related to asymptomatic infection and mask wearing.
    Clin Infect Dis. 2021 Mar 23. pii: 6180410. doi: 10.1093.
    >> Share

  294. BADDLEY JW
    COVID-19 Associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes?
    Clin Infect Dis. 2021 Mar 23. pii: 6180413. doi: 10.1093.
    >> Share

  295. CUMMINS NW
    Remdesivir: An antiviral still seeking a raison d'etre.
    Clin Infect Dis. 2021 Mar 22. pii: 6179767. doi: 10.1093.
    >> Share


  296. Corrigendum to: A Case of 2019 Novel Coronavirus in a Pregnant Woman With Preterm Delivery.
    Clin Infect Dis. 2021 Mar 19. pii: 6178940. doi: 10.1093.
    >> Share

  297. MCNAB S, Ha Do LA, Clifford V, Crawford NW, et al
    Changing Epidemiology of Respiratory Syncytial Virus in Australia - delayed re-emergence in Victoria compared to WA/NSW after prolonged lock-down for COVID-19.
    Clin Infect Dis. 2021 Mar 18. pii: 6178344. doi: 10.1093.
    >> Share

  298. POLAND GA
    Antibody Dynamics, Seroreversion, and Persistence After SARS-CoV-2: Another Answer.
    Clin Infect Dis. 2021 Mar 17. pii: 6175316. doi: 10.1093.
    >> Share

  299. SLUGGETT JK, Dinh YH, Wesselingh SL, Inacio MC, et al
    National Changes in Outpatient Systemic Antibiotic Use During the Coronavirus Disease 2019 Pandemic in Australia.
    Clin Infect Dis. 2021 Mar 17. pii: 6175263. doi: 10.1093.
    >> Share


  300. Corrigendum to: Changing Disease Epidemiology to Inform Expanded Coronavirus Disease 2019 Testing.
    Clin Infect Dis. 2021;72:1108.
    >> Share

  301. SHEEHAN MM, Reddy AJ, Rothberg MB
    Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study.
    Clin Infect Dis. 2021 Mar 15. pii: 6170939. doi: 10.1093.
    >> Share

  302. JORDAN I, de Sevilla MF, Fumado V, Bassat Q, et al
    Transmission of SARS-CoV-2 infection among children in summer schools applying stringent control measures in Barcelona, Spain.
    Clin Infect Dis. 2021 Mar 12. pii: 6168543. doi: 10.1093.
    >> Share

  303. SORIANO-ARANDES A, Gatell A, Serrano P, Biosca M, et al
    Household SARS-CoV-2 transmission and children: a network prospective study.
    Clin Infect Dis. 2021 Mar 12. pii: 6168547. doi: 10.1093.
    >> Share

  304. KLOMPAS M, Baker MA, Griesbach D, Tucker R, et al
    Transmission of SARS-CoV-2 from asymptomatic and presymptomatic individuals in healthcare settings despite medical masks and eye protection.
    Clin Infect Dis. 2021 Mar 11. pii: 6168040. doi: 10.1093.
    >> Share

  305. TANDE AJ, Pollock BD, Shah ND, Farrugia G, et al
    Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening.
    Clin Infect Dis. 2021 Mar 10. pii: 6167855. doi: 10.1093.
    >> Share

  306. VAN DEN BERG P, Schechter-Perkins EM, Jack RS, Epshtein I, et al
    Effectiveness of three versus six feet of physical distancing for controlling spread of COVID-19 among primary and secondary students and staff: A retrospective, state-wide cohort study.
    Clin Infect Dis. 2021 Mar 10. pii: 6167856. doi: 10.1093.
    >> Share

  307. GOUIN KA, Creasy S, Beckerson M, Wdowicki M, et al
    Trends in Prescribing of Antibiotics and Drugs Investigated for COVID-19 Treatment in U.S. Nursing Home Residents During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 Mar 10. pii: 6167836. doi: 10.1093.
    >> Share

  308. LIN DY, Zeng D, Gilbert PB
    Evaluating the Long-Term Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2021 Mar 10. pii: 6167839. doi: 10.1093.
    >> Share

  309. PERMPALUNG N, Chiang TP, Massie AB, Zhang SX, et al
    COVID-19 Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.
    Clin Infect Dis. 2021 Mar 9. pii: 6164950. doi: 10.1093.
    >> Share

  310. PIANTADOSI A
    SARS-CoV-2 Episode 2? A sequel nobody wants to see.
    Clin Infect Dis. 2021 Mar 9. pii: 6164969. doi: 10.1093.
    >> Share

  311. VAN ELSLANDE J, Gruwier L, Godderis L, Vermeersch P, et al
    Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers.
    Clin Infect Dis. 2021 Mar 8. pii: 6162856. doi: 10.1093.
    >> Share

  312. CAPETTI AF, Stangalini CA, Borgonovo F, Mileto D, et al
    Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine.
    Clin Infect Dis. 2021 Mar 6. pii: 6159798. doi: 10.1093.
    >> Share

  313. RAPAKA RR, Hammershaimb EA, Neuzil KM
    Are some COVID vaccines better than others? Interpreting and comparing estimates of efficacy in trials of COVID-19 vaccines.
    Clin Infect Dis. 2021 Mar 6. pii: 6159795. doi: 10.1093.
    >> Share

  314. PAUL LA, Daneman N, Brown KA, Johnson J, et al
    Characteristics associated with household transmission of SARS-CoV-2 in Ontario, Canada: A cohort study.
    Clin Infect Dis. 2021 Mar 5. pii: 6159706. doi: 10.1093.
    >> Share

  315. TSE H, Lung DC, Wong SC, Ip KF, et al
    Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 virus variant with novel genomic architecture in Hong Kong.
    Clin Infect Dis. 2021 Mar 2. pii: 6155931. doi: 10.1093.
    >> Share

  316. VAN LOON W, Hommes F, Theuring S, von der Haar A, et al
    Renewed absence of SARS-CoV-2 infections in the day care context in Berlin, January 2021.
    Clin Infect Dis. 2021 Mar 2. pii: 6155930. doi: 10.1093.
    >> Share

  317. RAWSON TM, Moore LSP, Zhu N, Ranganathan N, et al
    Reply to Dudoignon et al.
    Clin Infect Dis. 2021;72:906-908.
    >> Share

    February 2021
  318. EYAL N, Lipsitch M
    How to test SARS-CoV-2 vaccines ethically even after one is available.
    Clin Infect Dis. 2021 Feb 26. pii: 6152007. doi: 10.1093.
    >> Share

  319. LIM T, Delorey M, Bestul N, Johannsen M, et al
    Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020.
    Clin Infect Dis. 2021 Feb 26. pii: 6152134. doi: 10.1093.
    >> Share

  320. HYDE Z
    Difference in SARS-CoV-2 attack rate between children and adults may reflect bias.
    Clin Infect Dis. 2021 Feb 26. pii: 6150026. doi: 10.1093.
    >> Share

  321. GROOTHOF D, Post A, Gans ROB, Bakker SJL, et al
    Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kidney Function?
    Clin Infect Dis. 2021 Feb 25. pii: 6149918. doi: 10.1093.
    >> Share

  322. SAFE IP, Lacerda MVG, Almeida Val FF, Sampaio VS, et al
    Severe Hypoxemia With Normal Heart and Respiratory Rate in Early-stage Coronavirus Disease 2019 Patients: The "Happy Hypoxemia Phenomenon".
    Clin Infect Dis. 2021 Feb 24. pii: 6149031. doi: 10.1093.
    >> Share

  323. DEN HARTOG G, Vos ERA, van den Hoogen LL, van Boven M, et al
    Persistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study.
    Clin Infect Dis. 2021 Feb 24. pii: 6149064. doi: 10.1093.
    >> Share

  324. REIMER JR, Ahmed SM, Brintz B, Shah RU, et al
    Using a clinical prediction rule to prioritize diagnostic testing leads to reduced transmission and hospital burden: A modeling example of early SARS-CoV-2.
    Clin Infect Dis. 2021 Feb 23. pii: 6148743. doi: 10.1093.
    >> Share

  325. DAI CL, Kornilov SA, Roper RT, Cohen-Cline H, et al
    Characteristics and Factors Associated with COVID-19 Infection, Hospitalization, and Mortality Across Race and Ethnicity.
    Clin Infect Dis. 2021 Feb 20. pii: 6145124. doi: 10.1093.
    >> Share

  326. LEE JT, Hesse EM, Paulin HN, Datta D, et al
    Clinical and Laboratory Findings in Patients with Potential SARS-CoV-2 Reinfection, May-July 2020.
    Clin Infect Dis. 2021 Feb 18. pii: 6142945. doi: 10.1093.
    >> Share

  327. XU J, Zhou M, Luo P, Yin Z, et al
    Plasma metabolomic profiling of patients recovered from COVID-19 with pulmonary sequelae 3 months after discharge.
    Clin Infect Dis. 2021 Feb 17. pii: 6141511. doi: 10.1093.
    >> Share

  328. FOLEY DA, Yeoh DK, Minney-Smith CA, Martin AC, et al
    The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019-Related Public Health Measures.
    Clin Infect Dis. 2021 Feb 17. pii: 6140790. doi: 10.1093/cid/ciaa1906.
    >> Share

  329. JACKSON ML, Starita L, Kiniry E, Phillips CH, et al
    Incidence of medically attended acute respiratory illnesses due to respiratory viruses across the life course during the 2018/19 influenza season.
    Clin Infect Dis. 2021 Feb 16. pii: 6137552. doi: 10.1093.
    >> Share

  330. KULKARNI O, Narreddy S, Zaveri L, Kalal IG, et al
    Evidence of SARS-CoV-2 reinfection without mutations in Spike protein.
    Clin Infect Dis. 2021 Feb 16. pii: 6137553. doi: 10.1093.
    >> Share

  331. WESTREICH D, Jenness SM, Marcus JL
    To Contact Tracing... and Beyond!
    Clin Infect Dis. 2021;72:724-725.
    >> Share

  332. SAM-AGUDU NA, Rabie H, Pipo MT, Byamungu LN, et al
    The Critical Need for Pooled Data on COVID-19 in African Children: An AFREhealth Call for Action through Multi-Country Research Collaboration.
    Clin Infect Dis. 2021 Feb 13. pii: 6134449. doi: 10.1093.
    >> Share

  333. BELL N, Bracchi M, Dalla Pria A, Nelson M, et al
    Indirect HIV morbidity and mortality due to COVID-19.
    Clin Infect Dis. 2021 Feb 13. pii: 6134310. doi: 10.1093.
    >> Share

  334. FELDMAN AG, O'Leary ST, Isakov LD
    The Risk of Resurgence in Vaccine Preventable Infections Due to COVID-Related Gaps in Immunization.
    Clin Infect Dis. 2021 Feb 13. pii: 6134309. doi: 10.1093.
    >> Share

  335. ZUCMAN N, Uhel F, Descamps D, Roux D, et al
    Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report.
    Clin Infect Dis. 2021 Feb 10. pii: 6132402. doi: 10.1093.
    >> Share

  336. SEE I, Paul P, Slayton RB, Steele MK, et al
    Modeling effectiveness of testing strategies to prevent COVID-19 in nursing homes -United States, 2020.
    Clin Infect Dis. 2021 Feb 10. pii: 6132104. doi: 10.1093.
    >> Share

  337. DUGDALE CM, Rubins DM, Lee H, McCluskey SM, et al
    COVID-19 Diagnostic Clinical Decision Support: a Pre-Post Implementation Study of CORAL (COvid Risk cALculator).
    Clin Infect Dis. 2021 Feb 10. pii: 6132091. doi: 10.1093.
    >> Share

  338. THOMPSON HA, Mousa A, Dighe A, Fu H, et al
    SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis.
    Clin Infect Dis. 2021 Feb 9. pii: 6131730. doi: 10.1093.
    >> Share

  339. MOMPLAISIR F, Haynes N, Nkwihoreze H, Nelson M, et al
    Understanding Drivers of COVID-19 Vaccine Hesitancy Among Blacks.
    Clin Infect Dis. 2021 Feb 9. pii: 6131729. doi: 10.1093.
    >> Share

  340. CROVETTO F, Crispi F, Llurba E, Pascal R, et al
    Impact of SARS-CoV-2 Infection on Pregnancy Outcomes: A Population-Based Study.
    Clin Infect Dis. 2021 Feb 8. pii: 6131375. doi: 10.1093.
    >> Share

  341. REBEIRO PF, Aronoff DM, Smith MK
    The Impact of State Mask-Wearing Requirements on the Growth of COVID-19 Cases in the United States.
    Clin Infect Dis. 2021 Feb 7. pii: 6129930. doi: 10.1093.
    >> Share

  342. JACOBSON KB, Rao M, Bonilla H, Subramanian A, et al
    Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic.
    Clin Infect Dis. 2021 Feb 7. pii: 6129932. doi: 10.1093.
    >> Share

  343. CONNORS JM, Iba T, Gandhi RT
    Thrombosis and COVID-19: Controversies and (Tentative) Conclusions.
    Clin Infect Dis. 2021 Feb 4. pii: 6128795. doi: 10.1093.
    >> Share

  344. ARNAOUT R, Lee RA, Lee GR, Callahan C, et al
    The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing.
    Clin Infect Dis. 2021 Feb 3. pii: 6127024. doi: 10.1093/cid/ciaa1382.
    >> Share

  345. PATEL MR, Carroll D, Ussery E, Whitham H, et al
    Performance of Oropharyngeal Swab Testing Compared With Nasopharyngeal Swab Testing for Diagnosis of Coronavirus Disease 2019-United States, January 2020-February 2020.
    Clin Infect Dis. 2021;72:403-410.
    >> Share

  346. CANADAY DH, Gravenstein S
    On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Clin Infect Dis. 2021;72:513-514.
    >> Share

  347. KAO CM, Orenstein WA, Anderson EJ
    The Importance of Advancing Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Children.
    Clin Infect Dis. 2021;72:515-518.
    >> Share

  348. MANDONNET E, Molina JM
    Household Coronavirus Disease 2019 (COVID-19) Prevalence.
    Clin Infect Dis. 2021;72:539.
    >> Share

  349. HAN L, Li N, Peng M, Yang L, et al
    Reply to Chen.
    Clin Infect Dis. 2021;72:538-539.
    >> Share

  350. CHEN HJ
    It Is Not a Case-control Study.
    Clin Infect Dis. 2021;72:538.
    >> Share

    January 2021
  351. LI C, Chen YX, Liu FF, Lee AC, et al
    Absence of vaccine-enhanced disease with unexpected positive protection against SARS-CoV-2 by inactivated vaccine given within three days of virus challenge in Syrian hamster model.
    Clin Infect Dis. 2021 Jan 30. pii: 6124512. doi: 10.1093.
    >> Share

  352. GOTTLIEB RL, Spak CW
    The Olympiad of SARS-CoV-2 vaccinology: Fundamentals to Complement Technical Frontiers.
    Clin Infect Dis. 2021 Jan 30. pii: 6124447. doi: 10.1093.
    >> Share

  353. RICHIER Q, Placais L, Lacombe K, Hermine O, et al
    Tocilizumab in COVID-19: Give it time!
    Clin Infect Dis. 2021 Jan 30. pii: 6124471. doi: 10.1093.
    >> Share

  354. MOGHADAS SM, Vilches TN, Zhang K, Wells CR, et al
    The impact of vaccination on COVID-19 outbreaks in the United States.
    Clin Infect Dis. 2021 Jan 30. pii: 6124429. doi: 10.1093.
    >> Share

  355. AKINBAMI LJ, Petersen LR, Sami S, Vuong N, et al
    COVID-19 symptoms and SARS-CoV-2 antibody positivity in a large survey of first responders and healthcare personnel, May-July 2020.
    Clin Infect Dis. 2021 Jan 30. pii: 6124470. doi: 10.1093.
    >> Share

  356. HENSLEY MK, Bain WG, Jacobs J, Nambulli S, et al
    Intractable COVID-19 and Prolonged SARS-CoV-2 Replication in a CAR-T-cell Therapy Recipient: A Case Study.
    Clin Infect Dis. 2021 Jan 28. pii: 6122591. doi: 10.1093.
    >> Share

  357. LANE MA, Brownsword EA, Babiker A, Ingersoll JM, et al
    Bioaerosol sampling for SARS-CoV-2 in a referral center with critically ill COVID-19 patients March-May 2020.
    Clin Infect Dis. 2021 Jan 28. pii: 6121685. doi: 10.1093/cid/ciaa1880.
    >> Share

  358. BIENIASZ P
    The case against delaying SARS-CoV-2 mRNA vaccine boosting doses.
    Clin Infect Dis. 2021 Jan 27. pii: 6121510. doi: 10.1093.
    >> Share

  359. LAPENNA D
    Antioxidant therapy in COVID-19: The crucial role of early treatment and antioxidant typology.
    Clin Infect Dis. 2021 Jan 27. pii: 6121547. doi: 10.1093.
    >> Share

  360. DIMEGLIO C, Herin F, Miedouge M, Martin-Blondel G, et al
    Protection of healthcare workers against SARS-CoV-2 reinfection.
    Clin Infect Dis. 2021 Jan 27. pii: 6121509. doi: 10.1093.
    >> Share

  361. PLOTKIN SA, Halsey N
    Accelerate COVID-19 Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines.
    Clin Infect Dis. 2021 Jan 27. pii: 6121304. doi: 10.1093.
    >> Share

  362. FUNG M, Babik JM
    COVID-19 in Immunocompromised Hosts: What We Know So Far.
    Clin Infect Dis. 2021;72:340-350.
    >> Share

  363. ERIKSTRUP C, Hother CE, Pedersen OBV, Molbak K, et al
    Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.
    Clin Infect Dis. 2021;72:249-253.
    >> Share

  364. ANGOULVANT F, Ouldali N, Yang DD, Filser M, et al
    Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections-a Time Series Analysis.
    Clin Infect Dis. 2021;72:319-322.
    >> Share

  365. NACHEGA JB, Grimwood A, Mahomed H, Fatti G, et al
    From Easing Lockdowns to Scaling Up Community-based Coronavirus Disease 2019 Screening, Testing, and Contact Tracing in Africa-Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality.
    Clin Infect Dis. 2021;72:327-331.
    >> Share

  366. SCHWIERZECK V, Konig JC, Kuhn J, Mellmann A, et al
    First Reported Nosocomial Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Dialysis Unit.
    Clin Infect Dis. 2021;72:265-270.
    >> Share

  367. CHAMILOS G, Lionakis MS, Kontoyiannis DP
    Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
    Clin Infect Dis. 2021;72:351-356.
    >> Share

  368. BUSCH MP, Stone M
    Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations.
    Clin Infect Dis. 2021;72:254-256.
    >> Share

  369. CONTEJEAN A, Leporrier J, Canoui E, Alby-Laurent F, et al
    Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.
    Clin Infect Dis. 2021;72:257-264.
    >> Share

  370. LYNCH KL, Whitman JD, Lacanienta NP, Beckerdite EW, et al
    Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
    Clin Infect Dis. 2021;72:301-308.
    >> Share

  371. LONG DR, Gombar S, Hogan CA, Greninger AL, et al
    Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients.
    Clin Infect Dis. 2021;72:323-326.
    >> Share

  372. ZHOU L, Wu Z, Li Z, Zhang Y, et al
    One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China.
    Clin Infect Dis. 2021;72:332-339.
    >> Share

  373. LYNCH KL, Whitman JD, Lacanienta NP, Beckerdite EW, et al
    Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
    Clin Infect Dis. 2021;72:301-308.
    >> Share

  374. ZHOU L, Wu Z, Li Z, Zhang Y, et al
    One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China.
    Clin Infect Dis. 2021;72:332-339.
    >> Share

  375. CONTEJEAN A, Leporrier J, Canoui E, Alby-Laurent F, et al
    Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.
    Clin Infect Dis. 2021;72:257-264.
    >> Share

  376. BUSCH MP, Stone M
    Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations.
    Clin Infect Dis. 2021;72:254-256.
    >> Share

  377. LONG DR, Gombar S, Hogan CA, Greninger AL, et al
    Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients.
    Clin Infect Dis. 2021;72:323-326.
    >> Share

  378. MAVES RC
    Making sense of contradictory evidence in Covid-19 trials.
    Clin Infect Dis. 2021 Jan 25. pii: 6119538. doi: 10.1093.
    >> Share

  379. SHAW J, Stewart T, Anderson KB, Hanley S, et al
    Assessment of U.S. health care personnel (HCP) attitudes towards COVID-19 vaccination in a large university health care system.
    Clin Infect Dis. 2021 Jan 25. pii: 6118651. doi: 10.1093.
    >> Share

  380. BRANCH-ELLIMAN W, Safdar N, Nelson R
    Economic Considerations in Infectious Diseases Emergency Response Preparedness: It's All About the Point of View.
    Clin Infect Dis. 2021;72:148-152.
    >> Share

  381. JI D, Qin E, Zhang D, Cheng G, et al
    Reply to Grifoni et al.
    Clin Infect Dis. 2021;72:183.
    >> Share

  382. HANSON KE, Caliendo AM, Arias CA, Hayden MK, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing.
    Clin Infect Dis. 2021 Jan 22. pii: 6106562. doi: 10.1093.
    >> Share

  383. PEKOSZ A, Parvu V, Li M, Andrews JC, et al
    Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral Culture.
    Clin Infect Dis. 2021 Jan 20. pii: 6105729. doi: 10.1093/cid/ciaa1706.
    >> Share

  384. GOYAL R, Hotchkiss J, Schooley RT, De Gruttola V, et al
    Evaluation of SARS-CoV-2 transmission mitigation strategies on a university campus using an agent-based network model.
    Clin Infect Dis. 2021 Jan 19. pii: 6104139. doi: 10.1093.
    >> Share

  385. SOMEKH I, Shohat T, Boker LK, Simoes EAF, et al
    Reopening Schools and the Dynamics of SARS-CoV-2 Infections in Israel: A Nationwide Study.
    Clin Infect Dis. 2021 Jan 18. pii: 6103916. doi: 10.1093.
    >> Share

  386. SAMET JM, Prather K, Benjamin G, Lakdawala S, et al
    Airborne Transmission of SARS-CoV-2: What We Know.
    Clin Infect Dis. 2021 Jan 18. pii: 6103221. doi: 10.1093.
    >> Share

  387. ALROY KA, Crossa A, Dominianni C, Sell J, et al
    Population-based Estimates of COVID-19-like Illness, COVID-19 Illness, and Rates of Case Ascertainment, Hospitalizations, and Deaths - Non-Institutionalized New York City Residents, March-April 2020.
    Clin Infect Dis. 2021 Jan 18. pii: 6103212. doi: 10.1093.
    >> Share

  388. HARRINGTON D, Kele B, Pereira S, Couto-Parada X, et al
    Confirmed Reinfection with SARS-CoV-2 Variant VOC-202012/01.
    Clin Infect Dis. 2021 Jan 9. pii: 6076528. doi: 10.1093.
    >> Share

  389. LEE M
    Lack of SARS-CoV2 neutralization by antibodies to seasonal coronaviruses: making sense of the COVID-19 pandemic.
    Clin Infect Dis. 2021 Jan 8. pii: 6071008. doi: 10.1093.
    >> Share

  390. BOYD S, Martin-Loeches I
    Rates of Aspergillus Co-infection in COVID patients in ICU not as high as previously reported.
    Clin Infect Dis. 2021 Jan 8. pii: 6071009. doi: 10.1093.
    >> Share

  391. ANDERSEN KM, Mehta HB, Palamuttam N, Ford D, et al
    Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System.
    Clin Infect Dis. 2021 Jan 7. pii: 6067567. doi: 10.1093/cid/ciaa1488.
    >> Share

  392. YANG B, Wu P, Lau EHY, Wong JY, et al
    Changing disparities in COVID-19 burden in the ethnically homogeneous population of Hong Kong through pandemic waves: an observational study.
    Clin Infect Dis. 2021 Jan 6. pii: 6066577. doi: 10.1093.
    >> Share

  393. LUMLEY SF, Wei J, O'Donnell D, Stoesser NE, et al
    The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers.
    Clin Infect Dis. 2021 Jan 6. pii: 6064824. doi: 10.1093.
    >> Share

  394. DALAGER-PEDERSEN M, Lund LC, Mariager T, Winther R, et al
    Venous thromboembolism and major bleeding in patients with COVID-19: A nationwide population-based cohort study.
    Clin Infect Dis. 2021 Jan 5. pii: 6064643. doi: 10.1093.
    >> Share

  395. PILOTTO A, Masciocchi S, Volonghi I, De Giuli V, et al
    SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses.
    Clin Infect Dis. 2021 Jan 4. pii: 6062486. doi: 10.1093/cid/ciaa1933.
    >> Share

  396. TRIANT VA, Gandhi RT
    When Epidemics Collide: Why People with HIV May Have Worse COVID-19 Outcomes and Implications for Vaccination.
    Clin Infect Dis. 2021 Jan 4. pii: 6062462. doi: 10.1093/cid/ciaa1946.
    >> Share

  397. WEINBERGER T, Steffen J, Osterman A, Mueller TT, et al
    Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany.
    Clin Infect Dis. 2021 Jan 3. pii: 6060065. doi: 10.1093/cid/ciaa1935.
    >> Share

  398. ZHANG Z, Guo L, Huang L, Zhang C, et al
    Distinct disease severity between children and older adults with COVID-19: Impacts of ACE2 expression, distribution, and lung progenitor cells.
    Clin Infect Dis. 2021 Jan 3. pii: 6059779. doi: 10.1093/cid/ciaa1911.
    >> Share

  399. HOEHL S, Kreutzer E, Schenk B, Westhaus S, et al
    Longitudinal testing for respiratory and gastrointestinal shedding of SARS-CoV-2 in day care centres in Hesse, Germany.
    Clin Infect Dis. 2021 Jan 3. pii: 6059778. doi: 10.1093/cid/ciaa1912.
    >> Share

  400. DAN J, Mehta S
    SARS-CoV-2 immunity and reinfection.
    Clin Infect Dis. 2021 Jan 2. pii: 6058751. doi: 10.1093/cid/ciaa1936.
    >> Share

    December 2020
  401. GRANICH R, Gupta S
    European Union, HIV, and Coronavirus Disease 2019 (COVID-19): Progress and Lessons Learned From the HIV Pandemic.
    Clin Infect Dis. 2020;71:2917-2919.
    >> Share

  402. TAYLOR SP, Kowalkowski MA, Beidas RS
    Where Is the Implementation Science? An Opportunity to Apply Principles During the COVID-19 Pandemic.
    Clin Infect Dis. 2020;71:2993-2995.
    >> Share

  403. SKURNIK D, Rybak A, Yang DD, Pons S, et al
    Unexpected lessons from the COVID-19 lockdowns in France: Low impact of school opening on common communicable pediatric airborne diseases.
    Clin Infect Dis. 2020 Dec 29. pii: 6054992. doi: 10.1093/cid/ciaa1899.
    >> Share

  404. KING LM, Lovegrove MC, Shehab N, Tsay S, et al
    Trends in U.S. outpatient antibiotic prescriptions during the COVID-19 pandemic.
    Clin Infect Dis. 2020 Dec 29. pii: 6054971. doi: 10.1093/cid/ciaa1896.
    >> Share

  405. SILVESTRE OM, Costa LR, Lopes BVR, Barbosa MR, et al
    Previous dengue infection and mortality in COVID-19.
    Clin Infect Dis. 2020 Dec 29. pii: 6054970. doi: 10.1093/cid/ciaa1895.
    >> Share

  406. PILAROWSKI G, Marquez C, Rubio L, Peng J, et al
    Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing.
    Clin Infect Dis. 2020 Dec 26. pii: 6052342. doi: 10.1093/cid/ciaa1890.
    >> Share

  407. HIRSCHFELD G, von Glischinski M, Thiele C
    Optimal cycle thresholds for COVID-19 screening - ROC-based methods highlight between-study differences.
    Clin Infect Dis. 2020 Dec 23. pii: 6044731. doi: 10.1093/cid/ciaa1883.
    >> Share

  408. GILES ML, Wallace EM, Alpren C, Brady N, et al
    Suppression of SARS-CoV-2 after a second wave in Victoria, Australia.
    Clin Infect Dis. 2020 Dec 23. pii: 6044730. doi: 10.1093/cid/ciaa1882.
    >> Share

  409. KIES KD, Thomas AS, Binnicker MJ, Bashynski KL, et al
    Decrease in Enteroviral Meningitis - An Unexpected Benefit of COVID-19 Mitigation?
    Clin Infect Dis. 2020 Dec 23. pii: 6044729. doi: 10.1093/cid/ciaa1881.
    >> Share

  410. LIN DY, Zeng D, Mehrotra DV, Corey L, et al
    Evaluating the Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2020 Dec 19. pii: 6042236. doi: 10.1093/cid/ciaa1863.
    >> Share

  411. GUARALDI G, Milic J, Martinez E, Kamarulzaman A, et al
    HIV care models during the COVID-19 era.
    Clin Infect Dis. 2020 Dec 19. pii: 6041857. doi: 10.1093/cid/ciaa1864.
    >> Share

  412. BOYCE RM, Shook-Sa BE, Aiello AE
    A tale of two studies: Study design and our understanding of SARS-CoV-2 seroprevalence.
    Clin Infect Dis. 2020 Dec 18. pii: 6041690. doi: 10.1093/cid/ciaa1868.
    >> Share

  413. COHEN JI, Burbelo PD
    Reinfection with SARS-CoV-2: Implications for Vaccines.
    Clin Infect Dis. 2020 Dec 18. pii: 6041697. doi: 10.1093/cid/ciaa1866.
    >> Share

  414. GOODMAN KE, Magder LS, Baghdadi JD, Pineles L, et al
    Impact of Sex and Metabolic Comorbidities on COVID-19 Mortality Risk Across Age Groups: 66,646 Inpatients Across 613 U.S. Hospitals.
    Clin Infect Dis. 2020 Dec 18. pii: 6041643. doi: 10.1093/cid/ciaa1787.
    >> Share

  415. HANSON KE, Azar MM, Banerjee R, Chou A, et al
    Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA's Diagnostics Committee.
    Clin Infect Dis. 2020;71:2744-2751.
    >> Share

  416. HUANG J, Liu F, Teng Z, Chen J, et al
    Care for the Psychological Status of Frontline Medical Staff Fighting Against Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2020;71:3268-3269.
    >> Share

  417. MODY A, Pfeifauf K, Bradley C, Fox B, et al
    Understanding Drivers of COVID-19 Racial Disparities: A Population-Level Analysis of COVID-19 Testing among Black and White Populations.
    Clin Infect Dis. 2020 Dec 14. pii: 6033727. doi: 10.1093/cid/ciaa1848.
    >> Share

  418. PETTIT NN, Pisano J, Nguyen CT, Lew AK, et al
    Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?
    Clin Infect Dis. 2020 Dec 14. pii: 6033734. doi: 10.1093/cid/ciaa1851.
    >> Share

  419. ABU-RADDAD LJ, Chemaitelly H, Malek JA, Ahmed AA, et al
    Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting.
    Clin Infect Dis. 2020 Dec 14. pii: 6033728. doi: 10.1093/cid/ciaa1846.
    >> Share

  420. SELHORST P, Van Ierssel S, Michiels J, Marien J, et al
    Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response.
    Clin Infect Dis. 2020 Dec 14. pii: 6033730. doi: 10.1093/cid/ciaa1850.
    >> Share

  421. COSTA SF, Giavina-Bianchi P, Buss L, Mesquita Peres CH, et al
    SARS-CoV-2 seroprevalence and risk factors among oligo/asymptomatic healthcare workers(HCW): estimating the impact of community transmission.
    Clin Infect Dis. 2020 Dec 13. pii: 6032715. doi: 10.1093/cid/ciaa1845.
    >> Share

  422. MOEHRING RW, Holland TL
    Compiling Observational Research During a Pandemic: A Necessary Bridge.
    Clin Infect Dis. 2020 Dec 11. pii: 6030989. doi: 10.1093/cid/ciaa1705.
    >> Share

  423. COOK AR, Dickens BL, Wilder-Smith A
    Differential household attack rates mirror the ability to control Covid-19.
    Clin Infect Dis. 2020 Dec 11. pii: 6030927. doi: 10.1093/cid/ciaa1842.
    >> Share

  424. BAJEMA KL, Dahlgren FS, Lim TW, Bestul N, et al
    Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey.
    Clin Infect Dis. 2020 Dec 10. pii: 6029296. doi: 10.1093/cid/ciaa1804.
    >> Share

  425. KAISER L, Vu-Cantero DL, Eberhardt CS
    Paradoxes and uncertainties of immunomodulatory treatments in the fight against COVID-19.
    Clin Infect Dis. 2020 Dec 8. pii: 6025515. doi: 10.1093/cid/ciaa1837.
    >> Share

  426. ZHU Y, Bloxham CJ, Hulme KD, Sinclair JE, et al
    A meta-analysis on the role of children in SARS-CoV-2 in household transmission clusters.
    Clin Infect Dis. 2020 Dec 6. pii: 6024998. doi: 10.1093/cid/ciaa1825.
    >> Share

  427. COVIN S, Rutherford GW
    Co-infection, SARS-CoV-2 and influenza: an evolving puzzle.
    Clin Infect Dis. 2020 Dec 5. pii: 6024509. doi: 10.1093/cid/ciaa1810.
    >> Share

  428. DOSHI P, Powers JH
    Determining the infectious potential of individuals with positive RT-PCR SARS-CoV-2 tests.
    Clin Infect Dis. 2020 Dec 4. pii: 6024448. doi: 10.1093/cid/ciaa1819.
    >> Share

  429. ZHANG N, Jia W, Lei H, Wang P, et al
    Effects of human behaviour changes during the COVID-19 pandemic on influenza spread in Hong Kong.
    Clin Infect Dis. 2020 Dec 4. pii: 6024447. doi: 10.1093/cid/ciaa1818.
    >> Share

  430. ROSENBERG ES, Bradley HM
    Improving surveillance estimates of COVID-19 incidence in the United States.
    Clin Infect Dis. 2020 Dec 4. pii: 6020000. doi: 10.1093/cid/ciaa1813.
    >> Share

  431. HOWARD LM
    Is there an association between SARS-CoV-2 and Streptococcus pneumoniae?
    Clin Infect Dis. 2020 Dec 4. pii: 6020002. doi: 10.1093/cid/ciaa1812.
    >> Share

  432. NEVES FS
    Dose-response effects of hydroxychloroquine on prophylaxis against SARS-CoV-2 / COVID-19 infection.
    Clin Infect Dis. 2020 Dec 3. pii: 6018203. doi: 10.1093/cid/ciaa1807.
    >> Share

  433. OWUSU D, Kim L, O'Halloran A, Whitaker M, et al
    Characteristics of Adults aged 18-49 Years without Underlying Conditions Hospitalized with Laboratory-Confirmed COVID-19 in the United States, COVID-NET - March-August 2020.
    Clin Infect Dis. 2020 Dec 3. pii: 6017811. doi: 10.1093/cid/ciaa1806.
    >> Share

  434. POSTON D, Weisblum Y, Wise H, Templeton K, et al
    Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection.
    Clin Infect Dis. 2020 Dec 3. pii: 6017810. doi: 10.1093/cid/ciaa1803.
    >> Share

  435. JEFFERSON T, Spencer EA, Brassey J, Heneghan C, et al
    Viral cultures for COVID-19 infectious potential assessment - a systematic review.
    Clin Infect Dis. 2020 Dec 3. pii: 6018217. doi: 10.1093/cid/ciaa1764.
    >> Share

  436. WADHWA A, Fisher KA, Silver R, Koh M, et al
    Identification of presymptomatic and asymptomatic cases using cohort-based testing approaches at a large correctional facility - Chicago, Illinois, USA, May 2020.
    Clin Infect Dis. 2020 Dec 3. pii: 6017809. doi: 10.1093/cid/ciaa1802.
    >> Share

  437. CHAN JF, Zhang AJ, Yuan S, Poon VK, et al
    Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.
    Clin Infect Dis. 2020;71:2428-2446.
    >> Share

  438. LEDNICKY JA
    A practical and economic approach for assessing potential SARS-CoV-2 transmission risk in COVID-19 patients.
    Clin Infect Dis. 2020 Dec 1. pii: 6015519. doi: 10.1093/cid/ciaa1789.
    >> Share

    November 2020
  439. PETERSEN MS, Kristiansen MF, Hanusson KD, Danielsen ME, et al
    Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients.
    Clin Infect Dis. 2020 Nov 30. pii: 6012625. doi: 10.1093/cid/ciaa1792.
    >> Share

  440. BASAVARAJU SV, Patton ME, Grimm K, Rasheed MAU, et al
    Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020.
    Clin Infect Dis. 2020 Nov 30. pii: 6012472. doi: 10.1093/cid/ciaa1785.
    >> Share

  441. BRAUNSTEIN SL, Lazar R, Wahnich A, Daskalakis DC, et al
    COVID-19 infection among people with HIV in New York City: A population-level analysis of linked surveillance data.
    Clin Infect Dis. 2020 Nov 30. pii: 6012626. doi: 10.1093/cid/ciaa1793.
    >> Share

  442. KUIPER VP, Rosendaal FR, Kamerling IMC, Visser LG, et al
    Assessment of risks associated with SARS-CoV-2 experimental human infection studies.
    Clin Infect Dis. 2020 Nov 29. pii: 6009505. doi: 10.1093/cid/ciaa1784.
    >> Share

  443. PADMANABHAN S
    The COVID-19 Pan-Syndemic - will we ever learn?
    Clin Infect Dis. 2020 Nov 29. pii: 6009406. doi: 10.1093/cid/ciaa1797.
    >> Share

  444. NGUYEN TV, Frost SA
    Effect of steroids on Covid-19 mortality risk: a Bayesian interpretation.
    Clin Infect Dis. 2020 Nov 29. pii: 6009383. doi: 10.1093/cid/ciaa1783.
    >> Share

  445. JIA R, Wang H
    How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?
    Clin Infect Dis. 2020 Nov 27. pii: 6007043. doi: 10.1093/cid/ciaa1325.
    >> Share

  446. HUGHES G, Merry C, Geary U, Noonan N, et al
    Changing Disease Epidemiology to Inform Expanded Coronavirus Disease 2019 Testing.
    Clin Infect Dis. 2020 Nov 26. pii: 6006321. doi: 10.1093/cid/ciaa1677.
    >> Share

  447. REESE H, Iuliano AD, Patel NN, Garg S, et al
    Estimated incidence of COVID-19 illness and hospitalization - United States, February-September, 2020.
    Clin Infect Dis. 2020 Nov 25. pii: 6000389. doi: 10.1093/cid/ciaa1780.
    >> Share

  448. VAN DEN BORST B, Peters JB, Brink M, Schoon Y, et al
    Comprehensive health assessment three months after recovery from acute COVID-19.
    Clin Infect Dis. 2020 Nov 21. pii: 5998118. doi: 10.1093/cid/ciaa1750.
    >> Share

  449. LEE JS, Kim SY, Kim TS, Hong KH, et al
    Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
    Clin Infect Dis. 2020 Nov 21. pii: 5997517. doi: 10.1093/cid/ciaa1421.
    >> Share

  450. ZELNER J, Trangucci R, Naraharisetti R, Cao A, et al
    Racial disparities in COVID-19 mortality are driven by unequal infection risks.
    Clin Infect Dis. 2020 Nov 21. pii: 5998295. doi: 10.1093/cid/ciaa1723.
    >> Share

  451. BHATT PJ, Shiau S, Brunetti L, Xie Y, et al
    Risk Factors and Outcomes of Hospitalized Patients with Severe COVID-19 and Secondary Bloodstream Infections: A Multicenter, Case-Control Study.
    Clin Infect Dis. 2020 Nov 20. pii: 5995838. doi: 10.1093/cid/ciaa1748.
    >> Share

  452. MEYEROWITZ EA, Sen P, Schoenfeld SR, Neilan TG, et al
    Immunomodulation as Treatment for Severe COVID-19: a systematic review of current modalities and future directions.
    Clin Infect Dis. 2020 Nov 20. pii: 5996142. doi: 10.1093/cid/ciaa1759.
    >> Share

  453. ZHANG AJ, Lee AC, Chan JF, Liu F, et al
    Co-infection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters.
    Clin Infect Dis. 2020 Nov 20. pii: 5995847. doi: 10.1093/cid/ciaa1747.
    >> Share

  454. MCLAUGHLIN JM, Khan F, Pugh S, Angulo FJ, et al
    County-Level Predictors of COVID-19 Cases and Deaths in the United States: What Happened, and Where Do We Go from Here?
    Clin Infect Dis. 2020 Nov 19. pii: 5992242. doi: 10.1093/cid/ciaa1729.
    >> Share

  455. PELUSO MJ, Bakkour S, Busch MP, Deeks SG, et al
    A High Percentage of People with HIV on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following COVID-19.
    Clin Infect Dis. 2020 Nov 19. pii: 5991913. doi: 10.1093/cid/ciaa1754.
    >> Share

  456. SULLIVAN SG
    The Need for Robust Epidemiological Evidence During a Pandemic.
    Clin Infect Dis. 2020;71:2289-2290.
    >> Share

  457. LORENTZEN HF, Schmidt S, Benfield T
    PCR Test Caveats After Discharge Following COVID-19.
    Clin Infect Dis. 2020;71:2302-2303.
    >> Share

  458. JAIN MK, Rollins N, Jain R
    Access to Coronavirus Disease 2019 Clinical Trials by English and Non-English Speakers Is Needed.
    Clin Infect Dis. 2020;71:2298-2299.
    >> Share

  459. POLONI C, Tsoukas C
    Evaluating Immune Dysregulation in Patients With COVID-19 Requires a More Accurate Definition of the CD45RA+ T-cell Phenotype.
    Clin Infect Dis. 2020;71:2306-2307.
    >> Share

  460. DOAN T, Hinterwirth A, Arzika AM, Worden L, et al
    Reduction of Coronavirus Burden With Mass Azithromycin Distribution.
    Clin Infect Dis. 2020;71:2282-2284.
    >> Share

  461. POLLETT S, Rivers C
    Social Media and the New World of Scientific Communication During the COVID-19 Pandemic.
    Clin Infect Dis. 2020;71:2184-2186.
    >> Share

  462. OUYANG Y, Yin J, Wang W, Shi H, et al
    Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19.
    Clin Infect Dis. 2020;71:2052-2060.
    >> Share

  463. LI N, Han L, Peng M, Lv Y, et al
    Maternal and Neonatal Outcomes of Pregnant Women With Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case-Control Study.
    Clin Infect Dis. 2020;71:2035-2041.
    >> Share

  464. SANVILLE B, Corbett R, Pidcock W, Hardin K, et al
    A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States.
    Clin Infect Dis. 2020;71:2222-2226.
    >> Share

  465. RUSSO A, Bellelli V, Ceccarelli G, Marincola Cattaneo F, et al
    Comparison between hospitalized patients affected or not by COVID-19 (RESILIENCY study).
    Clin Infect Dis. 2020 Nov 18. pii: 5989494. doi: 10.1093/cid/ciaa1745.
    >> Share

  466. STAPLETON JT
    SARS-CoV-2 Antibody Testing: Important but Imperfect.
    Clin Infect Dis. 2020 Nov 18. pii: 5989218. doi: 10.1093/cid/ciaa1755.
    >> Share

  467. TLEYJEH IM
    The misleading "pooled effect estimate" of crude data from observational studies at critical risk of bias: The case of Tocilizumab in COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985641. doi: 10.1093/cid/ciaa1735.
    >> Share

  468. LADHANI SN, Andrews N, Aiano F, Baawuah F, et al
    Secondary attack rate and family clustering of SARS-CoV-2 infection in children of healthcare workers with confirmed COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985642. doi: 10.1093/cid/ciaa1737.
    >> Share

  469. HUANG YT, Chao CM, Lai CC
    The impact of tocilizumab on the mortality of patients with COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985678. doi: 10.1093/cid/ciaa1738.
    >> Share

  470. EMANUELS A, Heimonen J, O'Hanlon J, Kim AE, et al
    Remote Household Observation for Non-influenza Respiratory Viral Illness.
    Clin Infect Dis. 2020 Nov 17. pii: 5983780. doi: 10.1093/cid/ciaa1719.
    >> Share

  471. AMIN-CHOWDHURY Z, Aiano F, Mensah A, Sheppard C, et al
    Impact of the COVID-19 Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection with SARS-CoV-2: prospective national cohort study, England.
    Clin Infect Dis. 2020 Nov 16. pii: 5983410. doi: 10.1093/cid/ciaa1728.
    >> Share

  472. MARAIS BJ
    COVID-19 disease spectrum in children - first insights from Africa.
    Clin Infect Dis. 2020 Nov 14. pii: 5981678. doi: 10.1093/cid/ciaa1731.
    >> Share

  473. BROTONS P, Launes C, Buetas E, Fumado V, et al
    Susceptibility to Sars-COV-2 Infection Among Children And Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain.
    Clin Infect Dis. 2020 Nov 12. pii: 5979490. doi: 10.1093/cid/ciaa1721.
    >> Share

  474. LUM BX, Liu EH, Archuleta S, Somani J, et al
    Establishing a New Normal for Hospital Care: A Whole of Hospital Approach to COVID-19.
    Clin Infect Dis. 2020 Nov 12. pii: 5974991. doi: 10.1093/cid/ciaa1722.
    >> Share

  475. VAN DER ZALM MM, Lishman J, Verhagen LM, Redfern A, et al
    Clinical experience with SARS CoV-2 related illness in children - hospital experience in Cape Town, South Africa.
    Clin Infect Dis. 2020 Nov 10. pii: 5973899. doi: 10.1093/cid/ciaa1666.
    >> Share

  476. CHE Y, Liu X, Pu Y, Zhou M, et al
    Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults.
    Clin Infect Dis. 2020 Nov 9. pii: 5962856. doi: 10.1093/cid/ciaa1703.
    >> Share

  477. COLLINS LF
    Persons with HIV and the COVID-19 Pandemic: A Viral Synergy of Biology and Sociology.
    Clin Infect Dis. 2020 Nov 8. pii: 5960297. doi: 10.1093/cid/ciaa1715.
    >> Share

  478. POSFAY-BARBE KM, Andrey DO, Virzi J, Cohen P, et al
    Prevalence of IgG against SARS-CoV-2 and evaluation of a rapid MEDsan IgG test in children seeking medical care.
    Clin Infect Dis. 2020 Nov 8. pii: 5960295. doi: 10.1093/cid/ciaa1702.
    >> Share

  479. SHERMAN AC, Babiker A, Sieben AJ, Pyden A, et al
    The Effect of SARS-CoV-2 Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of Two Large Metropolitan Centers in the United States.
    Clin Infect Dis. 2020 Nov 8. pii: 5960296. doi: 10.1093/cid/ciaa1704.
    >> Share

  480. GOLDMAN JD
    Hydroxychloroquine for Prevention of SARS-CoV-2 Infection: challenges to trial conduct during the global pandemic.
    Clin Infect Dis. 2020 Nov 7. pii: 5959847. doi: 10.1093/cid/ciaa1707.
    >> Share

  481. HUH K, Jung J, Hong J, Kim M, et al
    Impact of non-pharmaceutical interventions on the incidence of respiratory infections during the COVID-19 outbreak in Korea: a nationwide surveillance study.
    Clin Infect Dis. 2020 Nov 5. pii: 5956267. doi: 10.1093/cid/ciaa1682.
    >> Share

  482. SIMS MD, Maine GN, Childers KL, Podolsky RH, et al
    COVID-19 seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking.
    Clin Infect Dis. 2020 Nov 5. pii: 5956266. doi: 10.1093/cid/ciaa1684.
    >> Share

  483. LEI JH, Xu Y, Jiang YF, Shi ZH, et al
    Clustering cases of Chlamydia psittaci pneumonia in COVID-19 screening ward staff.
    Clin Infect Dis. 2020 Nov 5. pii: 5956268. doi: 10.1093/cid/ciaa1681.
    >> Share

  484. QIN G, Zhang L, Yu CJ
    Nonpharmaceutical Interventions and Epidemic Intensity During the 2019 Novel Coronavirus Disease Pandemic.
    Clin Infect Dis. 2020;71:2019-2020.
    >> Share

  485. HTUN HL, Lim DW, Kyaw WM, Loh WJ, et al
    Responding to the COVID-19 Outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems.
    Clin Infect Dis. 2020;71:1947-1952.
    >> Share

  486. PETERSEN LR, Sami S, Vuong N, Pathela P, et al
    Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons.
    Clin Infect Dis. 2020 Nov 4. pii: 5956137. doi: 10.1093/cid/ciaa1685.
    >> Share

  487. ARVISAIS-ANHALT S, Lehmann CU, Park JY, Araj E, et al
    What the COVID-19 Pandemic Has Reinforced: The Need for Accurate Data.
    Clin Infect Dis. 2020 Nov 4. pii: 5956084. doi: 10.1093/cid/ciaa1686.
    >> Share

  488. HURST JH, Heston SM, Chambers HN, Cunningham HM, et al
    SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study.
    Clin Infect Dis. 2020 Nov 3. pii: 5952826. doi: 10.1093/cid/ciaa1693.
    >> Share

  489. VIJAYAN T, Shin M, Adamson PC, Harris C, et al
    Beyond the 405 and the 5: Geographic variations and factors associated with SARS-CoV-2 positivity rates in Los Angeles County.
    Clin Infect Dis. 2020 Nov 3. pii: 5952808. doi: 10.1093/cid/ciaa1692.
    >> Share

    October 2020
  490. MASTRANGELO A, Germinario BN, Ferrante M, Frangi C, et al
    Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls.
    Clin Infect Dis. 2020 Oct 30. pii: 5943480. doi: 10.1093/cid/ciaa1594.
    >> Share

  491. ZHANG X, Wang J
    Dose-response Relation Deduced for Coronaviruses from COVID-19, SARS and MERS Meta-analysis Results and its Application for Infection Risk Assessment of Aerosol Transmission.
    Clin Infect Dis. 2020 Oct 29. pii: 5943160. doi: 10.1093/cid/ciaa1675.
    >> Share

  492. VOETEN HACM, Sikkema RS, Damen M, Oude Munnink BB, et al
    Unravelling the modes of transmission of SARS-CoV-2 during a nursing home outbreak: looking beyond the church super-spread event.
    Clin Infect Dis. 2020 Oct 29. pii: 5943000. doi: 10.1093/cid/ciaa1664.
    >> Share

  493. HOFFMANN C, Wolf E
    The Low Case Fatality Rate of COVID-19 in Hong Kong Could Be Deceptive.
    Clin Infect Dis. 2020 Oct 29. pii: 5942945. doi: 10.1093/cid/ciaa1676.
    >> Share

  494. MARQUEZ H, Ramers C, Northrup A, Tam A, et al
    Response to the COVID-19 pandemic among people experiencing homelessness in congregant living settings in San Diego, CA.
    Clin Infect Dis. 2020 Oct 28. pii: 5942619. doi: 10.1093/cid/ciaa1668.
    >> Share

  495. YANG HC
    Isolation or De-isolation: Measuring the Infectivity of SARS-CoV-2?
    Clin Infect Dis. 2020 Oct 28. pii: 5942612. doi: 10.1093/cid/ciaa1671.
    >> Share

  496. FAN VS, Dominitz JA, Eastment MC, Locke E, et al
    Risk Factors for testing positive for SARS-CoV-2 in a national US healthcare system.
    Clin Infect Dis. 2020 Oct 27. pii: 5940590. doi: 10.1093/cid/ciaa1624.
    >> Share

  497. PREMACHANDRAN KP, Senthur Nambi P, Ramasubramanian V, Gopalakrishnan R, et al
    Avifavir in Treating Patients with Moderate Covid 19.
    Clin Infect Dis. 2020 Oct 27. pii: 5940577. doi: 10.1093/cid/ciaa1601.
    >> Share

  498. GNIAZDOWSKI V, Morris CP, Wohl S, Mehoke T, et al
    Repeat COVID-19 Molecular Testing: Correlation of SARS-CoV-2 Culture with Molecular Assays and Cycle Thresholds.
    Clin Infect Dis. 2020 Oct 27. pii: 5940589. doi: 10.1093/cid/ciaa1616.
    >> Share

  499. IWATA K, Yoshimura K
    A concern regarding estimated sensitivities and specificities of nasopharyngeal and saliva specimens for SARS-CoV-2 infection.
    Clin Infect Dis. 2020 Oct 26. pii: 5940522. doi: 10.1093/cid/ciaa1655.
    >> Share

  500. GUHAROY R, Krenzelok EP
    FDA Emergency Use Authorization: Glass Half Empty?
    Clin Infect Dis. 2020 Oct 26. pii: 5940147. doi: 10.1093/cid/ciaa1653.
    >> Share

  501. FANG FC, Benson CA, Del Rio C, Edwards KM, et al
    COVID-19 - Lessons Learned and Questions Remaining.
    Clin Infect Dis. 2020 Oct 26. pii: 5940148. doi: 10.1093/cid/ciaa1654.
    >> Share

  502. RHEE C, Kanjilal S, Baker M, Klompas M, et al
    Reply to Cimolai: Even With Variable Viral Culture Methods, Culturing SARS-CoV-2 After 10 Days Appears to be Rare and Has Unclear Implications for Transmission.
    Clin Infect Dis. 2020 Oct 26. pii: 5940146. doi: 10.1093/cid/ciaa1634.
    >> Share

  503. KOBAYASHI T, Trannel A, Holley SA, Alsuhaibani M, et al
    COVID-19 Serial Testing among Hospitalized Patients in a Midwest Tertiary Medical Center, July-September 2020.
    Clin Infect Dis. 2020 Oct 26. pii: 5939900. doi: 10.1093/cid/ciaa1630.
    >> Share

  504. MALSY J, Veletzky L, Heide J, Hennigs A, et al
    Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19.
    Clin Infect Dis. 2020 Oct 26. pii: 5939946. doi: 10.1093/cid/ciaa1637.
    >> Share

  505. ANDERSON L, Caniza M
    COVID-19 and preventative medicine for HIV infected children.
    Clin Infect Dis. 2020 Oct 26. pii: 5939859. doi: 10.1093/cid/ciaa1626.
    >> Share

  506. HAGE R, Schuurmans MM
    COVID-19 in solid organ transplant recipients.
    Clin Infect Dis. 2020 Oct 26. pii: 5939886. doi: 10.1093/cid/ciaa1629.
    >> Share

  507. PEDERSEN OB, Nissen J, Dinh KM, Schwinn M, et al
    SARS-CoV-2 infection fatality rate among elderly retired Danish blood donors - A cross-sectional study.
    Clin Infect Dis. 2020 Oct 26. pii: 5939898. doi: 10.1093/cid/ciaa1627.
    >> Share

  508. CHIN ET, Huynh BQ, Chapman LAC, Murrill M, et al
    Frequency of Routine Testing for Coronavirus Disease 2019 (COVID-19) in High-risk Healthcare Environments to Reduce Outbreaks.
    Clin Infect Dis. 2020 Oct 26. pii: 5939986. doi: 10.1093/cid/ciaa1383.
    >> Share

  509. SANTORO F, Monitillo F, Raimondo P, Lopizzo A, et al
    QTc interval prolongation and life-threatening arrhythmias during hospitalization in patients with COVID-19. Results from a multi-center prospective registry.
    Clin Infect Dis. 2020 Oct 24. pii: 5938528. doi: 10.1093/cid/ciaa1578.
    >> Share

  510. BASILE K, McPhie K, Carter I, Alderson S, et al
    Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19.
    Clin Infect Dis. 2020 Oct 24. pii: 5937368. doi: 10.1093/cid/ciaa1579.
    >> Share

  511. GERETTI AM, Stockdale AJ, Kelly SH, Cevik M, et al
    Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study.
    Clin Infect Dis. 2020 Oct 23. pii: 5937133. doi: 10.1093/cid/ciaa1605.
    >> Share

  512. OLDONI E, van Gool A, Garcia Bermejo L, Scherer A, et al
    Biomarker Research and Development for Coronavirus Disease 2019 (COVID-19): European Medical Research Infrastructures Call for Global Coordination.
    Clin Infect Dis. 2020 Oct 22. pii: 5935756. doi: 10.1093/cid/ciaa1250.
    >> Share

  513. ASLAM A, Singh J, Robilotti E, Chow K, et al
    SARS CoV-2 Surveillance and Exposure in the Perioperative Setting with Universal testing and Personal Protective Equipment (PPE) Policies.
    Clin Infect Dis. 2020 Oct 22. pii: 5934921. doi: 10.1093/cid/ciaa1607.
    >> Share

  514. DU P, Song C, Li R, Song Y, et al
    Specific re-distribution of SARS-CoV-2 variants in the respiratory system and intestinal tract.
    Clin Infect Dis. 2020 Oct 22. pii: 5934821. doi: 10.1093/cid/ciaa1617.
    >> Share

  515. AHMAD MF, Mahakkanukrauh P, Das S
    The detection of SARS-CoV-2 virus in the vaginal fluid of females with severe COVID-19 infection: scientific facts.
    Clin Infect Dis. 2020 Oct 21. pii: 5934738. doi: 10.1093/cid/ciaa1608.
    >> Share

  516. AZZI L
    Saliva is the Key Element for SARS-CoV-2 Mass Screening.
    Clin Infect Dis. 2020 Oct 21. pii: 5933821. doi: 10.1093/cid/ciaa1440.
    >> Share

  517. LEI H, Wu X, Wang X, Xu M, et al
    Different transmission dynamics of COVID-19 and influenza suggest the relative efficiency of isolation/quarantine and social distancing against COVID-19 in China.
    Clin Infect Dis. 2020 Oct 20. pii: 5932276. doi: 10.1093/cid/ciaa1584.
    >> Share

  518. O'DRISCOLL M, Harry C, Donnelly CA, Cori A, et al
    A comparative analysis of statistical methods to estimate the reproduction number in emerging epidemics with implications for the current COVID-19 pandemic.
    Clin Infect Dis. 2020 Oct 20. pii: 5932264. doi: 10.1093/cid/ciaa1599.
    >> Share

  519. XU J, Teng Y, Shang L, Gu X, et al
    The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2020 Oct 20. pii: 5932274. doi: 10.1093/cid/ciaa1592.
    >> Share

  520. YANG B, Fulcher JA, Ahn J, Berro M, et al
    Clinical Characteristics and Outcomes of COVID-19 Patients Receiving Compassionate Use Leronlimab.
    Clin Infect Dis. 2020 Oct 20. pii: 5932277. doi: 10.1093/cid/ciaa1583.
    >> Share

  521. KOJIMA N, Turner F, Slepnev V, Bacelar A, et al
    Self-Collected Oral Fluid and Nasal Swab Specimens Demonstrate Comparable Sensitivity to Clinician-Collected Nasopharyngeal Swab Specimens for the Detection of SARS-CoV-2.
    Clin Infect Dis. 2020 Oct 19. pii: 5930814. doi: 10.1093/cid/ciaa1589.
    >> Share

  522. DAUBY N
    Favipiravir as an antiviral agent in COVID-19: same script, different cast?
    Clin Infect Dis. 2020 Oct 19. pii: 5930653. doi: 10.1093/cid/ciaa1600.
    >> Share

  523. ANESI GL
    Hospital transfers across U.S. regions to address the "space" shortage in a pandemic: a public good.
    Clin Infect Dis. 2020 Oct 18. pii: 5929668. doi: 10.1093/cid/ciaa1596.
    >> Share

  524. PIMENOFF VN, Elfstrom M, Baussano I, Bjornstedt M, et al
    Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden.
    Clin Infect Dis. 2020 Oct 18. pii: 5929661. doi: 10.1093/cid/ciaa1593.
    >> Share

  525. CONOVER CS
    Transmission of SARS-CoV-2 via Contaminated Surfaces: What is to be Done?
    Clin Infect Dis. 2020 Oct 18. pii: 5929662. doi: 10.1093/cid/ciaa1586.
    >> Share

  526. RODRIGUEZ JY, Le Pape P, Lopez O, Esquea K, et al
    Candida auris: a latent threat to critically ill patients with COVID-19.
    Clin Infect Dis. 2020 Oct 18. pii: 5929667. doi: 10.1093/cid/ciaa1595.
    >> Share

  527. WHITE PL, Dhillon R, Healy B, Wise MP, et al
    Candidaemia in COVID-19, a link to disease pathology or increased clinical pressures?
    Clin Infect Dis. 2020 Oct 18. pii: 5929669. doi: 10.1093/cid/ciaa1597.
    >> Share

  528. RAJASINGHAM R, Bangdiwala AS, Nicol MR, Skipper CP, et al
    Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial.
    Clin Infect Dis. 2020 Oct 17. pii: 5929230. doi: 10.1093/cid/ciaa1571.
    >> Share

  529. LESSLER J
    An overlooked role for fecal transmission of SARS-CoV-2?
    Clin Infect Dis. 2020 Oct 16. pii: 5925219. doi: 10.1093/cid/ciaa1575.
    >> Share

  530. YOSHIOKA T, Funada S, Luo Y
    The inherent problems with the generalizability of the CALL score: towards reliable clinical prediction models for COVID-19.
    Clin Infect Dis. 2020 Oct 16. pii: 5925185. doi: 10.1093/cid/ciaa1564.
    >> Share

  531. MCCAW ZR, Tian L, Kim DH, Localio AR, et al
    Survival analysis of treatment efficacy in comparative COVID-19 studies.
    Clin Infect Dis. 2020 Oct 14. pii: 5923375. doi: 10.1093/cid/ciaa1563.
    >> Share

  532. ZENG HL, Lu QB, Yang Q, Wang X, et al
    Longitudinal Profile of Laboratory Parameters and Their Application in the Prediction for Fatal Outcome Among Patients Infected With SARS-CoV-2: A Retrospective Cohort Study.
    Clin Infect Dis. 2020 Oct 13. pii: 5922241. doi: 10.1093.
    >> Share

  533. ZANG X, Krebs E, Chen S, Piske M, et al
    The potential epidemiological impact of COVID-19 on the HIV/AIDS epidemic and the cost-effectiveness of linked, opt-out HIV testing: A modeling study in six US cities.
    Clin Infect Dis. 2020 Oct 12. pii: 5921245. doi: 10.1093/cid/ciaa1547.
    >> Share

  534. FUNG HF, Martinez L, Alarid-Escudero F, Salomon JA, et al
    The household secondary attack rate of SARS-CoV-2: A rapid review.
    Clin Infect Dis. 2020 Oct 12. pii: 5921151. doi: 10.1093/cid/ciaa1558.
    >> Share

  535. YUAN J, Chen Z, Gong C, Liu H, et al
    Sewage as a Possible Transmission Vehicle During a Coronavirus Disease 2019 Outbreak in a Densely populated Community: Guangzhou, China, April 2020.
    Clin Infect Dis. 2020 Oct 12. pii: 5920983. doi: 10.1093/cid/ciaa1494.
    >> Share

  536. STEVENSON DR, Sahemey M, Cevallos Morales J, Martin-Lazaro J, et al
    Improving Antimicrobial Stewardship in Critically-Ill Patients with COVID-19.
    Clin Infect Dis. 2020 Oct 11. pii: 5920705. doi: 10.1093/cid/ciaa1559.
    >> Share

  537. ROGERS R, Shehadeh F, Mylona EK, Rich J, et al
    Convalescent plasma for patients with severe COVID-19: a matched cohort study.
    Clin Infect Dis. 2020 Oct 10. pii: 5920703. doi: 10.1093/cid/ciaa1548.
    >> Share

  538. EDWARDS KM
    The Impact of Social Distancing for SARS-CoV-2 on Respiratory Syncytial Virus and Influenza Burden.
    Clin Infect Dis. 2020 Oct 10. pii: 5920710. doi: 10.1093/cid/ciaa1543.
    >> Share

  539. MICHELSON KA, Rees CA, Sarathy J, VonAchen P, et al
    Inter-Region Transfers for Pandemic Surges.
    Clin Infect Dis. 2020 Oct 10. pii: 5920707. doi: 10.1093/cid/ciaa1549.
    >> Share

  540. KIM AY, Gandhi RT
    Re-infection with SARS-CoV-2: What Goes Around May Come Back Around.
    Clin Infect Dis. 2020 Oct 9. pii: 5920338. doi: 10.1093/cid/ciaa1541.
    >> Share

  541. MUNBLIT D, Nekliudov NA, Bugaeva P, Blyuss O, et al
    StopCOVID cohort: An observational study of 3,480 patients admitted to the Sechenov University hospital network in Moscow city for suspected COVID-19 infection.
    Clin Infect Dis. 2020 Oct 9. pii: 5920244. doi: 10.1093/cid/ciaa1535.
    >> Share

  542. MURUGESAN K, Jagannathan P, Pham TD, Pandey S, et al
    Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response.
    Clin Infect Dis. 2020 Oct 9. pii: 5920279. doi: 10.1093/cid/ciaa1537.
    >> Share

  543. MCCAULEY BD, Ortega-Legaspi JM
    Learning more about what can make COVID-19 deadly: Insights from the Atlanta Metropolitan Area.
    Clin Infect Dis. 2020 Oct 9. pii: 5920339. doi: 10.1093/cid/ciaa1540.
    >> Share

  544. ARMSTRONG WS, Agwu AL, Barrette EP, Ignacio RB, et al
    Innovations in HIV care delivery during the COVID-19 pandemic: Policies to strengthen the Ending the Epidemic Initiative - A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
    Clin Infect Dis. 2020 Oct 9. pii: 5920317. doi: 10.1093/cid/ciaa1532.
    >> Share

  545. WOOD BR, Young JD, Abdel-Massih RC, McCurdy L, et al
    Advancing Digital Health Equity: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
    Clin Infect Dis. 2020 Oct 9. pii: 5919799. doi: 10.1093/cid/ciaa1525.
    >> Share

  546. MULDER M, van der Vegt DSJM, Oude Munnink BB, GeurtsvanKessel CH, et al
    Reinfection of SARS-CoV-2 in an immunocompromised patient: a case report.
    Clin Infect Dis. 2020 Oct 9. pii: 5920950. doi: 10.1093/cid/ciaa1538.
    >> Share

  547. BURWICK RM, Yawetz S, Stephenson KE, Collier AY, et al
    Compassionate Use of Remdesivir in Pregnant Women with Severe Covid-19.
    Clin Infect Dis. 2020 Oct 8. pii: 5919737. doi: 10.1093/cid/ciaa1466.
    >> Share

  548. HIROSE R, Ikegaya H, Naito Y, Watanabe N, et al
    Survival of SARS-CoV-2 and influenza virus on the human skin: Importance of hand hygiene in COVID-19.
    Clin Infect Dis. 2020 Oct 3. pii: 5917611. doi: 10.1093/cid/ciaa1517.
    >> Share

  549. ROSENBERG ES, Holtgrave DR
    Widespread and frequent testing is essential to controlling COVID-19 in the United States.
    Clin Infect Dis. 2020 Oct 3. pii: 5917595. doi: 10.1093/cid/ciaa1508.
    >> Share

  550. TSAI AC, Harling G, Reynolds Z, Gilbert RF, et al
    COVID-19 transmission in the U.S. before vs. after relaxation of statewide social distancing measures.
    Clin Infect Dis. 2020 Oct 3. pii: 5917573. doi: 10.1093/cid/ciaa1502.
    >> Share

  551. JESPERSEN S, Mikkelsen S, Greve T, Kaspersen KA, et al
    SARS-CoV-2 seroprevalence survey among 17,971 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region.
    Clin Infect Dis. 2020 Oct 3. pii: 5917713. doi: 10.1093/cid/ciaa1471.
    >> Share

  552. LUI GC, Yip TC, Wong VW, Chow VC, et al
    Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study.
    Clin Infect Dis. 2020 Oct 1. pii: 5917130. doi: 10.1093/cid/ciaa1187.
    >> Share

    September 2020
  553. FOCOSI D, Iorio MC, Lanza M
    ABO Blood Group Correlations With COVID-19: Cohort Choice Makes A Difference.
    Clin Infect Dis. 2020 Sep 30. pii: 5913429. doi: 10.1093/cid/ciaa1495.
    >> Share

  554. HASAN ALI O, Bomze D, Risch L, Brugger SD, et al
    Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies.
    Clin Infect Dis. 2020 Sep 30. pii: 5913451. doi: 10.1093/cid/ciaa1496.
    >> Share

  555. LI H, Sun K, Persing DH, Tang YW, et al
    Real-time Screening of Specimen Pools for Coronavirus Disease 2019 (COVID-19) Infection at Sanya Airport, Hainan Island, China.
    Clin Infect Dis. 2020 Sep 30. pii: 5913344. doi: 10.1093/cid/ciaa1074.
    >> Share

  556. SACHITHANANDHAM J, Thio CL, Balagopal A
    The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Composite But Incomplete Picture.
    Clin Infect Dis. 2020 Sep 29. pii: 5912956. doi: 10.1093/cid/ciaa1413.
    >> Share

  557. LINAS BP, Cunningham CO
    Coronavirus Disease 2019 (COVID-19) Disparities: A Call for Equity in Health Outcomes and Clinical Research.
    Clin Infect Dis. 2020 Sep 29. pii: 5912957. doi: 10.1093/cid/ciaa1460.
    >> Share

  558. ANTONIO-VILLA NE, Bello-Chavolla OY, Vargas-Vazquez A, Fermin-Martinez CA, et al
    Health-care workers with COVID-19 living in Mexico City: clinical characterization and related outcomes.
    Clin Infect Dis. 2020 Sep 28. pii: 5912602. doi: 10.1093/cid/ciaa1487.
    >> Share

  559. FRIEDRICH F, Ongaratto R, Scotta MC, Veras TN, et al
    Early Impact of social distancing in response to COVID-19 on hospitalizations for acute bronchiolitis in infants in Brazil.
    Clin Infect Dis. 2020 Sep 28. pii: 5912563. doi: 10.1093/cid/ciaa1458.
    >> Share

  560. MARTINOT M, Jary A, Fafi-Kremer S, Leducq V, et al
    Remdesivir failure with SARS-CoV-2 RNA-dependent RNA-polymerase mutation in a B-cell immunodeficient patient with protracted Covid-19.
    Clin Infect Dis. 2020 Sep 28. pii: 5912587. doi: 10.1093/cid/ciaa1474.
    >> Share

  561. YEOH DK, Foley DA, Minney-Smith CA, Martin AC, et al
    The impact of COVID-19 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter.
    Clin Infect Dis. 2020 Sep 28. pii: 5912591. doi: 10.1093/cid/ciaa1475.
    >> Share

  562. DELANGHE JR, De Buyzere ML, Speeckaert MM
    ABO blood groups and COVID-19.
    Clin Infect Dis. 2020 Sep 28. pii: 5912552. doi: 10.1093/cid/ciaa1472.
    >> Share

  563. JAAFAR R, Aherfi S, Wurtz N, Grimaldier C, et al
    Correlation between 3790 qPCR positives samples and positive cell cultures including 1941 SARS-CoV-2 isolates.
    Clin Infect Dis. 2020 Sep 28. pii: 5912603. doi: 10.1093/cid/ciaa1491.
    >> Share

  564. BOUDIN L, Dutasta F
    Relationship between ABO blood groups and COVID-19: study design matters.
    Clin Infect Dis. 2020 Sep 28. pii: 5912554. doi: 10.1093/cid/ciaa1473.
    >> Share

  565. MATSUNAGA N, Hayakawa K, Terada M, Ohtsu H, et al
    Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19 REGISTRY JAPAN.
    Clin Infect Dis. 2020 Sep 28. pii: 5912544. doi: 10.1093/cid/ciaa1470.
    >> Share

  566. CLARK AE, Lee FM
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Screening With Specimen Pools: Time to Swim, or Too Deep for Comfort?
    Clin Infect Dis. 2020 Sep 28. pii: 5912416. doi: 10.1093/cid/ciaa1145.
    >> Share

  567. SALVATORE PP, Dawson P, Wadhwa A, Rabold EM, et al
    Epidemiological Correlates of PCR Cycle Threshold Values in the Detection of SARS-CoV-2.
    Clin Infect Dis. 2020 Sep 28. pii: 5912493. doi: 10.1093/cid/ciaa1469.
    >> Share

  568. GUERRERO-TORRES L, Caro-Vega Y, Crabtree-Ramirez B, Sierra-Madero JG, et al
    Clinical Characteristics and Mortality of Healthcare Workers with SARS-CoV-2 infection in Mexico City.
    Clin Infect Dis. 2020 Sep 28. pii: 5912498. doi: 10.1093/cid/ciaa1465.
    >> Share

  569. BHARGAVA A, Sharma M, Riederer K, Fukushima EA, et al
    Risk Factors for In-hospital Mortality from COVID-19 Infection among Black Patients - An Urban Center Experience.
    Clin Infect Dis. 2020 Sep 28. pii: 5912353. doi: 10.1093/cid/ciaa1468.
    >> Share

  570. KANAMORI H, Weber DJ, Rutala WA
    The role of the healthcare surface environment in SARS-CoV-2 transmission and potential control measures.
    Clin Infect Dis. 2020 Sep 28. pii: 5912347. doi: 10.1093/cid/ciaa1467.
    >> Share

  571. CLARK KEN, Nevin WD, Mahungu T, Lachmann H, et al
    Assessment of the Haemophagocytic lymphohistiocytosis HScore in patients with COVID-19.
    Clin Infect Dis. 2020 Sep 28. pii: 5912317. doi: 10.1093/cid/ciaa1463.
    >> Share

  572. TOOR J, Adams ER, Aliee M, Amoah B, et al
    Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation.
    Clin Infect Dis. 2020 Sep 28. pii: 5912106. doi: 10.1093.
    >> Share

  573. YOKOTA I, Shane PY, Okada K, Unoki Y, et al
    Mass screening of asymptomatic persons for SARS-CoV-2 using saliva.
    Clin Infect Dis. 2020 Sep 25. pii: 5911780. doi: 10.1093/cid/ciaa1388.
    >> Share

  574. JACKSON BR, Gold JAW, Natarajan P, Rossow J, et al
    Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with COVID-19.
    Clin Infect Dis. 2020 Sep 24. pii: 5911241. doi: 10.1093/cid/ciaa1459.
    >> Share

  575. IBRAHIM Y, Raut A, Varney J, Sidhu A, et al
    Lessons Learned from the Re-emergent COVID-19 Cases in Areas of Long Reported No Community Transmission.
    Clin Infect Dis. 2020 Sep 24. pii: 5911203. doi: 10.1093/cid/ciaa1438.
    >> Share

  576. GERSH F, Lavie CJ, O'Keefe JH
    Menopause status and COVID-19.
    Clin Infect Dis. 2020 Sep 23. pii: 5910673. doi: 10.1093/cid/ciaa1447.
    >> Share

  577. TO KK, Hung IF, Chan KH, Yuan S, et al
    Serum antibody profile of a patient with COVID-19 reinfection.
    Clin Infect Dis. 2020 Sep 23. pii: 5910650. doi: 10.1093/cid/ciaa1368.
    >> Share

  578. HOGAN CA, Stevens BA, Sahoo MK, Huang C, et al
    High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease.
    Clin Infect Dis. 2020 Sep 23. pii: 5910434. doi: 10.1093/cid/ciaa1054.
    >> Share

  579. GUPTA V, Bhoyar RC, Jain A, Srivastava S, et al
    Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2.
    Clin Infect Dis. 2020 Sep 23. pii: 5910388. doi: 10.1093/cid/ciaa1451.
    >> Share

  580. CEVIK M, Marcus JL, Buckee C, Smith TC, et al
    SARS-CoV-2 transmission dynamics should inform policy.
    Clin Infect Dis. 2020 Sep 23. pii: 5910315. doi: 10.1093/cid/ciaa1442.
    >> Share

  581. DE ALENCAR JCG, Moreira CL, Muller AD, Chaves CE, et al
    Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19.
    Clin Infect Dis. 2020 Sep 23. pii: 5910353. doi: 10.1093/cid/ciaa1443.
    >> Share

  582. MALGIE J, Schoones JW, Pijls BG
    Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies.
    Clin Infect Dis. 2020 Sep 23. pii: 5910379. doi: 10.1093/cid/ciaa1445.
    >> Share

  583. WANG M, Zhao Y, Hu W, Zhao D, et al
    Treatment of COVID-19 Patients with Prolonged Post-Symptomatic Viral Shedding with Leflunomide -- a Single-Center, Randomized, Controlled Clinical Trial.
    Clin Infect Dis. 2020 Sep 21. pii: 5909448. doi: 10.1093/cid/ciaa1417.
    >> Share

  584. LUCEY M, Macori G, Mullane N, Sutton-Fitzpatrick U, et al
    Whole-genome sequencing to track SARS-CoV-2 transmission in nosocomial outbreaks.
    Clin Infect Dis. 2020 Sep 19. pii: 5909421. doi: 10.1093/cid/ciaa1433.
    >> Share

  585. LARSON D, Brodniak SL, Voegtly LJ, Cer RZ, et al
    A Case of Early Re-infection with SARS-CoV-2.
    Clin Infect Dis. 2020 Sep 19. pii: 5908892. doi: 10.1093/cid/ciaa1436.
    >> Share

  586. RYBICKI FJ
    3D Printing in Medicine: COVID-19 Testing with 3D Printed Nasopharyngeal Swabs.
    Clin Infect Dis. 2020 Sep 19. pii: 5908885. doi: 10.1093/cid/ciaa1437.
    >> Share

  587. KOW CS, Hasan SS
    Corticosteroid-related in-hospital hyperglycemia: does it negate mortality benefits in COVID-19?
    Clin Infect Dis. 2020 Sep 18. pii: 5908741. doi: 10.1093/cid/ciaa1423.
    >> Share

  588. ROLDAN-SANTIAGO E, Benito-Berlinches A, Martinez-Garcia L, Quereda C, et al
    SARS-CoV-2 spreads to lymph nodes and strongly expands CD4+ TEMRA cells in a patient with mild COVID-19.
    Clin Infect Dis. 2020 Sep 18. pii: 5908740. doi: 10.1093/cid/ciaa1422.
    >> Share

  589. FLAHERMAN VJ, Afshar Y, Boscardin J, Keller RL, et al
    Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study.
    Clin Infect Dis. 2020 Sep 18. pii: 5908705. doi: 10.1093/cid/ciaa1411.
    >> Share

  590. MILLER J, Fadel RA, Tang A, Perrotta G, et al
    The Impact of Sociodemographic Factors, Comorbidities and Physiologic Response on 30-day Mortality in COVID-19 Patients in Metropolitan Detroit.
    Clin Infect Dis. 2020 Sep 18. pii: 5908303. doi: 10.1093/cid/ciaa1420.
    >> Share

  591. KO JY, Danielson ML, Town M, Derado G, et al
    Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System.
    Clin Infect Dis. 2020 Sep 18. pii: 5908300. doi: 10.1093/cid/ciaa1419.
    >> Share

  592. NEILAN AM, Losina E, Bangs AC, Flanagan C, et al
    Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts.
    Clin Infect Dis. 2020 Sep 18. pii: 5908298. doi: 10.1093/cid/ciaa1418.
    >> Share

  593. BAHL P, de Silva C, Bhattacharjee S, Stone H, et al
    Droplets and Aerosols generated by singing and the risk of COVID-19 for choirs.
    Clin Infect Dis. 2020 Sep 18. pii: 5908276. doi: 10.1093/cid/ciaa1241.
    >> Share

  594. ANDERSON EJ, Campbell JD, Creech CB, Frenck R, et al
    Warp Speed for COVID-19 Vaccines: Why are Children Stuck in Neutral?
    Clin Infect Dis. 2020 Sep 18. pii: 5908283. doi: 10.1093/cid/ciaa1425.
    >> Share

  595. PINSKY BA, Hogan CA
    Carving out a niche for SARS-CoV-2 plasma RNA testing.
    Clin Infect Dis. 2020 Sep 17. pii: 5907919. doi: 10.1093/cid/ciaa1412.
    >> Share

  596. WASFY JH
    American Politics and the Spread of SARS-CoV-2.
    Clin Infect Dis. 2020 Sep 17. pii: 5907812. doi: 10.1093/cid/ciaa1414.
    >> Share

  597. BRAHIER T, Meuwly JY, Pantet O, Brochu Vez MJ, et al
    Lung ultrasonography for risk stratification in patients with COVID-19: a prospective observational cohort study.
    Clin Infect Dis. 2020 Sep 17. pii: 5907893. doi: 10.1093/cid/ciaa1408.
    >> Share

  598. COLLINS GS, Riley RD, van Smeden M
    Flaws in the development and validation of a covid-19 prediction model.
    Clin Infect Dis. 2020 Sep 16. pii: 5906588. doi: 10.1093/cid/ciaa1406.
    >> Share

  599. POON KS, Wen-Sim Tee N
    Caveats of Reporting Cycles Threshold from SARS-CoV-2 Qualitative PCR Assays: A Molecular Diagnostic Laboratory Perspective.
    Clin Infect Dis. 2020 Sep 15. pii: 5905681. doi: 10.1093/cid/ciaa1399.
    >> Share

  600. KASLOW NJ, White DT, Cook SC
    A Psychological Perspective on the Association between Critical Care Resource Availability and Emotional Wellness during the COVID-19 Pandemic.
    Clin Infect Dis. 2020 Sep 15. pii: 5905679. doi: 10.1093/cid/ciaa1398.
    >> Share

  601. LUO YR, Chakraborty I, Yun C, Wu AHB, et al
    Kinetics of SARS-CoV-2 Antibody Avidity Maturation and Association with Disease Severity.
    Clin Infect Dis. 2020 Sep 14. pii: 5905578. doi: 10.1093/cid/ciaa1389.
    >> Share

  602. WHYLER NCA, Sherry NL, Lane CR, Seemann T, et al
    Viral genomics to inform infection control response in occupational COVID-19 transmission.
    Clin Infect Dis. 2020 Sep 14. pii: 5905584. doi: 10.1093/cid/ciaa1385.
    >> Share

  603. DOOKIE N, Padayatchi N, Naidoo K
    Tuberculosis Elimination in the Era of COVID-19: A Moving Target.
    Clin Infect Dis. 2020 Sep 14. pii: 5905579. doi: 10.1093/cid/ciaa1400.
    >> Share

  604. CHONG CY, Kam KQ, Li J, Maiwald M, et al
    Saliva is not a useful diagnostic specimen in children with Coronavirus Disease 2019.
    Clin Infect Dis. 2020 Sep 14. pii: 5905581. doi: 10.1093/cid/ciaa1376.
    >> Share

  605. HANSON KE, Caliendo AM, Arias CA, Englund JA, et al
    Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19:Serologic Testing.
    Clin Infect Dis. 2020 Sep 12. pii: 5904785. doi: 10.1093/cid/ciaa1343.
    >> Share

  606. CHAN JF, To KK, Yuen KY
    A Case Series of Children With Coronavirus Disease 2019: What Have We Learned?
    Clin Infect Dis. 2020;71:1552-1553.
    >> Share

  607. JIEHAO C, Jin X, Daojiong L, Zhi Y, et al
    A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features.
    Clin Infect Dis. 2020;71:1547-1551.
    >> Share

  608. CANTOS VD, Rebolledo PA
    Structural vulnerability to COVID-19 among Latinx communities in the United States.
    Clin Infect Dis. 2020 Sep 11. pii: 5904342. doi: 10.1093/cid/ciaa1378.
    >> Share

  609. MOURAD A, Turner NA, Baker AW, Okeke NL, et al
    Social Disadvantage, Politics, and SARS-CoV-2 Trends: A County-Level Analysis of United States Data.
    Clin Infect Dis. 2020 Sep 11. pii: 5904339. doi: 10.1093/cid/ciaa1374.
    >> Share

  610. DECKER SJ, Goldstein TA, Ford JM, Teng MN, et al
    3D Printed Alternative to the Standard Synthetic Flocked Nasopharyngeal Swabs Used for COVID-19 testing.
    Clin Infect Dis. 2020 Sep 10. pii: 5903830. doi: 10.1093/cid/ciaa1366.
    >> Share

  611. DANDACHI D, Geiger G, Montgomery MW, Karmen-Tuohy S, et al
    Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19.
    Clin Infect Dis. 2020 Sep 9. pii: 5903368. doi: 10.1093/cid/ciaa1339.
    >> Share

  612. WALKER J, Fleece ME, Griffin RL, Leal SM, et al
    Decreasing High Risk Exposures for Healthcare-workers through Universal Masking and Universal SARS-CoV-2 Testing upon entry to a Tertiary Care Facility.
    Clin Infect Dis. 2020 Sep 8. pii: 5903054. doi: 10.1093/cid/ciaa1358.
    >> Share

  613. YOON JC, Montgomery MP, Buff AM, Boyd AT, et al
    COVID-19 Prevalence among People Experiencing Homelessness and Homelessness Service Staff during Early Community Transmission in Atlanta, Georgia, April-May 2020.
    Clin Infect Dis. 2020 Sep 8. pii: 5902935. doi: 10.1093/cid/ciaa1340.
    >> Share

  614. JACOBS JL, Mellors JW
    Detection of SARS-CoV-2 RNA in Blood of Patients with COVID-19: What Does It Mean?
    Clin Infect Dis. 2020 Sep 8. pii: 5902941. doi: 10.1093/cid/ciaa1316.
    >> Share

  615. KIM YS, Aigerim A, Park U, Kim Y, et al
    Sustained responses of neutralizing antibodies against MERS-CoV in recovered patients and their therapeutic applicability.
    Clin Infect Dis. 2020 Sep 8. pii: 5902973. doi: 10.1093/cid/ciaa1345.
    >> Share

  616. YANG DD, Ouldali N, Gajdos V, Thomas-Sertillanges R, et al
    Common pediatric respiratory infectious diseases may serve as an early predictor for SARS-CoV-2 new wave of infections.
    Clin Infect Dis. 2020 Sep 7. pii: 5902551. doi: 10.1093/cid/ciaa1359.
    >> Share

  617. GUILAMO-RAMOS V, Benzekri A, Thimm-Kaiser M, Hidalgo A, et al
    Reconsidering assumptions of adolescent and young adult SARS-CoV-2 transmission dynamics.
    Clin Infect Dis. 2020 Sep 7. pii: 5902518. doi: 10.1093/cid/ciaa1348.
    >> Share

  618. NOLEN LD, Seeman S, Bruden D, Klejka J, et al
    Impact of Social Distancing and Travel Restrictions on non-COVID-19 Respiratory Hospital Admissions in Young Children in Rural Alaska.
    Clin Infect Dis. 2020 Sep 5. pii: 5901658. doi: 10.1093/cid/ciaa1328.
    >> Share

  619. PREBENSEN C, Hre PLM, Jonassen C, Rangberg A, et al
    SARS-CoV-2 RNA in plasma is associated with ICU admission and mortality in patients hospitalized with COVID-19.
    Clin Infect Dis. 2020 Sep 5. pii: 5901727. doi: 10.1093/cid/ciaa1338.
    >> Share

  620. HOENIGL M
    Invasive Fungal Disease complicating COVID-19: when it rains it pours.
    Clin Infect Dis. 2020 Sep 5. pii: 5901729. doi: 10.1093/cid/ciaa1342.
    >> Share

  621. RILEY ED, Hickey MD, Imbert E, Clemenzi-Allen AA, et al
    COVID-19 and HIV spotlight the U.S. imperative for permanent affordable housing.
    Clin Infect Dis. 2020 Sep 5. pii: 5901720. doi: 10.1093/cid/ciaa1327.
    >> Share

  622. VAN ELSLANDE J, Vermeersch P, Vandervoort K, Wawina-Bokalanga T, et al
    Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain.
    Clin Infect Dis. 2020 Sep 5. pii: 5901661. doi: 10.1093/cid/ciaa1330.
    >> Share

  623. SQUILLACE N, Pozzi MR, Gustinetti G, Ricci E, et al
    Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment?
    Clin Infect Dis. 2020 Sep 4. pii: 5901570. doi: 10.1093/cid/ciaa1282.
    >> Share

  624. DE OLIVEIRA B, Mallat J
    Efficacy of Tocilizumab for treatment of severe COVID-19 Pneumonia: more evidence is needed.
    Clin Infect Dis. 2020 Sep 4. pii: 5901587. doi: 10.1093/cid/ciaa1284.
    >> Share

  625. BROUWER AF, Myers JL, Martin ET, Konopka KE, et al
    SARS-CoV-2 surveillance in decedents in a large, urban medical examiner's office.
    Clin Infect Dis. 2020 Sep 2. pii: 5900757. doi: 10.1093/cid/ciaa1312.
    >> Share

  626. CLIPMAN SJ, Wesolowski AP, Gibson DG, Agarwal S, et al
    Rapid real-time tracking of non-pharmaceutical interventions and their association with SARS-CoV-2 positivity: The COVID-19 Pandemic Pulse Study.
    Clin Infect Dis. 2020 Sep 2. pii: 5900759. doi: 10.1093/cid/ciaa1313.
    >> Share

  627. SHARMA M, Creutzfeldt CJ, Lewis A, Patel PV, et al
    Healthcare professionals' perceptions of critical care resource availability and factors associated with mental well-being during COVID-19: Results from a US survey.
    Clin Infect Dis. 2020 Sep 2. pii: 5900684. doi: 10.1093/cid/ciaa1311.
    >> Share

  628. ALI F, Sweeney DA
    No One Likes a Stick up Their Nose: Making the Case for Saliva-Based Testing for COVID-19.
    Clin Infect Dis. 2020 Sep 2. pii: 5900404. doi: 10.1093/cid/ciaa1314.
    >> Share

  629. BUETTI N, Patrier J, Le Hingrat Q, Loiodice A, et al
    Risk factors for SARS-CoV-2 detection in blood of critically ill patients.
    Clin Infect Dis. 2020 Sep 2. pii: 5900408. doi: 10.1093/cid/ciaa1315.
    >> Share

    August 2020
  630. VENTER WDF, Nel J
    COVID-19: First data from Africa.
    Clin Infect Dis. 2020 Aug 31. pii: 5899682. doi: 10.1093/cid/ciaa1293.
    >> Share

  631. DZINAMARIRA T, Mukwenha S, Eghtessadi R, Cuadros DF, et al
    COVID-19 response in Zimbabwe: A Call for Urgent Scale-up of Testing to meet National Capacity.
    Clin Infect Dis. 2020 Aug 31. pii: 5899551. doi: 10.1093/cid/ciaa1301.
    >> Share

  632. BOULLE A, Davies MA, Hussey H, Ismail M, et al
    Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa.
    Clin Infect Dis. 2020 Aug 29. pii: 5899044. doi: 10.1093/cid/ciaa1198.
    >> Share

  633. WHITE PL, Dhillon R, Cordey A, Hughes H, et al
    A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU.
    Clin Infect Dis. 2020 Aug 29. pii: 5899192. doi: 10.1093/cid/ciaa1298.
    >> Share

  634. LIU Q, Lu P, Shen Y, Li C, et al
    Collateral Impact of the Covid-19 Pandemic on Tuberculosis Control in Jiangsu Province, China.
    Clin Infect Dis. 2020 Aug 28. pii: 5898659. doi: 10.1093/cid/ciaa1289.
    >> Share

  635. LEVINE MM, Abdullah S, Arabi YM, Darko DM, et al
    Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers.
    Clin Infect Dis. 2020 Aug 28. pii: 5898660. doi: 10.1093/cid/ciaa1290.
    >> Share

  636. MA J, Qi X, Chen H, Li X, et al
    COVID-19 patients in earlier stages exhaled millions of SARS-CoV-2 per hour.
    Clin Infect Dis. 2020 Aug 28. pii: 5898624. doi: 10.1093/cid/ciaa1283.
    >> Share

  637. DORA AV, Winnett A, Fulcher JA, Sohn L, et al
    Using Serologic Testing to Assess the Effectiveness of Outbreak Control Efforts, Serial PCR Testing, and Cohorting of Positive SARS-CoV-2 Patients in a Skilled Nursing Facility.
    Clin Infect Dis. 2020 Aug 28. pii: 5898656. doi: 10.1093/cid/ciaa1286.
    >> Share

  638. BELLO-CHAVOLLA OY, Antonio-Villa NE, Vargas-Vazquez A, Fermin-Martinez CA, et al
    Profiling cases with non-respiratory symptoms and asymptomatic SARS-CoV-2 infections in Mexico City.
    Clin Infect Dis. 2020 Aug 28. pii: 5898658. doi: 10.1093/cid/ciaa1288.
    >> Share

  639. DE MAN P, Paltansing S, Ong DSY, Vaessen N, et al
    Outbreak of COVID-19 in a nursing home associated with aerosol transmission as a result of inadequate ventilation.
    Clin Infect Dis. 2020 Aug 28. pii: 5898577. doi: 10.1093/cid/ciaa1270.
    >> Share

  640. YOUNG BE, Ong SWX, Ng LFP, Anderson DE, et al
    Viral dynamics and immune correlates of COVID-19 disease severity.
    Clin Infect Dis. 2020 Aug 28. pii: 5898476. doi: 10.1093/cid/ciaa1280.
    >> Share

  641. BAKER MA, Fiumara K, Rhee C, Williams SA, et al
    Low risk of COVID-19 among patients exposed to infected healthcare workers.
    Clin Infect Dis. 2020 Aug 28. pii: 5898497. doi: 10.1093/cid/ciaa1269.
    >> Share

  642. HAGMAN K, Hedenstierna M, Gille-Johnson P, Hammas B, et al
    SARS-CoV-2 RNA in serum as predictor of severe outcome in COVID-19: a retrospective cohort study.
    Clin Infect Dis. 2020 Aug 28. pii: 5898271. doi: 10.1093/cid/ciaa1285.
    >> Share

  643. FRIED MW, Crawford JM, Mospan AR, Watkins SE, et al
    Patient Characteristics and Outcomes of 11,721 Patients with COVID19 Hospitalized Across the United States.
    Clin Infect Dis. 2020 Aug 28. pii: 5898276. doi: 10.1093/cid/ciaa1268.
    >> Share

  644. HUFF HV
    Controlling the COVID-19 Pandemic Blindly: Silent Spread in Absence of Rapid Viral Screening.
    Clin Infect Dis. 2020 Aug 28. pii: 5896910. doi: 10.1093/cid/ciaa1251.
    >> Share

  645. DOFFERHOFF ASM, Piscaer I, Schurgers LJ, Visser MPJ, et al
    Reduced vitamin K status as a potentially modifiable risk factor of severe COVID-19.
    Clin Infect Dis. 2020 Aug 27. pii: 5898121. doi: 10.1093/cid/ciaa1258.
    >> Share

  646. LENNOX JL
    Methylprednisolone for COVID-19: Was Benjamin Rush prescient?
    Clin Infect Dis. 2020 Aug 26. pii: 5897431. doi: 10.1093/cid/ciaa1262.
    >> Share

  647. JUNG CY, Park H, Kim DW, Lim H, et al
    Association between Body Mass Index and Risk of COVID-19: A Nationwide Case-Control Study in South Korea.
    Clin Infect Dis. 2020 Aug 25. pii: 5897045. doi: 10.1093/cid/ciaa1257.
    >> Share

  648. MARRIOTT D, Beresford R, Mirdad F, Stark D, et al
    Concomitant marked decline in prevalence of SARS-CoV-2 and other respiratory viruses among symptomatic patients following public health interventions in Australia: data from St Vincent's Hospital and associated screening clinics, Sydney, NSW.
    Clin Infect Dis. 2020 Aug 25. pii: 5897048. doi: 10.1093/cid/ciaa1256.
    >> Share

  649. PELUSO MJ, Dee L, Shao S, Taylor J, et al
    Operationalizing HIV cure-related trials with analytic treatment interruptions during the SARS-CoV-2 pandemic: A collaborative approach.
    Clin Infect Dis. 2020 Aug 25. pii: 5897039. doi: 10.1093/cid/ciaa1260.
    >> Share

  650. TO KK, Hung IF, Ip JD, Chu AW, et al
    COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing.
    Clin Infect Dis. 2020 Aug 25. pii: 5897019. doi: 10.1093/cid/ciaa1275.
    >> Share

  651. BUSANI S, Bedini A, Biagioni E, Serio L, et al
    Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies.
    Clin Infect Dis. 2020 Aug 25. pii: 5896943. doi: 10.1093/cid/ciaa1246.
    >> Share

  652. REN L, Fan G, Wu W, Guo L, et al
    Antibody Responses and Clinical Outcomes in Adults Hospitalized with Severe COVID-19: A Post hoc Analysis of LOTUS China Trial.
    Clin Infect Dis. 2020 Aug 25. pii: 5896896. doi: 10.1093/cid/ciaa1247.
    >> Share

  653. RHEE C, Kanjilal S, Baker M, Klompas M, et al
    Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?
    Clin Infect Dis. 2020 Aug 25. pii: 5896916. doi: 10.1093/cid/ciaa1249.
    >> Share

  654. LESHO E, Reno L, Newhart D, Clifford R, et al
    Temporal, Spatial, and Epidemiologic Relationships of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Gene Cycle Thresholds: A Pragmatic Ambi-directional Observation.
    Clin Infect Dis. 2020 Aug 25. pii: 5896900. doi: 10.1093/cid/ciaa1248.
    >> Share

  655. DE CHAISEMARTIN C, de Chaisemartin L
    BCG vaccination in infancy does not protect against COVID-19. Evidence from a natural experiment in Sweden.
    Clin Infect Dis. 2020 Aug 23. pii: 5896039. doi: 10.1093/cid/ciaa1223.
    >> Share

  656. MCCARTY TR, Hathorn KE, Redd WD, Rodriguez NJ, et al
    How Do Presenting Symptoms and Outcomes Differ by Race/Ethnicity Among Hospitalized Patients with COVID-19 Infection? Experience in Massachusetts.
    Clin Infect Dis. 2020 Aug 22. pii: 5896009. doi: 10.1093/cid/ciaa1245.
    >> Share

  657. LIN DY, Zeng D, Eron JJ
    Evaluating the Efficacy of Therapies in COVID-19 Patients.
    Clin Infect Dis. 2020 Aug 21. pii: 5895068. doi: 10.1093/cid/ciaa1231.
    >> Share

  658. CHAMIE G, Marquez C, Crawford E, Peng J, et al
    SARS-CoV-2 Community Transmission disproportionately affects Latinx population during Shelter-in-Place in San Francisco.
    Clin Infect Dis. 2020 Aug 21. pii: 5895337. doi: 10.1093/cid/ciaa1234.
    >> Share

  659. VAUGHN VM, Gandhi T, Petty LA, Patel PK, et al
    Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study.
    Clin Infect Dis. 2020 Aug 21. pii: 5895253. doi: 10.1093/cid/ciaa1239.
    >> Share

  660. RIVERA F, Safdar N, Ledeboer N, Schaack G, et al
    Prevalence of SARS-CoV-2 asymptomatic infections in two large academic health systems in Wisconsin.
    Clin Infect Dis. 2020 Aug 19. pii: 5894146. doi: 10.1093/cid/ciaa1225.
    >> Share

  661. BRUGGEMANN RJ, van de Veerdonk FL, Verweij PE
    The challenge of managing COVID-19 associated pulmonary aspergillosis.
    Clin Infect Dis. 2020 Aug 18. pii: 5893994. doi: 10.1093/cid/ciaa1211.
    >> Share

  662. HARTMANN S, Rubin Z, Sato H, OYong K, et al
    Coronavirus 2019 (COVID-19) Infections Among Healthcare Workers, Los Angeles County, February - May 2020.
    Clin Infect Dis. 2020 Aug 17. pii: 5893141. doi: 10.1093/cid/ciaa1200.
    >> Share

  663. ZUNIGA-MOYA JC, Norwood DA, Romero Reyes LE, Barrueto Saavedra E, et al
    Epidemiology, outcomes and associated factors of COVID-19 RT-PCR confirmed cases in the San Pedro Sula Metropolitan Area, Honduras.
    Clin Infect Dis. 2020 Aug 17. pii: 5893117. doi: 10.1093/cid/ciaa1188.
    >> Share

  664. VEYER D, Kerneis S, Poulet G, Wack M, et al
    Highly sensitive quantification of plasma SARS-CoV-2 RNA shelds light on its potential clinical value.
    Clin Infect Dis. 2020 Aug 17. pii: 5893132. doi: 10.1093/cid/ciaa1196.
    >> Share

  665. HUANG J, Xie N, Hu X, Yan H, et al
    Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study.
    Clin Infect Dis. 2020 Aug 17. pii: 5893115. doi: 10.1093/cid/ciaa1186.
    >> Share

  666. LEWIS NM, Chu VT, Ye D, Conners EE, et al
    Household Transmission of SARS-CoV-2 in the United States.
    Clin Infect Dis. 2020 Aug 16. pii: 5893024. doi: 10.1093/cid/ciaa1166.
    >> Share

  667. YAMAGISHI T, Doi Y
    Insights on COVID-19 epidemiology from a historic cruise ship quarantine.
    Clin Infect Dis. 2020 Aug 14. pii: 5892913. doi: 10.1093/cid/ciaa1214.
    >> Share

  668. CERDA-CONTRERAS C, Nuzzolo-Shihadeh L, Camacho-Ortiz A, Perez-Alba E, et al
    Baricitinib as treatment for COVID-19: friend or foe of the pancreas?
    Clin Infect Dis. 2020 Aug 14. pii: 5892883. doi: 10.1093/cid/ciaa1209.
    >> Share

  669. JORGENSEN SCJ, Burry L, Tse CLY, Dresser LD, et al
    Baricitinib: Impact on COVID-19 coagulopathy?
    Clin Infect Dis. 2020 Aug 14. pii: 5892859. doi: 10.1093/cid/ciaa1208.
    >> Share

  670. TITANJI BK, Farley MM, Schinazi RF, Marconi VC, et al
    Response to Correspondence: Baricitinib as Treatment of COVID-19 Friend or Foe of the Pancreas? Cerda-Contreras et.al.
    Clin Infect Dis. 2020 Aug 14. pii: 5892912. doi: 10.1093/cid/ciaa1212.
    >> Share

  671. LUSTIG Y, Keler S, Kolodny R, Ben-Tal N, et al
    Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses.
    Clin Infect Dis. 2020 Aug 14. pii: 5892809. doi: 10.1093/cid/ciaa1207.
    >> Share

  672. TITANJI BK, Farley MM, Schinazi RF, Marconi VC, et al
    Response to Correspondence: Baricitinib - Impact on COVID-19 Coagulopathy? Jorgensen et. al.
    Clin Infect Dis. 2020 Aug 14. pii: 5892909. doi: 10.1093/cid/ciaa1210.
    >> Share

  673. JERONIMO CMP, Farias MEL, Val FFA, Sampaio VS, et al
    Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial.
    Clin Infect Dis. 2020 Aug 12. pii: 5891816. doi: 10.1093/cid/ciaa1177.
    >> Share

  674. BAYAT V, Phelps S, Ryono R, Lee C, et al
    A SARS-CoV-2 Prediction Model from Standard Laboratory Tests.
    Clin Infect Dis. 2020 Aug 12. pii: 5891814. doi: 10.1093/cid/ciaa1175.
    >> Share

  675. PLUCINSKI MM, Wallace M, Uehara A, Kurbatova EV, et al
    COVID-19 in Americans aboard the Diamond Princess cruise ship.
    Clin Infect Dis. 2020 Aug 12. pii: 5891779. doi: 10.1093/cid/ciaa1180.
    >> Share

  676. ATCHISON C, Pristera P, Cooper E, Papageorgiou V, et al
    Usability and acceptability of home-based self-testing for SARS-CoV-2 antibodies for population surveillance.
    Clin Infect Dis. 2020 Aug 12. pii: 5891615. doi: 10.1093/cid/ciaa1178.
    >> Share

  677. COBELENS FG, Harris VC
    Untangling SARS-CoV-2 epidemic control - lessons from Vietnam.
    Clin Infect Dis. 2020 Aug 11. pii: 5891228. doi: 10.1093/cid/ciaa1195.
    >> Share

  678. CHAGLA Z, Hota S, Khan S, Mertz D, et al
    Airborne Transmission of COVID-19.
    Clin Infect Dis. 2020 Aug 11. pii: 5891227. doi: 10.1093/cid/ciaa1118.
    >> Share

  679. HAIDAR G
    COVID-19, organ transplantation, and the nuances of immunomodulation: lessons learned and what comes next.
    Clin Infect Dis. 2020 Aug 11. pii: 5891286. doi: 10.1093/cid/ciaa1193.
    >> Share

  680. KLANN E, Rich S, Mai V
    Gut microbiota and COVID-19: A superfluous diagnostic biomarker or therapeutic target?
    Clin Infect Dis. 2020 Aug 11. pii: 5891289. doi: 10.1093/cid/ciaa1191.
    >> Share

  681. GONZALEZ-RUBIO F, Ioakeim-Skoufa I, Poblador-Plou B, Gimeno-Miguel A, et al
    Influenza vaccination: an ally to mitigate influenza-associated risks during the coronavirus pandemics.
    Clin Infect Dis. 2020 Aug 11. pii: 5891288. doi: 10.1093/cid/ciaa1190.
    >> Share

  682. NELSON BC, Laracy J, Shoucri S, Dietz D, et al
    Clinical Outcomes Associated with Methylprednisolone in Mechanically Ventilated Patients with COVID-19.
    Clin Infect Dis. 2020 Aug 9. pii: 5890108. doi: 10.1093/cid/ciaa1163.
    >> Share

  683. IVASHCHENKO AA, Dmitriev KA, Vostokova NV, Azarova VN, et al
    AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.
    Clin Infect Dis. 2020 Aug 9. pii: 5890024. doi: 10.1093/cid/ciaa1176.
    >> Share

  684. OTTO MP, Darles C, Valero E, Benner P, et al
    Posterior oropharyngeal salivafor the detection of SARS-CoV-2.
    Clin Infect Dis. 2020 Aug 8. pii: 5889992. doi: 10.1093/cid/ciaa1181.
    >> Share

  685. KOW CS, Hasan SS
    Do the meta-analyses provide a clean bill of health to the use of renin-angiotensin system inhibitors in COVID-19?
    Clin Infect Dis. 2020 Aug 8. pii: 5889984. doi: 10.1093/cid/ciaa1167.
    >> Share

  686. BELLON M, Schweblin C, Lambeng N, Cherpillod P, et al
    Cerebrospinal fluid features in SARS-CoV-2 RT-PCR positive patients.
    Clin Infect Dis. 2020 Aug 8. pii: 5890019. doi: 10.1093/cid/ciaa1165.
    >> Share

  687. RISTAGNO EH, Bryant KA
    COVID-19 and Children: Adding Another Piece to the Puzzle.
    Clin Infect Dis. 2020 Aug 8. pii: 5889991. doi: 10.1093/cid/ciaa1182.
    >> Share

  688. KENDALL EA
    When infections don't reflect infectiousness: interpreting contact investigation data with care.
    Clin Infect Dis. 2020 Aug 8. pii: 5889982. doi: 10.1093/cid/ciaa1144.
    >> Share

  689. SIPAHI OR
    What should be the ideal definite COVID-19 case definition?
    Clin Infect Dis. 2020 Aug 8. pii: 5889989. doi: 10.1093/cid/ciaa1179.
    >> Share

  690. KHALIL A, Hill R, Wright A, Ladhani S, et al
    SARS-CoV-2-specific antibody detection in healthcare workers in a UK maternity Hospital: Correlation with SARS-CoV-2 RT-PCR results.
    Clin Infect Dis. 2020 Aug 8. pii: 5889986. doi: 10.1093.
    >> Share

  691. BLOT M, Jacquier M, Manoha C, Piroth L, et al
    Alveolar SARS-CoV-2 viral load is tightly correlated with severity in COVID-19 ARDS.
    Clin Infect Dis. 2020 Aug 8. pii: 5889988. doi: 10.1093/cid/ciaa1172.
    >> Share

  692. BUSCH MP, Stone M
    Serosurveillance for SARS-CoV-2 incidence using global blood donor populations.
    Clin Infect Dis. 2020 Aug 8. pii: 5889969. doi: 10.1093/cid/ciaa1116.
    >> Share

  693. CHAMILOS G, Lionakis MS, Kontoyiannis DP
    Are all patients with cancer at heightened risk for severe Coronavirus Disease 2019 (COVID-19)?
    Clin Infect Dis. 2020 Aug 7. pii: 5885104. doi: 10.1093/cid/ciaa1079.
    >> Share

  694. WALD ER, Schmit KM, Gusland DY
    A Pediatric Infectious Disease Perspective on COVID-19.
    Clin Infect Dis. 2020 Aug 7. pii: 5885157. doi: 10.1093/cid/ciaa1095.
    >> Share

  695. PEREZ-GUZMAN PN, Daunt A, Mukherjee S, Crook P, et al
    Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study.
    Clin Infect Dis. 2020 Aug 7. pii: 5885151. doi: 10.1093/cid/ciaa1091.
    >> Share

  696. KATES OS, Haydel BM, Florman SS, Rana MM, et al
    COVID-19 in solid organ transplant: A multi-center cohort study.
    Clin Infect Dis. 2020 Aug 7. pii: 5885162. doi: 10.1093/cid/ciaa1097.
    >> Share

  697. RAO M, Rashid FA, Sabri FSAH, Jamil NN, et al
    Comparing nasopharyngeal swab and early morning saliva for the identification of SARS-CoV-2.
    Clin Infect Dis. 2020 Aug 6. pii: 5882012. doi: 10.1093/cid/ciaa1156.
    >> Share

  698. BAGGIO S, L'Huillier AG, Yerly S, Bellon M, et al
    SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19.
    Clin Infect Dis. 2020 Aug 6. pii: 5881997. doi: 10.1093/cid/ciaa1157.
    >> Share

  699. CLARK E, Chiao EY, Amirian ES
    Why contact tracing efforts have failed to curb COVID-19 transmission in much of the U.S.
    Clin Infect Dis. 2020 Aug 6. pii: 5881818. doi: 10.1093/cid/ciaa1155.
    >> Share

  700. TO KK, Chan WM, Ip JD, Chu AW, et al
    Unique SARS-CoV-2 clusters causing a large COVID-19 outbreak in Hong Kong.
    Clin Infect Dis. 2020 Aug 5. pii: 5881446. doi: 10.1093/cid/ciaa1119.
    >> Share

  701. GANG A, Gang J
    Evaluation of COVID-19 RT-qPCR tests in multi-sample pools.
    Clin Infect Dis. 2020 Aug 5. pii: 5881409. doi: 10.1093/cid/ciaa1099.
    >> Share

  702. ZHAO J, Yang Y, Huang H, Li D, et al
    Relationship between the ABO Blood Group and the COVID-19 Susceptibility.
    Clin Infect Dis. 2020 Aug 4. pii: 5880600. doi: 10.1093/cid/ciaa1150.
    >> Share

  703. WANG K, Long QX, Deng HJ, Hu J, et al
    Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection.
    Clin Infect Dis. 2020 Aug 3. pii: 5880016. doi: 10.1093/cid/ciaa1143.
    >> Share

  704. IMBERT E, Kinley PM, Scarborough A, Cawley C, et al
    Coronavirus Disease 2019 (COVID-19) Outbreak in a San Francisco Homeless Shelter.
    Clin Infect Dis. 2020 Aug 3. pii: 5879965. doi: 10.1093/cid/ciaa1071.
    >> Share

  705. PHAM QT, Rabaa MA, Duong HL, Dang QT, et al
    The first 100 days of SARS-CoV-2 control in Vietnam.
    Clin Infect Dis. 2020 Aug 1. pii: 5879764. doi: 10.1093/cid/ciaa1130.
    >> Share

    July 2020
  706. GANDHI RT
    The Multidimensional Challenge of Treating COVID-19: Remdesivir is a Foot in the Door.
    Clin Infect Dis. 2020 Jul 31. pii: 5879440. doi: 10.1093/cid/ciaa1132.
    >> Share

  707. CHENG GS, Hill JA
    To Toci or Not to Toci for COVID-19: Is That Still the Question?
    Clin Infect Dis. 2020 Jul 31. pii: 5879444. doi: 10.1093/cid/ciaa1133.
    >> Share

  708. HU M, Lin H, Wang J, Xu C, et al
    The risk of COVID-19 transmission in train passengers: an epidemiological and modelling study.
    Clin Infect Dis. 2020 Jul 29. pii: 5877944. doi: 10.1093/cid/ciaa1057.
    >> Share

  709. XU D, Zhou F, Sun W, Chen L, et al
    Relationship Between serum SARS-CoV-2 nucleic acid(RNAemia) and Organ Damage in COVID-19 Patients: A Cohort Study.
    Clin Infect Dis. 2020 Jul 28. pii: 5877289. doi: 10.1093/cid/ciaa1085.
    >> Share

  710. YOUSAF AR, Duca LM, Chu V, Reses HE, et al
    A prospective cohort study in non-hospitalized household contacts with SARS-CoV-2 infection: symptom profiles and symptom change over time.
    Clin Infect Dis. 2020 Jul 28. pii: 5877084. doi: 10.1093/cid/ciaa1072.
    >> Share

  711. SANTOS DS, Menezes MO, Andreucci CB, Nakamura-Pereira M, et al
    Disproportionate impact of COVID-19 among pregnant and postpartum Black Women in Brazil through structural racism lens.
    Clin Infect Dis. 2020 Jul 28. pii: 5877027. doi: 10.1093/cid/ciaa1066.
    >> Share

  712. BARTOLETTI M, Pascale R, Cricca M, Rinaldi M, et al
    Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study.
    Clin Infect Dis. 2020 Jul 28. pii: 5876990. doi: 10.1093/cid/ciaa1065.
    >> Share

  713. BENE MC, de Carvalho Bittencourt M, Eveillard M, Le Bris Y, et al
    Good IgA Bad IgG in SARS-CoV-2 Infection?
    Clin Infect Dis. 2020;71:897-898.
    >> Share

  714. RUAN L, Wen M, Zeng Q, Chen C, et al
    New Measures for the Coronavirus Disease 2019 Response: A Lesson From the Wenzhou Experience.
    Clin Infect Dis. 2020;71:866-869.
    >> Share

  715. HANFF TC, Harhay MO, Brown TS, Cohen JB, et al
    Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System? A Call for Epidemiologic Investigations.
    Clin Infect Dis. 2020;71:870-874.
    >> Share

  716. GIACOMELLI A, Pezzati L, Conti F, Bernacchia D, et al
    Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.
    Clin Infect Dis. 2020;71:889-890.
    >> Share

  717. PAGLIANO P, Piazza O, De Caro F, Ascione T, et al
    Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019?
    Clin Infect Dis. 2020;71:887-888.
    >> Share

  718. YI H
    2019 Novel Coronavirus Is Undergoing Active Recombination.
    Clin Infect Dis. 2020;71:884-887.
    >> Share

  719. ZHANG L, Shen FM, Chen F, Lin Z, et al
    Origin and Evolution of the 2019 Novel Coronavirus.
    Clin Infect Dis. 2020;71:882-883.
    >> Share

  720. JEONG HE, Lee H, Shin HJ, Choe YJ, et al
    Association between NSAIDs use and adverse clinical outcomes among adults hospitalized with COVID-19 in South Korea: A nationwide study.
    Clin Infect Dis. 2020 Jul 27. pii: 5876905. doi: 10.1093/cid/ciaa1056.
    >> Share

  721. ROWLEY AH
    Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium.
    Clin Infect Dis. 2020 Jul 27. pii: 5876871. doi: 10.1093/cid/ciaa1080.
    >> Share

  722. DEL BRUTTO OH, Costa AF, Mera RM, Recalde BY, et al
    SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador.
    Clin Infect Dis. 2020 Jul 27. pii: 5876901. doi: 10.1093/cid/ciaa1055.
    >> Share

  723. LYNCH JB, Davitkov P, Anderson DJ, Bhimraj A, et al
    Infectious Diseases Society of America Guidelines on Infection Prevention for Health Care Personnel Caring for Patients with Suspected or Known COVID-19.
    Clin Infect Dis. 2020 Jul 27. pii: 5876809. doi: 10.1093/cid/ciaa1063.
    >> Share

  724. LI J, Wu C, Zhang X, Chen L, et al
    Post-pandemic testing of SARS-CoV-2 in Huanan Seafood Market area in Wuhan, China.
    Clin Infect Dis. 2020 Jul 25. pii: 5876349. doi: 10.1093/cid/ciaa1043.
    >> Share

  725. POLINE J, Gaschignard J, Leblanc C, Madhi F, et al
    Systematic SARS-CoV-2 screening at hospital admission in children:a French prospective multicenter study.
    Clin Infect Dis. 2020 Jul 25. pii: 5876373. doi: 10.1093/cid/ciaa1044.
    >> Share

  726. MORALEDA C, Serna-Pascual M, Soriano-Arandes A, Simo S, et al
    Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain.
    Clin Infect Dis. 2020 Jul 25. pii: 5876334. doi: 10.1093/cid/ciaa1042.
    >> Share

  727. OLENDER SA, Perez KK, Go AS, Balani B, et al
    Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care.
    Clin Infect Dis. 2020 Jul 24. pii: 5876045. doi: 10.1093/cid/ciaa1041.
    >> Share

  728. DING T, Zhang J, Wang T, Cui P, et al
    Potential Influence of Menstrual Status and Sex Hormones on female SARS-CoV-2 Infection: A Cross-sectional Study from Multicentre in Wuhan, China.
    Clin Infect Dis. 2020 Jul 22. pii: 5875093. doi: 10.1093/cid/ciaa1022.
    >> Share

  729. ESCOBAR DJ, Lanzi M, Saberi P, Love R, et al
    Mitigation of a COVID-19 Outbreak in a Nursing Home Through Serial Testing of Residents and Staff.
    Clin Infect Dis. 2020 Jul 20. pii: 5873784. doi: 10.1093/cid/ciaa1021.
    >> Share

  730. FLANNERY B, Meece JK, Williams JV, Martin ET, et al
    Systematic testing for influenza and COVID-19 among patients with respiratory illness.
    Clin Infect Dis. 2020 Jul 20. pii: 5873821. doi: 10.1093/cid/ciaa1023.
    >> Share

  731. ERLICHSTER M, Chana G, Zantomio D, Goudey B, et al
    Pan-Family Assays for Rapid Viral Screening: Reducing Delays in Public Health Responses During Pandemics.
    Clin Infect Dis. 2020 Jul 20. pii: 5873823. doi: 10.1093/cid/ciaa1028.
    >> Share

  732. LOUIE JK, Scott HM, DuBois A, Sturtz N, et al
    Lessons from Mass-Testing for COVID-19 in Long Term Care Facilities for the Elderly in San Francisco.
    Clin Infect Dis. 2020 Jul 20. pii: 5873783. doi: 10.1093/cid/ciaa1020.
    >> Share

  733. LARREMORE DB, Bubar KM, Grad YH
    Implications of test characteristics and population seroprevalence on 'immune passport' strategies.
    Clin Infect Dis. 2020 Jul 20. pii: 5873748. doi: 10.1093/cid/ciaa1019.
    >> Share

  734. PLOTKIN SA
    The Value of Human Challenges in SARS-2-nCoV Vaccine Development.
    Clin Infect Dis. 2020 Jul 16. pii: 5872587. doi: 10.1093/cid/ciaa1013.
    >> Share

  735. ALTERI C, Cento V, Vecchi M, Colagrossi L, et al
    Nasopharyngeal SARS-CoV-2 load at hospital admission as predictor of mortality.
    Clin Infect Dis. 2020 Jul 16. pii: 5872588. doi: 10.1093.
    >> Share

  736. MITJA O, Corbacho-Monne M, Ubals M, Tebe C, et al
    Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.
    Clin Infect Dis. 2020 Jul 16. pii: 5872589. doi: 10.1093/cid/ciaa1009.
    >> Share

  737. KIM L, Garg S, O'Halloran A, Whitaker M, et al
    Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET).
    Clin Infect Dis. 2020 Jul 16. pii: 5872581. doi: 10.1093/cid/ciaa1012.
    >> Share

  738. DUPONT V, Kanagaratnam L, Goury A, Poitevin G, et al
    Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients.
    Clin Infect Dis. 2020 Jul 16. pii: 5872439. doi: 10.1093/cid/ciaa1007.
    >> Share

  739. WI YM, Lim SJ, Kim SH, Lim S, et al
    Response System for and Epidemiological Features of COVID-19 in Gyeongsangnam-do Province in South Korea.
    Clin Infect Dis. 2020 Jul 16. pii: 5872474. doi: 10.1093.
    >> Share

  740. SING CW, Tan KCB, Wong ICK, Cheung BMY, et al
    Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors.
    Clin Infect Dis. 2020 Jul 16. pii: 5872092. doi: 10.1093.
    >> Share

  741. FANG FC, Schooley RT
    Treatment of COVID-19 - Evidence-Based or Personalized Medicine?
    Clin Infect Dis. 2020 Jul 15. pii: 5872014. doi: 10.1093.
    >> Share

  742. ZHANG AJ, Lee AC, Chu H, Chan JF, et al
    SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters.
    Clin Infect Dis. 2020 Jul 15. pii: 5871998. doi: 10.1093.
    >> Share

  743. GOLDBERG SA, Lennerz J, Klompas M, Mark E, et al
    Presymptomatic Transmission of SARS-CoV-2 Amongst Residents and Staff at a Skilled Nursing Facility: Results of Real-Time PCR and Serologic Testing.
    Clin Infect Dis. 2020 Jul 15. pii: 5871989. doi: 10.1093.
    >> Share

  744. CONTEJEAN A, Leporrier J, Canoui E, Alby-Laurent F, et al
    Comparing dynamics and determinants of SARS-CoV-2 transmissions among health care workers of adult and pediatric settings in central Paris.
    Clin Infect Dis. 2020 Jul 15. pii: 5871438. doi: 10.1093.
    >> Share

  745. LYNCH KL, Whitman JD, Lacanienta NP, Beckerdite EW, et al
    Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity.
    Clin Infect Dis. 2020 Jul 14. pii: 5871431. doi: 10.1093.
    >> Share

  746. SOMERS EC, Eschenauer GA, Troost JP, Golob JL, et al
    Tocilizumab for treatment of mechanically ventilated patients with COVID-19.
    Clin Infect Dis. 2020 Jul 11. pii: 5870306. doi: 10.1093.
    >> Share

  747. GARCIA-VIDAL C, Moreno-Garcia E, Hernandez-Meneses M, Puerta-Alcalde P, et al
    Personalized therapy approach for hospitalized patients with COVID-19.
    Clin Infect Dis. 2020 Jul 10. pii: 5869871. doi: 10.1093.
    >> Share

  748. TORRES JP, Pinera C, De La Maza V, Lagomarcino AJ, et al
    SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study.
    Clin Infect Dis. 2020 Jul 10. pii: 5869860. doi: 10.1093.
    >> Share

  749. WONG YC, Lau SY, Wang To KK, Mok BWY, et al
    Natural transmission of bat-like SARS-CoV-2PRRA variants in COVID-19 patients.
    Clin Infect Dis. 2020 Jul 10. pii: 5869859. doi: 10.1093.
    >> Share

  750. DONG YM, Sun J, Li YX, Chen Q, et al
    Development and Validation of a Nomogram for Assessing Survival in Patients with COVID-19 Pneumonia.
    Clin Infect Dis. 2020 Jul 10. pii: 5869870. doi: 10.1093.
    >> Share

  751. CURRY SR, Salgado CD
    When hospitals Harm: Multi-modal entry of SARS-CoV-2 into inpatient healthcare.
    Clin Infect Dis. 2020 Jul 10. pii: 5869668. doi: 10.1093.
    >> Share

  752. WILDER JM
    The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States.
    Clin Infect Dis. 2020 Jul 10. pii: 5869621. doi: 10.1093.
    >> Share

  753. MATHERS AJ
    The practical challenges of making clinical use of the quantitative value for SARS-CoV-2 viral load across several dynamics.
    Clin Infect Dis. 2020 Jul 10. pii: 5869506. doi: 10.1093.
    >> Share

  754. MARCIALIS MA, Bardanzellu F, Fanos V
    Microbiota and Covid-19. Which came first, the chicken or the egg?
    Clin Infect Dis. 2020 Jul 10. pii: 5869504. doi: 10.1093.
    >> Share

  755. CUMMINGS DAT, Radonovich LJ, Gorse GJ, Gaydos CA, et al
    Risk Factors for Healthcare Personnel Infection with Endemic Coronaviruses (HKU1, OC43, NL63, 229E): Results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT).
    Clin Infect Dis. 2020 Jul 9. pii: 5869459. doi: 10.1093.
    >> Share

  756. LI Z, Li Y, Chen L, Li S, et al
    A Confirmed Case of SARS-CoV-2 Pneumonia with Routine RT-PCR Negative and Virus Variation in Guangzhou, China.
    Clin Infect Dis. 2020 Jul 9. pii: 5869155. doi: 10.1093.
    >> Share

  757. REICHBERG SB, Mitra PP, Haghamad A, Ramrattan G, et al
    Rapid Emergence of SARS-CoV-2 in the Greater New York Metropolitan Area: Geolocation, Demographics, Positivity Rates, and Hospitalization for 46,793 Persons Tested by Northwell Health.
    Clin Infect Dis. 2020 Jul 8. pii: 5868956. doi: 10.1093.
    >> Share

  758. WANG Y, Liu Y, Struthers J, Lian M, et al
    Spatiotemporal Characteristics of COVID-19 Epidemic in the United States.
    Clin Infect Dis. 2020 Jul 8. pii: 5868985. doi: 10.1093.
    >> Share

  759. SIEDNER MJ, Gandhi RT
    Proposing minimum requirements for announcing clinical trial results during the COVID-19 pandemic.
    Clin Infect Dis. 2020 Jul 8. pii: 5868929. doi: 10.1093.
    >> Share

  760. QIAN Q, Fan L, Liu W, Li J, et al
    Direct evidence of active SARS-CoV-2 replication in the intestine.
    Clin Infect Dis. 2020 Jul 8. pii: 5868547. doi: 10.1093.
    >> Share

  761. CHEN J, Bai H, Liu J, Chen G, et al
    Distinct clinical characteristics and risk factors for mortality in female COVID-19 inpatients: a sex-stratified large-scale cohort study in Wuhan, China.
    Clin Infect Dis. 2020 Jul 8. pii: 5868544. doi: 10.1093.
    >> Share

  762. YEHYA N, Venkataramani A, Harhay MO
    Statewide Interventions and Covid-19 Mortality in the United States: An Observational Study.
    Clin Infect Dis. 2020 Jul 8. pii: 5868545. doi: 10.1093.
    >> Share

  763. KRAGHOLM K, Andersen MP, Gerds TA, Butt JH, et al
    Association between male sex and outcomes of Coronavirus Disease 2019 (Covid-19) - a Danish nationwide, register-based study.
    Clin Infect Dis. 2020 Jul 8. pii: 5868546. doi: 10.1093.
    >> Share

  764. ZHOU J, Otter JA, Price JR, Cimpeanu C, et al
    Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London.
    Clin Infect Dis. 2020 Jul 8. pii: 5868534. doi: 10.1093.
    >> Share

  765. SANDMANN FG, White PJ, Ramsay M, Jit M, et al
    Optimising benefits of testing key workers for infection with SARS-CoV-2: A mathematical modelling analysis.
    Clin Infect Dis. 2020 Jul 8. pii: 5868532. doi: 10.1093.
    >> Share

  766. PRICE JR, Mookerjee S, Dyakova E, Myall A, et al
    Development and delivery of a real-time hospital-onset COVID-19 surveillance system using network analysis.
    Clin Infect Dis. 2020 Jul 8. pii: 5868508. doi: 10.1093.
    >> Share

  767. LEE DICKENS BS, Lim JT, Low JW, Lee CK, et al
    Simple 'Rule-of-6' predicts severe COVID-19 disease.
    Clin Infect Dis. 2020 Jul 6. pii: 5868031. doi: 10.1093.
    >> Share

  768. STUBBLEFIELD WB, Talbot HK, Feldstein L, Tenforde MW, et al
    Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for COVID-19 Patients - Nashville, Tennessee.
    Clin Infect Dis. 2020 Jul 6. pii: 5868028. doi: 10.1093.
    >> Share

  769. NGUYEN LC, Bakerlee CW, McKelvey TG, Rose SM, et al
    Evaluating use cases for human challenge trials in accelerating SARS-CoV-2 vaccine development.
    Clin Infect Dis. 2020 Jul 6. pii: 5868014. doi: 10.1093.
    >> Share

  770. NICHOLS BE, Jamieson L, Zhang SRC, Rao GA, et al
    The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing ICU capacity.
    Clin Infect Dis. 2020 Jul 6. pii: 5868030. doi: 10.1093.
    >> Share

  771. MORAWSKA L, Milton DK
    It is Time to Address Airborne Transmission of COVID-19.
    Clin Infect Dis. 2020 Jul 6. pii: 5867798. doi: 10.1093.
    >> Share

  772. LENZ HJ, Richardson P, Stebbing J
    The Emergence of Baricitinib: A Story of Tortoises Versus Hares.
    Clin Infect Dis. 2020 Jul 6. pii: 5868032. doi: 10.1093.
    >> Share

  773. OUSSALAH A, Gleye S, Clerc Urmes I, Laugel E, et al
    Long-Term ACE Inhibitor/ARB Use Is Associated with Severe Renal Dysfunction and Acute Kidney Injury in Patients with severe COVID-19: Results from a Referral Center Cohort in the North East of France.
    Clin Infect Dis. 2020 Jul 5. pii: 5867535. doi: 10.1093.
    >> Share

  774. DE FERIA A, Ortega-Legaspi JM
    ACE inhibitors/ARB use and COVID-19. Time to change practice or keep gathering data?
    Clin Infect Dis. 2020 Jul 4. pii: 5867490. doi: 10.1093.
    >> Share

  775. BRYANT KA, Isaacs P
    Commentary: Rapid Testing of Healthcare Employees for COVID-19: What Can We Learn from the Seattle Experience?
    Clin Infect Dis. 2020 Jul 4. pii: 5867496. doi: 10.1093.
    >> Share

  776. TSO RV, Cowling BJ
    Importance of face masks for COVID-19 - a call for effective public education.
    Clin Infect Dis. 2020 Jul 2. pii: 5866410. doi: 10.1093.
    >> Share

  777. KAMERLIN SCL, Kasson PM
    Managing COVID-19 spread with voluntary public-health measures: Sweden as a case study for pandemic control.
    Clin Infect Dis. 2020 Jul 1. pii: 5866094. doi: 10.1093.
    >> Share

  778. MANG S, Kaddu-Mulindwa D, Metz C, Becker A, et al
    Pneumocystis Jirovecii Pneumonia and SARS-CoV-2 Co-Infection in newly diagnosed HIV-1 infection.
    Clin Infect Dis. 2020 Jul 1. pii: 5865456. doi: 10.1093.
    >> Share

  779. VAHIA A, Chaudhry ZS, Kaljee L, Parraga-Acosta T, et al
    Rapid Reorganization of an Academic Infectious Diseases Program During the COVID-19 Pandemic in Detroit: A Novel Unit-Based Group Rounding Model.
    Clin Infect Dis. 2020 Jul 1. pii: 5865454. doi: 10.1093.
    >> Share

  780. LEHMANN CJ, Pho MT, Pitrak D, Ridgway JP, et al
    Community Acquired Co-infection in COVID-19: A Retrospective Observational Experience.
    Clin Infect Dis. 2020 Jul 1. pii: 5865452. doi: 10.1093.
    >> Share

  781. HALL MW, Joshi I, Leal L, Ooi EE, et al
    Immune modulation in COVID-19: Strategic considerations for personalized therapeutic intervention.
    Clin Infect Dis. 2020 Jul 1. pii: 5865455. doi: 10.1093.
    >> Share

    June 2020
  782. MAGLEBY R, Westblade LF, Trzebucki A, Simon MS, et al
    Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019.
    Clin Infect Dis. 2020 Jun 30. pii: 5865363. doi: 10.1093.
    >> Share

  783. TITANJI BK, Farley MM, Mehta A, Connor-Schuler R, et al
    Use of Baricitinib in Patients with Moderate and Severe COVID-19.
    Clin Infect Dis. 2020 Jun 29. pii: 5864596. doi: 10.1093.
    >> Share

  784. PINNINTI S, Trieu C, Pati SK, Latting M, et al
    Comparing Nasopharyngeal and Mid-Turbinate Nasal Swab Testing for the Identification of SARS-CoV-2.
    Clin Infect Dis. 2020 Jun 29. pii: 5864592. doi: 10.1093.
    >> Share

  785. MALTEZOU HC, Dedoukou X, Tseroni M, Tsonou E, et al
    SARS-CoV-2 infection in healthcare personnel with high-risk occupational exposure: evaluation of seven-day exclusion from work policy.
    Clin Infect Dis. 2020 Jun 29. pii: 5864498. doi: 10.1093.
    >> Share

  786. GARCIA-PRATS AJ, Salazar-Austin N, Conway JH, Radtke K, et al
    COVID-19 pharmacologic treatments for children: research priorities and approach to pediatric studies.
    Clin Infect Dis. 2020 Jun 29. pii: 5864500. doi: 10.1093.
    >> Share

  787. BIELECKI M, Zust R, Siegrist D, Meyerhofer D, et al
    Social distancing alters the clinical course of COVID-19 in young adults: A comparative cohort study.
    Clin Infect Dis. 2020 Jun 29. pii: 5864495. doi: 10.1093.
    >> Share

  788. SHRESTHA NK, Marco Canosa F, Nowacki AS, Procop GW, et al
    Distribution of Transmission Potential during Non-Severe COVID-19 Illness.
    Clin Infect Dis. 2020 Jun 29. pii: 5864499. doi: 10.1093.
    >> Share

  789. SIGEL K, Swartz T, Golden E, Paranjpe I, et al
    Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients in New York City.
    Clin Infect Dis. 2020 Jun 28. pii: 5864410. doi: 10.1093.
    >> Share

  790. LEEGWATER E, Strik A, Wilms EB, Bosma LBE, et al
    Drug-induced liver injury in a COVID-19 patient: potential interaction of remdesivir with P-glycoprotein inhibitors.
    Clin Infect Dis. 2020 Jun 28. pii: 5864408. doi: 10.1093.
    >> Share

  791. NAGLER AR, Goldberg ER, Aguero-Rosenfeld ME, Cangiarella J, et al
    Early Results from SARS-CoV-2 PCR testing of Healthcare Workers at an Academic Medical Center in New York City.
    Clin Infect Dis. 2020 Jun 28. pii: 5864404. doi: 10.1093.
    >> Share

  792. YANG P, Esper AM
    Investigating the sex differences in COVID-19: Another step forward, but many unanswered questions.
    Clin Infect Dis. 2020 Jun 28. pii: 5864403. doi: 10.1093.
    >> Share

  793. KEMPKER RR, Kempker JA, Peters M, Rebolledo PA, et al
    Loss of Smell and Taste Among Healthcare Personnel Screened for Coronavirus 2019.
    Clin Infect Dis. 2020 Jun 28. pii: 5879851. doi: 10.1093.
    >> Share

  794. FUNG M, Babik JM
    COVID-19 in Immunocompromised Hosts: What We Know So Far.
    Clin Infect Dis. 2020 Jun 27. pii: 5864040. doi: 10.1093.
    >> Share

  795. LI S, Hu Z, Song X
    High-dose but not low-dose corticosteroids potentially delay viral shedding of patients with COVID-19.
    Clin Infect Dis. 2020 Jun 26. pii: 5863128. doi: 10.1093.
    >> Share

  796. CRUZ AF, Ruiz-Antoran B, Munez Rubio E, Lopez AS, et al
    THE RIGHT TIME FOR STEROIDS IN COVID-19.
    Clin Infect Dis. 2020 Jun 25. pii: 5862696. doi: 10.1093.
    >> Share

  797. YUNG CF, Kam KQ, Nadua KD, Chong CY, et al
    Novel coronavirus 2019 transmission risk in educational settings.
    Clin Infect Dis. 2020 Jun 25. pii: 5862649. doi: 10.1093.
    >> Share

  798. JAMAL AJ, Mozafarihashjin M, Coomes E, Powis J, et al
    Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Clin Infect Dis. 2020 Jun 25. pii: 5862658. doi: 10.1093.
    >> Share

  799. VERMUND SH, Pitzer VE
    Asymptomatic transmission and the infection fatality risk for COVID-19: Implications for school reopening.
    Clin Infect Dis. 2020 Jun 25. pii: 5862668. doi: 10.1093.
    >> Share

  800. ERIKSTRUP C, Hother CE, Pedersen OBV, Molbak K, et al
    Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors.
    Clin Infect Dis. 2020 Jun 25. pii: 5862661. doi: 10.1093.
    >> Share

  801. JORDAN SC, Zakowski P, Tran HP, Smith EA, et al
    Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia.
    Clin Infect Dis. 2020 Jun 23. pii: 5861638. doi: 10.1093.
    >> Share

  802. MATAR R, Alrahmani L, Monzer N, Debiane LG, et al
    Clinical Presentation and Outcomes of Pregnant Women with COVID-19: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2020 Jun 23. pii: 5861636. doi: 10.1093.
    >> Share

  803. KIMBERLIN DW, Puopolo KM
    Breastmilk and COVID-19: What Do We Know?
    Clin Infect Dis. 2020 Jun 21. pii: 5860618. doi: 10.1093.
    >> Share

  804. CHEUK S, Wong Y, Tse H, Siu HK, et al
    Posterior oropharyngeal saliva for the detection of SARS-CoV-2.
    Clin Infect Dis. 2020 Jun 21. pii: 5860439. doi: 10.1093.
    >> Share

  805. DAWSON P, Rabold EM, Laws RL, Conners EE, et al
    Loss of Taste and Smell as Distinguishing Symptoms of COVID-19.
    Clin Infect Dis. 2020 Jun 21. pii: 5860440. doi: 10.1093.
    >> Share

  806. WIESE AD, Everson J, Grijalva CG
    Social distancing measures: evidence of interruption of seasonal influenza activity and early lessons of the SARS-CoV-2 pandemic.
    Clin Infect Dis. 2020 Jun 20. pii: 5860406. doi: 10.1093.
    >> Share

  807. RICKMAN HM, Rampling T, Shaw K, Martinez-Garcia G, et al
    Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital.
    Clin Infect Dis. 2020 Jun 20. pii: 5860253. doi: 10.1093.
    >> Share

  808. TAI DBG, Shah A, Doubeni CA, Sia IG, et al
    The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States.
    Clin Infect Dis. 2020 Jun 20. pii: 5860249. doi: 10.1093.
    >> Share

  809. NAIK GOA
    COVID-19 and the RAAS.
    Clin Infect Dis. 2020 Jun 20. pii: 5860242. doi: 10.1093.
    >> Share

  810. ANNWEILER C, Sacco G, Salles N, Aquino JP, et al
    National French survey of COVID-19 symptoms in people aged 70 and over.
    Clin Infect Dis. 2020 Jun 18. pii: 5859558. doi: 10.1093.
    >> Share

  811. WU S, Du Z, Shen S, Zhang B, et al
    Identification and validation of a novel clinical signature to predict the prognosis in confirmed COVID-19 patients.
    Clin Infect Dis. 2020 Jun 18. pii: 5859562. doi: 10.1093.
    >> Share

  812. XU XK, Liu XF, Wu Y, Ali ST, et al
    Reconstruction of Transmission Pairs for novel Coronavirus Disease 2019 (COVID-19) in mainland China: Estimation of Super-spreading Events, Serial Interval, and Hazard of Infection.
    Clin Infect Dis. 2020 Jun 18. pii: 5859582. doi: 10.1093.
    >> Share

  813. PACCOUD O, Tubach F, Baptiste A, Bleibtreu A, et al
    Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital.
    Clin Infect Dis. 2020 Jun 18. pii: 5859555. doi: 10.1093.
    >> Share

  814. ZHANG X, Li M, Chen T, Lv D, et al
    Persistent negative antibody test in COVID-19 patient: a case report.
    Clin Infect Dis. 2020 Jun 17. pii: 5859154. doi: 10.1093.
    >> Share

  815. PATEL MR, Carroll D, Ussery E, Whitham H, et al
    Performance of oropharyngeal swab testing compared to nasopharyngeal swab testing for diagnosis of COVID-19 -United States, January-February 2020.
    Clin Infect Dis. 2020 Jun 16. pii: 5858273. doi: 10.1093.
    >> Share

  816. PATEL MC, Chaisson LH, Borgetti S, Burdsall D, et al
    Asymptomatic SARS-CoV-2 infection and COVID-19 mortality during an outbreak investigation in a skilled nursing facility.
    Clin Infect Dis. 2020 Jun 16. pii: 5858271. doi: 10.1093.
    >> Share

  817. CHROBOCZEK T, Lacoste M, Wackenheim C, Challan-Belval T, et al
    Corticosteroids in patients with COVID-19: what about the control group?
    Clin Infect Dis. 2020 Jun 16. pii: 5858270. doi: 10.1093.
    >> Share

  818. MANI NS, Budak JZ, Lan KF, Bryson-Cahn C, et al
    Prevalence of COVID-19 Infection and Outcomes Among Symptomatic Healthcare Workers in Seattle, Washington.
    Clin Infect Dis. 2020 Jun 16. pii: 5858272. doi: 10.1093.
    >> Share

  819. SHEPHERD J, Friedland G
    Preventing COVID-19 collateral damage.
    Clin Infect Dis. 2020 Jun 16. pii: 5858267. doi: 10.1093.
    >> Share

  820. SORIANO V, Meirino R, Corral O, Guallar MP, et al
    SARS-CoV-2 antibodies in adults in Madrid, Spain.
    Clin Infect Dis. 2020 Jun 16. pii: 5858269. doi: 10.1093.
    >> Share

  821. ZHANG HJ, Su YY, Xu SL, Chen GQ, et al
    Asymptomatic and symptomatic SARS-CoV-2 infections in close contacts of COVID-19 patients: a seroepidemiological study.
    Clin Infect Dis. 2020 Jun 16. pii: 5858266. doi: 10.1093.
    >> Share

  822. BILDER CR, Iwen PC, Abdalhamid B
    Pool size selection when testing for SARS-CoV-2.
    Clin Infect Dis. 2020 Jun 16. pii: 5858265. doi: 10.1093.
    >> Share

  823. MALECKI K, Keating JA, Safdar N
    Crisis Communication and Public Perception of COVID-19 Risk in the Era of Social Media.
    Clin Infect Dis. 2020 Jun 16. pii: 5858208. doi: 10.1093.
    >> Share

  824. NIEUWLAAT R, Mbuagbaw L, Mertz D, Burrows L, et al
    COVID-19 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.
    Clin Infect Dis. 2020 Jun 16. pii: 5858203. doi: 10.1093.
    >> Share

  825. DUDOIGNON E, Camelena F, Deniau B, Habay A, et al
    Bacterial Pneumonia in COVID-19 critically ill patients: a case series.
    Clin Infect Dis. 2020 Jun 16. pii: 5858200. doi: 10.1093.
    >> Share

  826. HANSON KE, Caliendo AM, Arias CA, Englund JA, et al
    Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19.
    Clin Infect Dis. 2020 Jun 16. pii: 5858938. doi: 10.1093.
    >> Share

  827. WILKINSON RJ
    Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.
    Clin Infect Dis. 2020 Jun 13. pii: 5857156. doi: 10.1093.
    >> Share

  828. ALTHOFF KN, Coburn SB, Nash D
    Contact tracing: Essential to the public health response and our understanding of the epidemiology of COVID-19.
    Clin Infect Dis. 2020 Jun 11. pii: 5856142. doi: 10.1093.
    >> Share

  829. BECKERMAN KP
    Pregnancy and Pandemic Disease.
    Clin Infect Dis. 2020 Jun 10. pii: 5855544. doi: 10.1093.
    >> Share

  830. BODKIN C, Mokashi V, Beal K, Wiwcharuk J, et al
    Pandemic Planning in Homeless Shelters: A pilot study of a COVID-19 testing and support program to mitigate the risk of COVID-19 outbreaks in congregate settings.
    Clin Infect Dis. 2020 Jun 8. pii: 5854739. doi: 10.1093.
    >> Share

  831. POIGNANT S, Baudouin L, Vinclair M, Mons S, et al
    COVID-19 : Pacific Islands challenges.
    Clin Infect Dis. 2020 Jun 8. pii: 5854755. doi: 10.1093.
    >> Share

  832. FANG FC, Naccache SN, Greninger AL
    The Laboratory Diagnosis of COVID-19-- Frequently-Asked Questions.
    Clin Infect Dis. 2020 Jun 8. pii: 5854652. doi: 10.1093.
    >> Share

  833. LONG DR, Gombar S, Hogan CA, Greninger AL, et al
    Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients.
    Clin Infect Dis. 2020 Jun 7. pii: 5854366. doi: 10.1093.
    >> Share

  834. BINNICKER MJ
    Can the SARS-CoV-2 PCR Cycle Threshold Value and Time from Symptom Onset to Testing Predict Infectivity?
    Clin Infect Dis. 2020 Jun 6. pii: 5854297. doi: 10.1093.
    >> Share

  835. ZHOU L, Wu Z, Li Z, Zhang Y, et al
    100 Days of COVID-19 Prevention and Control in China.
    Clin Infect Dis. 2020 Jun 5. pii: 5851925. doi: 10.1093.
    >> Share

  836. ANUGWOM CM, Aby ES, Debes JD
    Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?
    Clin Infect Dis. 2020 Jun 5. pii: 5851928. doi: 10.1093.
    >> Share

  837. GRIFFITH DE, Cegielski JP
    Tuberculosis Healthcare Workers: There Goes My Hero.
    Clin Infect Dis. 2020 Jun 5. pii: 5853603. doi: 10.1093.
    >> Share

  838. CHAU NVV, Thanh Lam V, Thanh Dung N, Yen LM, et al
    The natural history and transmission potential of asymptomatic SARS-CoV-2 infection.
    Clin Infect Dis. 2020 Jun 4. pii: 5851471. doi: 10.1093.
    >> Share

  839. WANG X, Guo X, Xin Q, Pan Y, et al
    Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.
    Clin Infect Dis. 2020 Jun 4. pii: 5851474. doi: 10.1093.
    >> Share

  840. GU S, Chen Y, Wu Z, Chen Y, et al
    Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.
    Clin Infect Dis. 2020 Jun 4. pii: 5851452. doi: 10.1093.
    >> Share

  841. CANADAY DH, Gravenstein S
    On setting expectations for a SARS-CoV-2 Vaccine.
    Clin Infect Dis. 2020 Jun 4. pii: 5851447. doi: 10.1093.
    >> Share

  842. KAO CM, Orenstein WA, Anderson EJ
    The Importance of Advancing SARS-CoV-2 Vaccines in Children.
    Clin Infect Dis. 2020 Jun 3. pii: 5850904. doi: 10.1093.